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Abstract 
Stroke is one of the major causes of death and disability worldwide. The area 
that surrounds the infarcted core is the location of the continuing damage that 
takes place hours and days following an insult, and is referred to as the 
penumbra. By creating an oxygen deprived environment in the neuronal-like 
PC12 and NT2 cells and an in vivo photothrombotic model of stroke (PTS) in 
mice, two different strategies were created to replicate the conditions of an 
ischaemic brain.  
In differentiated PC12 and NT2 cells, following hypoxia, preferential 
activation of HIF-2α transcription and protein expression was detected. 
Increased expression of the neural progenitor stem cell-like markers, thought 
to be transcriptionally regulated by HIF-2α, were also observed. Furthermore, 
hypoxia caused loss of neuronal characteristics in differentiated cells. This is 
highly significant as it shows neuronal cells possess molecular mechanisms 
which could trigger recovery following ischaemic insult. 
The expression of the chloride co-transporters, NKCC1 and KCC2, mediators 
of the GABAergic response, was assessed following hypoxia in differentiated 
PC12 and NT2 cells and PTS. In PC12 and NT2 cells exposed to hypoxia, 
the expression of KCC2 was significantly decreased at both the transcript 
and protein level whereas NKCC1 expression remained unmodified. In the in 
vivo model, the development of the penumbra in the days following injury 
was assessed with specific markers allowing the identification of the 
penumbra up to 200 m from the ischaemic core and a progressive neuronal 
loss was observed within. Our results show an increase in the number of 
neurons expressing NKCC1 in the penumbra up to 5 days following the insult 
when compared to the contralateral hemisphere. On the contrary, KCC2 
positive cells were dramatically decreased in this area. In mice treated with 
bumetanide, an NKCC1 antagonist, a significant reduction in neuronal loss 
was observed. Our results show a reversal on the chloride co-transporters 
expression in vitro and in vivo and how treatments targeting these channels 
might represent a novel strategy to reduce the damage associated with 
stroke. 
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1. Introduction 
1.1 Stroke 
 
Stroke is the second leading cause of death, and the leading cause of 
disability, worldwide (World Health Organisation, 2014). The consequences 
have devastating effects, due to irreversible neuronal death, ranging from 
impaired speech and loss of vision, to movement deficits. For approximately 
one third of patients, a stroke will be fatal, for another third it will cause severe 
to very severe motor impairments, while the remainder will recover but have 
an increased risk of having another event (Go et al., 2014). In the United 
Kingdom, more than 100,000 individuals will suffer a stroke each year 
(SSNAP, 2016), which carries a huge personal and economic burden to 
society. The estimated annual cost of stroke in the UK, which includes health 
care services, treatment, and loss of productivity, is around £9 billion (Saka 
et al., 2009). Despite this, while approximately £241 is spent each year on 
medical research for each cancer sufferer, less than £48 is spent per stroke 
patient (Stroke Association, 2017). 
 
There are currently few pharmacological strategies employed to reduce the 
damage and social burden triggered by this pathology. The harm caused by 
the interruption of blood flow to the brain evolves over the following hours 
and days (Go et al., 2014), so it is critical to identify new therapeutic targets 
that could reduce the neuronal death associated with the spread of the 
damage.   
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1.1.1 Different types of stroke 
 
The most prevalent type of stroke in the UK is ischaemic, which accounts for 
85% of all cases (Intercollegiate Stroke Working Party, 2016). This results 
from either atherosclerosis in large arteries, a blood clot forming in the heart 
and travelling to the brain, or lacunar strokes, which affect small arteries that 
provide blood to deeper areas of the brain. In contrast, haemorrhagic strokes 
are a consequence of either a primary intracerebral haemorrhage or a 
subarachnoid haemorrhage caused by bleeding in the area between the 
arachnoid membrane and the pia matter, normally produced by trauma, and 
result in a mortality of 30% (Gonzalez-Perez et al., 2013). The majority of 
haemorrhagic strokes occur due to weakening of arteries and concurrent 
high blood pressure.  Since the two types of stroke have very different causes 
and prognoses, it is important to distinguish between them in order to provide 
the most appropriate treatment.   
 
Distinguishing between the different types of stroke can only be performed 
once the patient is admitted to hospital, by either magnetic resonance 
imaging (MRI) or computer tomography (CT). Due to the need for highly-
specialised equipment, and cost, a diagnosis is not usually made directly 
after admission. In the UK, almost nine out of ten stroke patients receive brain 
scan within 12 hours, taking an average of seven hours from the onset of 
symptoms to be admitted to a stroke unit (SSNAP, 2016). However, since 
neuronal cell death begins soon after the onset of ischaemia, rapid diagnosis 
and treatment are essential to limit long-term damage (Goyal et al., 2015). 
Furthermore, the type of treatment administered is dependent upon the 
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nature of the stroke. For example, prescribing anti-coagulants to help reduce 
their risk of developing further blood clots in the future in a haemorrhagic 
event, would have the opposite of the desired effect. 
 
1.1.2 Current treatments for ischaemic stroke 
 
Despite years of intensive research, the only current effective and approved 
treatments for ischaemic stroke rely on the pharmacological and/or 
mechanical revascularisation of the affected artery. Mechanical 
revascularisation can only be performed when a large artery is affected.  In 
such cases, when large thrombi are resistant to pharmacological dissolution, 
a mechanical thrombectomy can produce a favourable clinical outcome 
(Jeromel et al., 2013; Akbik et al., 2016). Tissue type-plasminogen activator 
(t-PA), commercially known as Alteplase, remains the only Federal Drug 
Administration-approved drug in use for this purpose. Its mode of action is to 
dissolve the clot causing the infarct; however, many patients do not benefit 
from this treatment because of various exclusion criteria, the most important 
being its short therapeutic window of 3 to 4.5 hours (Fugate and Rabinstein 
2015; Holmes et al., 2015). In addition, according to European guidelines 
(The European Agency for the Evaluation of Medicinal Products, 2002), 
alteplase cannot be used on patients more than 80 years of age, as this 
demographic have an increased risk of haemorrhage and mortality 
(Longstreth et al., 2010; Wardlaw et al., 2012). Major side effects of t-PA 
include an increased risk of haemorrhage in ischemic tissue, activation of 
matrix metalloproteinases that can disrupt the blood-brain barrier (BBB), and 
induction of excitotoxicity due to excessive glutamate release. t-PA induces 
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an increase in the influx of calcium via a plasmin-independent cleavage of 
the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor, potentiating 
receptor signalling (reviewed in Yepes et al., 2009 and discussed in more 
detail in section 1.7).  Thus, current research is aimed at developing a more 
fibrin-specific agent with a shorter half-life and less neurotoxic side effects 
than t-PA (Frendl and Csiba 2011). Interestingly, a recent study in an animal 
model of stroke has shown an increase in the therapeutic window of t-PA by 
combining it with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-
pyranoside (SalA-4g; Yu et al., 2016).  This effect is due to an increase in 
glucose uptake via elevated glucose transporter 3 expression (Yu et al., 2014), 
improving brain energy metabolism. 
 
1.1.3 Risk factors for ischaemic stroke 
 
Risk factors for stroke include hypertension, obesity, diabetes, smoking, and 
high cholesterol (Hankey 2006), many of which are on the increase.  
Interestingly, mortality from stroke has decreased over time due to better 
management of risk factors, education and the general improvements to 
health systems. Interestingly, there is a sex-specific difference in the 
occurrence of stroke, being more common in males than in females.  
However, women are more severely affected (a one-month case fatality of 
24.7% compared with 19.7% for men; Appelros et al., 2009). Together with 
the aging population, it seems reasonable to conclude that the occurrence of 
stroke will not significantly decrease in the near future, and that the number 
of patients suffering from stroke-associated disabilities will likely grow.  It is, 
therefore, essential to find and develop novel and effective approaches to 
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either prevent neuronal death that occurs in both ischaemic and 
haemorrhagic strokes and/or promote functional recovery.  After a stroke, 
neurons within the core of the infarct are unlikely to be salvageable (Muir et 
al., 2006). However, it may be possible to rescue those within the 
surrounding area, the penumbra, which would limit motor and other deficits 
(Figure 1.1). Salvaging the penumbra requires understanding of the early 
molecular events occurring after an ischaemic insult; including changes in 
gene expression, biochemical pathways and neuronal ion regulation.   
 
1.2 The ischaemic core versus the penumbra 
 
The ischaemic core, which is the brain area immediately impacted by a 
dramatic reduction in blood supply after a stroke, becomes rapidly and 
irreversibly damaged affecting neuronal, glial and vascular cells (Figure 1.1).  
The infarcted tissue suffers from oxygen and glucose deprivation, leading to 
neuronal death as a consequence of bioenergetic failure, reduced adenosine 
triphosphate (ATP) and impairment of ionic homeostasis across the cell 
membrane (Astrup et al., 1981). Lack of oxygen inhibits mitochondrial activity 
and inefficient anaerobic glucose metabolism generates lactate as an end 
product (Kalogeris et al., 2012). Calcium overload, accumulation of oxygen 
free radicals and the stimulation of intracellular lysosomal enzymes results in 
the loss of cell membrane function (Sims and Muyderman 2010). Neurons 
also begin to undergo apoptosis, but due to the lack of ATP they shift from 
an apoptotic route to a necrotic one, leading to unprogrammed cell death 
(Figure 1.1; Yuan 2009; Chelluboina et al., 2014). This appears to be 
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mediated by the caspase cleavage of calcium pumps, altering intracellular 
calcium homeostasis, which ultimately triggers necrosis (Schwab et al., 
2002). These cellular cascades are triggered within minutes of the onset of 
stroke, making protection of the ischemic core essentially impossible (Go et 
al., 2014). This region is therefore considered as non-salvageable tissue. In 
contrast, the penumbra that surrounds the ischaemic core is only partially 
metabolically compromised due to collateral blood supply and therefore may 
be salvaged. This area is of great therapeutic relevance because it is the 
location of the ensuing damage that takes place in the hours and days 
following an insult (Hartings et al., 2003).  
 
The penumbra has been classically defined as the area that surrounds the 
core, yet has sufficient collateral blood flow to be salvaged (Figure 1.1).  
Regions within the brain with a cerebral blood flow below 20 ml/100 g/min 
define this area; this is compared with a normal blood flow of ~50 
ml/100g/min.  When blood flow is less than 10 ml/100 g/min, the tissue loses 
ionic homeostasis and forms the infarct core (Hakim 1998).  Neuroimaging 
techniques have provided a method to anatomically distinguish between the 
core and penumbra (Wey et al., 2013).  The method of choice to discriminate 
between these two regions is positron emission tomography/single photon 
emission CT, which measures cerebral blood flow and glucose metabolism. 
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Figure 1.1. The ischaemic core and penumbra. Two physiologically and 
molecularly defined areas develop following a thrombus formation in the 
brain, the ischaemic core and the penumbra. The precise extent of the 
penumbra within the peri-infarct tissue is currently unclear; however, different 
physiological and molecular characteristics define each area (shown in 
boxes). 
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1.2.1 Development of the penumbra 
 
There are also a number of molecular events that help to understand the 
development of the penumbra, and its progression towards a damaged core-
like state.   
 
1.2.1.1 Protein stress 
 
Protein synthesis is a highly energy dependent process which is therefore 
compromised following an ischaemic event. A decrease in protein synthesis 
is observed, which is mediated by the unfolded protein response (UPR) in 
the endoplasmic reticulum, and translational arrest mainly through the 
phosphorylation of eukaryotic initiation factor 2 (Figure 1.1; eIF2; Hata et al., 
2000; DeGracia and Hu 2007). Activation of the UPR increases the ability of 
the endoplasmic reticulum to deal with the accumulation of misfolded 
proteins, which arises due to stress, and this is beneficial in the short-term. 
However, prolonged induction leads to apoptosis due to global translational 
arrest (Han et al., 2009). Expression of the UPR response genes appears to 
be decreased in aged animals (Llorente et al., 2013), which could be a factor 
contributing to the higher mortality observed in the aged population.  
 
Heat shock protein 70 (HSP70) is an inducible molecular chaperone, the 
expression of which is induced under different stress conditions.  This 
molecule binds to nascent polypeptides preventing their aggregation, 
supporting protein folding and trafficking across intracellular compartments.  
It is particularly relevant in ischaemia as it is considered to have 
neuroprotective potential (Rajdev et al., 2000), and it is not expressed in the 
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adult brain under normal physiological conditions.  HSP70 is strongly induced 
in neurons of the penumbra, at both the mRNA and protein level, but not in 
the core where little or no mRNA is found, apart from in blood vessels where 
significant HSP70 protein levels have been detected (Zhan et al., 2008; De 
La Rosa et al., 2013). Modified versions of HSP70 with increased BBB 
permeability (Doeppner et al., 2009; Doeppner et al., 2013) or recombinant 
HSP70 formulated in alginate granules with retarded release of protein 
(Shevtsov et al., 2014) have provided neuroprotection in different animal 
models of stroke, making this protein a very interesting target to promote 
neuroprotection following ischaemic stroke. 
 
1.2.1.2 Peri-infarct depolarisations 
 
The penumbra is thought to develop due to anoxic depolarisation-like events 
known as peri-infarct depolarisations (PIDs) that propagate from the 
ischaemic core (Nedergaard and Hansen 1993). PIDs are triggered by an 
increase in extracellular concentration of potassium, and the vast release of 
excitatory neurotransmitters. The resultant spontaneous and continuous 
neuronal depolarisations deplete the glucose pool in the penumbra 
(Feuerstein et al., 2010) and, consequently, depolarised neurons lack the 
energy to repolarize. This progressive process causes the observed 
spreading effect, resulting in increased infarct volume (Back et al., 1996; 
Hartings et al., 2003). However, they also provide the opportunity for 
neuroprotective intervention (Ramos-Cabrer et al., 2011). Constant 
depolarisations have also been shown to induce BBB disruption (Gursoy-
Ozdemir et al., 2004), providing a drug delivery route to limit the growth of 
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infarct tissue. The wave of depolarisation can also be beneficial, in the long 
term, by triggering axonal sprouting and, thus, the formation of new 
connections in the brain (Hinman et al., 2013). 
 
The energy demand of the brain is achieved by an increase in blood flow to 
satisfy the requirements for glucose and oxygen. However, during the spread 
of PIDs, a loss of vasoreactivity due to diminished vasodilation and, 
occasionally, even vasoconstriction is observed (Chang et al., 2010).  This 
leads to a glucose and oxygen supply that is insufficient for the high demands 
of the ischemic tissue necessary to restore the ionic balance and membrane 
repolarisation.  The observed vasoconstrictor response is due to an increase 
in the extracellular potassium concentration, as a result of reduced sodium-
potassium ATPase activity, and a decrease in nitric oxide production by the 
inhibition of nitric oxide synthase (Shin et al., 2006). This overrides the 
vasodilatory effect of low pH, caused by anaerobic metabolism (Dreier 2011).  
The inhibition of PIDs with either channel blockers or antagonists, and 
targeting the vasoconstrictor response, are obvious candidates for 
neuroprotective strategies in stroke. However, a large number of clinical trials 
with channel blockers, specifically NMDA receptor antagonists, have failed 
to translate bench findings into successful patient therapies (O’Collins et al., 
2006; Tymianski 2010; Grupke et al., 2015 and covered in detail in section 
1.7). 
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1.3 Glial scar 
 
Following stroke there is an increase in the number of glial cells (i.e. 
microglia, oligodendrocytes and astrocytes) in the area immediately 
bordering the infarct within the penumbra, which is called the glial scar. The 
glial scar consists predominately of reactive astrocytes and proteoglycans 
(Silver and Miller 2004). Reactive astroglyosis is a finely regulated process 
of alterations in gene expression and cellular changes in astrocytes that 
occur in response to various central nervous system (CNS) insults, such as 
stroke (Sofroniew 2009). In its extreme form, reactive astroglyosis can lead 
to astrocyte proliferation and glial scar formation (Carlén et al., 2009).  
 
The glial scar surrounds the ischaemic core, and confers both beneficial and 
detrimental effects. During the acute phase of ischaemia, the glial scar 
prevents spreading of the core through different mechanisms such as, uptake 
of excitotoxic glutamate (Swanson et al., 2004), protection from oxidative 
stress via glutathione production (Chen et al., 2001), limiting the responses 
to vasogenic oedema (Zador et al., 2009), protection from growth factors and 
free radicals release (Rolls et al., 2009), and promoting axonal regeneration 
(Anderson et al., 2016). Furthermore, genetic ablation or attenuation of 
reactive astroglyosis has been shown to increase infarct size and neuronal 
loss following ischaemia (Li et al., 2008). 
 
Conversely, glial scar formation has also been shown to interfere with the 
innate process of axonal sprouting, by producing growth-inhibitory molecules 
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such as chondroitin sulphate proteoglycans, and creating a physical barrier 
to regenerating axons (Carmichael et al., 2016). Thus, the beneficial or 
detrimental role of the glial scar may be dependent on timing, as it appears 
to be beneficial in the acute phase, but detrimental to the promotion of 
neuronal recovery. Old age is associated with increase in mortality, 
susceptibility and poor recovery after stroke (Go et al., 2014). Aged animals, 
that are also more likely to suffer from a stroke, present an increased 
astrocytic and microglial reactivity and premature glial scar formation (Popa-
Wagner et al., 2007). This rapid glial scar formation may impede the recovery 
of neuronal function compared to younger animals (Badan et al., 2003; 
Anuncibay-Soto et al., 2014). 
 
1.4 Reperfusion injury and inflammation 
 
The primary goal in the early treatment of ischaemic stroke is achieving the 
rapid revascularisation of the affected blood vessel(s) in order to restore the 
blood supply.  However, paradoxically, reperfusion can lead to further injury. 
The BBB is composed of endothelial cells together with pericytes, astrocytes, 
neurons, and extracellular-matrix (comprising the neurovascular unit). It 
maintains cerebral homeostasis by preventing hydrophilic and large 
molecules from entering the brain. After a stroke, the release of reactive 
oxygen species and massive ionic dysregulation leads to the breakdown of 
the BBB, and activation of inflammatory processes. Furthermore, blood 
vessels that have been weakened by an ischaemic episode can rupture upon 
re-establishment of blood flow and, thus, cause secondary haemorrhagic 
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strokes (Sandoval and Witt 2008), exacerbating the morbidity and mortality 
following an ischaemic event. 
 
Two types of inflammation take place in the brain after a stroke: cytotoxic and 
vasogenic. Cytotoxic oedema is caused by the ionic dysregulation that 
follows energy depletion, as the entrance of ions into cells (sodium entrance 
exceeds potassium loss) is accompanied by water and, thus, cell swelling 
(Young et al., 1987). Vasogenic oedema is due to the breakdown of the BBB, 
which allows the cellular entrance of large macromolecules, as well as 
intravascular to extravascular fluid movement, and produces an increase in 
brain volume (Schoknecht et al., 2015). The formation of cerebral oedema 
can result, if untreated, in elevated intracranial pressure, reduced cerebral 
blood flow, and ultimately contribute to stroke mortality (Khanna et al., 2014). 
 
Recombinant human erythropoietin is a promising candidate for the 
prevention of oedema formation in acute ischaemic stroke (Ehrenreich et al., 
2009). The expression of human erythropoietin is regulated by hypoxia 
inducible factor (HIF)-1/2α, and is proposed to reduce brain oedema and 
infarction through maintenance of matrix metalloproteinase-mediated BBB 
integrity (Wang et al., 2014; Zhao et al., 2015). 
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1.5 Neuronal adaptation to hypoxia: the HIF response 
 
Neurons suffer from a dramatic decrease in oxygen availability following an 
ischaemic insult, a condition known as hypoxia. Neurons have evolved 
adaptive mechanisms which enable them to survive this decrease in oxygen 
availability. Therefore, hypoxia triggers a large number of physiological and 
pathophysiological molecular responses. Hypoxia inducible factors (HIFs) 
are  the best-described regulators of oxygen homeostasis and critical for 
adaptation to hypoxic insults (Semenza 2012). In normoxic conditions, HIF-
α is hydroxylated by the prolyl-hydroxylase domain (PHD) family of 
dioxygenases. This hydroxylation promotes the binding of von Hippel-Lindau 
protein (pVHL) which forms the substrate for the recognition and 
ubiquitination of the complex, facilitating proteosomal degradation (Figure 
1.2; Schofield and Ratcliffe 2004). Following a hypoxic insult, HIF-α is 
stabilised, binds to HIF-β and translocates into the nucleus, where it binds to 
genes possessing a hypoxia responsive element (HRE) in their regulatory 
region, promoting their expression (Ke and Costa 2006). There are three HIF-
α subunits, HIF-1α, -2α and -3α; HIF-1α and 2α are structurally similar whilst 
HIF-3α is thought to be an alternative splice form, which may negatively 
regulate HIF-1α function (Maynard et al., 2005; Yamashita et al., 2008).  
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Figure 1.2 The HIF response in normoxia and hypoxia. Under normal 
physiological levels of oxygen HIF-1/2α are rapidly degraded through the 
ubiquitin protease pathway. Under hypoxia, HIF-1/2 can bind to the HIFβ 
subunit and translocate into the nucleus promoting the transcription of 
different hypoxia-responsive genes bearing the hypoxia responsive element 
(HRE) in their regulatory sequence. pVHL: von Hippel-Lindau protein; PHD:  
prolyl-hydroxylase domain dyoxygenases. 
 
Whilst HIF-1α and 2α share common transcriptional gene targets (Koh and 
Powis 2012), they also regulate distinct subsets of genes and elicit differerent 
cellular responses. HIF-1α regulates glycolytic genes such as pyruvate 
dehydrogenase kinase (Pdk) to activate anaerobic glycolysis in order to 
maintain ATP production under low O2 tension (Kim et al., 2006). It has also 
been shown to regulate the expression of carbonic anhydrase IX (Ca9) which 
has role in intracellular pH maintenance (Kaluz et al., 2009), and can activate 
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BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (Bnip3) to trigger 
apoptosis (Guo et al., 2001). HIF-1 is also involved in the activation of genes 
that participate in the UPR in order to decrease protein stress such as 
glucose-related proteins 94-76 (Grp94-76), C/EBP homologous protein 
(CHOP) or the protein disulphide isomerase (PDI) (Keith et al., 2012). HIF-1 
is predominantly induced  in the penumbra (Bergeron et al., 1999) and is 
therefore considered a good marker of this therapeutically relevant area 
(Figure 1.1; Shi 2009). Conversely, HIF-2α promotes other adaptations to 
reduce neuronal death following hypoxic stress such as angiogenesis, cell 
division and tissue regeneration by regulating expression of erythropoietin 
(EPO), Cyclin D1 and the stem cell marker, octamer-binding transcription 
factor 4 (Oct4), amongst other targets (Raval et al., 2005; Covello et al., 2006; 
Haase 2013).  
 
Despite the limited regenerative capacity of the nervous system, a degree of 
spontaneous recovery can occur following ischaemic stroke (Carmichael 
2016). Studies suggest HIF mediated angiogenesis and neurogenesis are 
central to this process (Ralph et al., 2004; Shi 2009; Barteczek et al., 2016). 
Neuron-specific knockout of HIF-1α dramatically increases ischaemic 
damage caused by transient middle cerebral artery occlusion (MCAO) and 
HIF-1α loss increases infarct volume and mortality (Baranova et al., 2007). 
Indirect induction of HIF signalling via genetic ablation of Phd2 also reduces 
infarct size and dramatically improves sensorimotor function following 
transient ischaemic insult (Reischl et al., 2014). Conversely, Helton et al. 
(2005) found that neuron-specific loss of HIF-1α in mice led to 
neuroprotection following acute ischaemia. Therefore, the exact function and 
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precise timing of the HIF response following ischaemic insults still needs to 
be ascertained, as both detrimental and beneficial effects of HIF have been 
observed in different experimental models of stroke (Shi 2009). 
 
HIF-α’s role in the pathophysiology of ischaemic insult is complicated as HIF-
1α and -2α signalling display temporal differences (Koh and Powis 2012); 
HIF-1α appears to be involved in the acute response whilst HIF-2α mediates 
the response to chronic hypoxic stress (Holmquist-Mengelbier et al., 2006). 
The timescale of HIF signalling is critical for effective recovery from 
ischaemic insult, as whilst genetic targeting of neuronal HIF-1α and HIF-2α 
was beneficial in acute stages, loss of HIF-1α and -2α correlated with 
increased apoptosis and reduced sensorimotor function at later stages 
(Barteczek et al., 2017). This may be due to HIF-2α regulating VEGF 
signalling and the importance of angiogenesis in post-stroke neurogenesis 
(Li et al., 2016). Together, these studies indicate the intricacies of HIF 
signalling, their neuroprotective role and importance in recovery from 
ischaemic damage. 
 
1.6 Ion dysregulation 
 
Although the weight of the human brain is only about 2% of total body weight, 
it has a high metabolic activity and uses 20% of the oxygen and 25% of the 
glucose consumed by the entire body (Zauner et al., 2002). This is required 
to generate sufficient ATP to maintain the high demand for energy needed 
for action and synaptic potentials (Magistretti and Allaman, 2015).  Following 
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global ischaemia, the available ATP is consumed within 2 minutes due to the 
inhibition of mitochondrial ATP synthesis (Caplan 2000). The membrane-
bound sodium-potassium ATPase consumes 70% of the brain-derived ATP, 
and this pump plays a key role in ion homeostasis by extruding sodium from 
the cell. This results in a relatively low intracellular sodium concentration, and 
a comparatively low external potassium concentration (Figure 1.3). Due to 
the ATP depletion that follows an ischaemic episode, the tightly regulated 
sodium-potassium ATPase-dependent homeostasis is lost.  However, there 
are additional ionic transporters, both ATP-dependent and independent 
ones, involved in the maintenance of ionic gradients.  Many of these 
transporters are dysregulated during ischaemic brain injury, contributing to 
cytotoxic cell swelling, neuronal depolarisation and ultimately cell death 
(Kahle et al., 2009; Sun and Kahle 2014). 
 
Glial cells are also very important players in the maintenance of the tightly-
controlled ion regulation in the brain as they interact with neurons and 
regulate their function (Fields et al., 2015). Ischaemic injury affects neuronal 
and glial ionic homeostasis and this significantly alters glial responses in the 
brain. This is due to their contribution to the regulation of extracellular ion 
concentrations necessary for neuronal excitability (Pannasch et al., 2011); 
Therefore, the modification of intra-glial ionic homeostasis in response to 
ischaemic injury, has a crucial role in inducing and maintaining glial 
responses in the ischemic brain (Annunziato et al., 2013). 
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1.7 Excitotoxicity and NMDA receptors 
 
NMDA receptors are found throughout the brain, playing an important role in 
synaptic development and learning and memory (Monyer et al., 1994; Sanz-
Clemente et al., 2013).  During an ischaemic event, energetic failure and the 
loss of ionic gradients leads to an increase in presynaptic glutamate release, 
and failure of glutamate re-uptake mechanisms (Rossi et al., 2000). This 
causes an increase in extracellular glutamate levels. Astrocytes are the 
principal mediators of glutamate recycling from the extracellular space 
(Uwechue et al., 2012). The expression of the transcription factors, tumour 
necrosis factor α (TNFα) and nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κβ) are increased during hypoxia and these 
downregulate the activity of excitatory amino acid transporters 1 and 2, 
EAAT1 and EAAT2, in astrocytes (Boycott et al., 2008). This contributes to 
the over-activation of DL-γ-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid (AMPA) and NMDA receptors, and an increased intracellular calcium 
concentration that triggers caspase activation, free radical formation and, 
eventually, cell death (Figure 1.3; Szydlowska and Tymianski 2010). This 
phenomenon is known as excitotoxicity (Olney and Sharpe 1969) and it is 
elicited by the onset of stroke being a major driver of neuronal death in the 
penumbra. Most studied neuroprotectants for the treatment of stroke have 
targeted the AMPA and the NMDA receptor, which are glutamate-activated 
ion channels (Besancon et al., 2008; Krzyżanowska et al., 2014). However, 
despite promising results of NMDA receptor antagonists in vitro and in in vivo 
animal models, all compounds have failed in clinical trials (Xu and Pan 2013). 
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Figure 1.3. Ionic balance in normoxic vs. ischaemic brain, and the 
development of excitotoxicity.   
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Figure 1.3. A. Under normal physiological conditions, the energy produced 
in the form of ATP by the tricarboxylic acid cycle is utilised by the Na+/K+ 
ATPase pump to maintain ionic homeostasis between the extracellular (E) 
and intracellular (I) spaces. Under normoxic conditions, KCC2 is highly 
expressed when compared to NKCC1, thereby maintaining a chloride 
gradient across the neuronal membrane with a high extracellular 
concentration and a low intracellular concentration. Upon GABA release from 
a presynaptic neuron, GABAA receptors are activated leading to chloride 
influx and subsequent hyperpolarisation of the post-synaptic neuron. B. An 
ischaemic brain suffers from a rapid energy and oxygen depletion that leads 
to an intense ion dysregulation. The Na+/K+ ATPase is unable to maintain 
sodium and potassium homeostasis and NKCC1 is up-regulated, modifying 
the chloride gradient. When GABAA receptors are activated, chloride effluxes 
from the neuron resulting in depolarisation.  In addition, glutamate release is 
greatly increased in the minutes immediately following stroke onset, 
contributing to the wave of depolarisation and an intracellular calcium 
overload mediated by NMDA and AMPA receptors. This increased calcium 
concentration generates reactive oxygen species (ROS) and causes 
caspase activation, that ultimately leads to cell death. 
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1.7.1 The failure of glutamate receptor modulators for ischaemic stroke 
 
Partial success was originally achieved in rat and mouse animal models of 
ischaemic stroke with two non-competitive NMDA receptor antagonists, MK-
801 (Margaill et al., 1996) and Dextrorphan (Steinberg et al., 1995), both of 
which exhibit a neuroprotective effect within therapeutic windows of 30 
minutes and 2 hours, respectively. These data indicate that the therapeutic 
window is too short, after the ischaemic injury, for these compounds to be of 
benefit. Other NMDA receptor antagonists have subsequently been tested, 
such as Memantine, Cerestat (CNS 1102) and Selfotel (CGS19755). 
Although all of these drugs were effective in animal models in both 
histological and behavioural studies (reviewed in Lau and Tymianski 2010), 
all of the corresponding human clinical trials were abandoned due to a lack 
of therapeutic effect, increased rates of mortality and/or unacceptable side 
effects such as hallucinations and psychotropic episodes (Morris et al., 1999; 
Davis et al., 2000; Albers et al., 2001). 
 
1.7.2 Novel glutamate receptor modulators for ischaemic stroke 
 
While activity of NMDA receptors is required for balanced cognitive, 
behavioral and physiological functioning, complete blockade of the receptor 
would intuitively lead to broad and unpredictable effects.  A more 
downstream-specific approach has been developed in animals in which the 
compound NA-1 blocks the interaction between NMDA receptors and the 
scaffold protein postsynaptic density-95 (PSD-95) to inhibit nitric oxide (NO) 
signalling (Instrum and Sun 2013). NA-1 disrupts the link between NMDA 
receptors and the neurotoxic NO cell death signalling pathway, without 
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disturbing normal NMDA receptor function.  Treatment with NA-1 has 
produced both neuroprotection, and preservation of neurological function in 
a primate model of stroke (Cook et al., 2012), and in a promising phase 2 
clinical trial in humans (Hill et al., 2012). NA-1 is currently undergoing a phase 
3 clinical trial (FRONTIER trial, 2014). 
 
A dual role for NMDA receptors in the development of stroke has been 
suggested in recent studies.  Whereas the more abundant, extrasynaptic 
NMDA receptors promote cell death, synaptic NMDA receptors might be 
neuroprotective through the calcium-dependent activation of survival genes, 
suppression of death genes, and protection against oxidative stress 
(Hardingham and Bading 2010; Baxter et al., 2015; Brassai et al., 2015). 
Activation of extrasynaptic NMDA receptors has opposing actions: i.) shutting 
down the cyclic AMP response element binding protein (CREB) pathway and 
inactivation of the protein kinases ERK (extracellular signal-regulated kinase) 
1/2; and ii.) activation of the forkhead box O (FOXO) and calpain cell death 
pathways (Wahl et al., 2009). Thus, more effort could be expended to 
elucidate the differentially-located NMDA receptors, and their down-stream 
signalling pathways, as a prelude to seeking neuroprotective strategies for 
ischaemic stroke. 
 
AMPA receptors are also candidates for neurorehabilitation in stroke. Like 
NMDA receptor agonists, early administration of positive allosteric 
modulators of AMPA receptors are detrimental to stroke recovery, because 
they contribute to excitotoxicity (Mehta et al., 2013). Ampakines potentiate 
the excitatory signalling of AMPA receptors, whereas a new generation of 
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drugs known as type II ampakines, increase the intracellular concentration of 
brain derived neurotrophic factor (BDNF), which is essential, together with 
NMDA receptors, for long-term potentiation (LTP) and rehabilitation post-
stroke (Ploughman et al., 2009).  LTP is a form of plasticity that involves a 
long-lasting strengthening of synaptic transmission, and which is triggered by 
brief periods of high-frequency stimulation (Bliss and Lomo 1973). An elegant 
study by Clarkson et al. (2011) showed improved motor recovery in a focal 
stroke model in young mice, where type II ampakines were administered five 
days after ischaemia, through potentiation of the AMPA-BDNF signalling 
system.  However, early administration of the drug, given at the time of 
induction of cerebral ischaemia, increased stroke damage.  By combining the 
ampakine CX1837, with BDNF, the level of which is reduced in aged 
populations, a significantly improved recovery two weeks after insult was 
observed in aged mice (Clarkson et al., 2015).  From the above, it may be 
concluded that blockade of NMDA/AMPA receptor channels could be either 
beneficial or harmful to neurons depending on their spatial location and the 
time of administration of a pharmacological agent.   
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1.8 Cation chloride co-transporters (CCCs) 
 
1.8.1 GABAAR activity is dependent on Cl- gradient 
 
γ-Aminobutyric acid (GABA) type A receptors (GABAAR) are ligand-gated ion 
channels that are the principal mediators of synaptic inhibition in the mature 
human brain. The chloride ion gradient across the neuronal membrane is 
crucial for the nature of GABAergic signalling. The direction of chloride 
movement is dependent upon the chloride gradient; chloride entry through 
GABAAR leads to hyperpolarisation while chloride extrusion results in cellular 
depolarisation (Figure 1.3; Rivera et al., 1999; Delpire 2000; Kaila et al., 
2014).  Cation-chloride co-transporters (CCCs) mediate coupled transport of 
sodium, potassium and chloride ions across neuronal membranes, thereby 
regulating the chloride electrochemical gradient (Kaila et al., 2014).  
 
1.8.2 The CCC family 
 
The CCC proteins are classified in terms of their physiological function into 
three categories: two members are Na+-K+-2Cl- co-transporters (NKCC1 and 
NKCC2), one is a Na+-Cl- co-transporter (NCC), and four are K+-Cl- co-
transporters (KCC1 to KCC4).  All CCCs are expressed in the mammalian 
nervous system at different developmental stages with the exception of NCC 
and NKCC2, which are found predominantly in the kidney where they play a 
key role in the salt transport pathway (Haas 1994; Liu et al., 2011).  However, 
a novel study has shown that the expression of NKCC2 in brain plays a role 
in osmoregulation following hydration insult (Konopacka et al., 2015).  The 
remaining two members of the CCC family, CCC interacting protein (CIP1) 
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and CCC9, have no known physiological role. However, CIP1 is thought to 
possibly be involved in the activation of KCC2 (Wenz et al., 2009).  Homo- 
and hetero-oligomers have been described for almost all CCCs. Associations 
of KCC1 and KCC3, KCC2 and KCC4, and NKCC1 and KCC4, have been 
found however, to date there is no conclusive data detailing how the different 
oligomerisation patterns affect protein function (Simard et al., 2007; 
Hartmann and Nothwang 2014). 
 
The genes SLC12A1-9 encode nine members of the CCC family, all of which 
are glycoproteins, having molecular weights of between 120 and 200 kDa.  
The predicted secondary structure of CCCs (only confirmed for NKCC1, by 
Gerelsaikhan and Turner 2000) comprises 12 transmembrane (TM) 
segments with a relatively small amino-terminus and a large carboxy-
terminus, both of which are intracellular (Figure 1.4). All KCC isoforms exhibit 
a long extracellular loop between the fifth and sixth TM domains, whereas 
the two NKCC isoforms present a large extracellular sequence between the 
seventh and eighth TM segments; these regions contain extracellular sites 
for N-linked glycosylation (Hebert et al., 2004). 
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Figure 1.4. Schematic diagram of the secondary structure of the cation 
chloride co-transporter (CCC) family. (A) Chloride importers (NKCC1-2 
and NCC) and (B) extruders (KCC1-4) of the SLC12A family of proteins all 
share a similar topology. Each CCC comprises 12 transmembrane (TM) 
domains, intracellular amino (-NH2) and carboxyl (COOH) terminals and a 
larger extracellular loop containing sites for N-glycosylation. This larger 
extracellular loop appears between TM 7 and 8 in NKCC1-2 peptides and 
NCC with two N-linked glycosylated extracellular (E) domains. However, in 
KCC1-4 the larger extracellular loop is located between TM domains 5 and 6 
with four N-linked glycosylation sites. 
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1.8.3 Reversal of the Cl- gradient in neuropathologies 
 
In early neuronal development (Rivera et al., 1999), and in certain 
pathological states, such as, cerebral oedema, traumatic and ischemic brain 
injury, temporal lobe epilepsy, schizophrenia, Andermann syndrome, Bartter 
syndrome and cancer, the normal gene expression patterns of CCCs appear 
altered (Uyanik et al., 2006; Benarroch 2013; Kaila et al., 2014; Kahle et al., 
2015).  In many cases, the changes in the expression of the CCCs lead to a 
reversal of the chloride gradient in neurons, resulting in subsequent 
GABAAR-mediated excitation (Figure 1.3; Huberfeld et al., 2007).   
 
1.8.4 NKCC1 
 
1.8.4.1 NKCC1 in early development 
 
Under physiological conditions, the activity of NKCC1 modulates the 
intracellular chloride concentration in neurons, glia, BBB endothelial cells, 
and choroid plexus epithelial cells (Gerelsaikhan and Turner 2000).  Thereby 
maintaining cellular volume against changes in extracellular osmolality and 
intracellular solute content to prevent either excessive cell swelling or 
shrinkage (Kahle et al., 2009).  In rodents, during embryonic and early 
postnatal life, NKCC1 shows robust expression, promoting an influx of 
chloride ions into the neuron that ultimately triggers GABA-mediated 
excitation and, hence, depolarisation (Figure 1.3 ; Pfeffer et al., 2009).  This 
chloride influx is achieved through an electroneutral Na+-K+-2Cl- co-transport 
mechanism, coupled with the activity of the sodium-potassium ATPase, that 
leads to a GABAA receptor-mediated chloride efflux.  The depolarising 
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GABA-mediated effect is necessary for normal mammalian brain 
development (Ben-Ari 2002; Wang and Kriegstein 2008). 
 
 1.8.4.2 NKCC1 splice variants 
 
There are two different splice variants of NKCC1 termed NKCC1a and 
NKCC1b.  Both are functional and ubiquitously expressed, but a considerably 
higher expression of the NKCC1b mRNA is detected in the adult brain (Vibat 
et al., 2001).  Furthermore, NKCC1b appears to undergo a more robust up-
regulation during development compared to NKCC1a (Morita et al., 2014).  
The difference between these two NKCC1 isoforms is a 16 amino-acid 
insertion encoded by exon 21 in the carboxy-terminus of NKCC1a, which 
contains a protein kinase A phosphorylation site (Blaesse et al., 2009).  Four 
novel splice variants of NKCC1, and changes in their expression, have 
recently been identified in brain, associated with schizophrenia and early 
brain development (Morita et al., 2014). 
 
1.8.4.3 NKCC1 regulation in stroke 
 
In a rat model of focal cerebral ischemia/reperfusion injury, created via 2-
hour middle cerebral artery occlusion (MCAO) and 24-hour reperfusion, 
NKCC1 transcript and protein expression were found to be significantly up-
regulated in cortical neurons, as well as in lysates from rat cerebral cortex 
and striatum (Yan et al., 2003; Wang et al., 2014). Elevated extracellular 
concentration of potassium, glutamate and interleukin-6, which occur in 
cerebral ischaemia, are known to stimulate NKCC1 activity in both neurons 
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and astrocytes (Chen and Sun 2005). The stimulation of NKCC1 via 
extracellular potassium seems to be calcium-dependent, as the activity of 
NKCC1 in astrocytes is completely abolished by either blocking L-type 
voltage-dependent calcium channels with nifedipine or by the removal of 
extracellular calcium (Su et al., 2002). 
 
Activation of NKCC1 is dependent on its phosphorylation state. Increased 
NKCC1 phosphorylation, on threonine184 and threonine189 (located in the 
intracellular amino-terminal domain; Figure 1.4) by either STE20 
(sterile20)/SPS-1 related proline-alanine-rich kinase (SPAK) or oxidative 
stress response kinase (OSR1), which are both serine-threonine kinases, 
has been demonstrated to induce the activation of NKCC1 in mouse brain 
(Piechotta et al., 2002). Oestradiol increases SPAK and OSR1 expression in 
a transcription-dependent manner, which subsequently leads to increased 
phosphorylation of NKCC1 in vivo (Nugent et al., 2012). Oestradiol is, thus, 
believed to up-regulate the activity of NKCC1 and promote GABAAR-
mediated depolarisation (Mccarthy 2009).  In a rat focal ischaemia model, 
oestradiol treatment has been shown to promote neurogenesis in the 
subventricular zone of the brain, improving neurological outcome (Zheng et 
al., 2013). This suggests that oestradiol has the potential to promote 
neurorehabilitation following stroke and that this effect might be due to the 
up-regulation of NKCC1 activity via oestradiol, promoting GABAAR-mediated 
depolarisation. 
 
Co-expression of WNK3 (with-no-lysine kinase 3) and NKCC1, in neurons, 
results in robust phosphorylation of threonine212 and threonine217, two 
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other known regulatory sites in NKCC1, and a consequent increase in 
NKCC1 activity (Kahle et al., 2005; Begum et al., 2015). The amino-terminus 
of NKCC1 contains a highly conserved RVNFVD sequence, which is the 
target of protein phosphatase 1, which recognises the consensus motif: 
RVXFXD; when this sequence is mutated, NKCC1 activity is increased 
(Gagnon and Delpire 2010). Also, calyculin A, a protein phosphatase 1 
inhibitor, restores the activity of NKCC1 (Dowd and Forbush 2003). 
 
1.8.4.4 Pharmacological modulation of NKCC1 in stroke 
 
Several studies have implicated NKCC1 in the development of oedema and 
cell death after the onset of stroke, suggesting that blocking NKCC1 might 
be a potential neuroprotective target (Kahle et al., 2009; Szydlowska and 
Tymianski 2010; Begum et al., 2015). The NKCC1 antagonist bumetanide, 
significantly attenuated neuronal sodium overload and decreased cell death 
in a pharmacological study, with a concurrent decrease in infarct volume and 
brain oedema (Chen et al., 2005). Bumetanide administration, after focal 
cerebral ischaemia in rats given 1 week after ischemia, and continued for 
3 weeks, increased behavioral recovery and promoted neurogenesis 28 days 
post-insult (Xu et al., 2016). Low concentrations(2-10 μM)  of bumetanide 
can be used to inhibit NKCCs in vitro without significantly affecting KCCs 
function; however, higher concentrations have been shown to antagonise 
both NKCC1 and KCC2 function (Payne et al., 2003; Hamidi and Avoli 2015). 
Similar effects were seen in mice deficient for the NKCC1 gene compared to 
wild-type controls (Chen et al., 2005). NKCC1 is expressed at the luminal 
side of endothelial cells of the BBB, where it can come into contact with 
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intravenously-administered bumetanide, which decreases brain oedema 
(O’Donnell et al., 2004). 
 
Bumetanide has poor pharmacokinetic properties that limit its access to BBB-
protected brain areas (Cleary et al., 2013). Therefore, bumetanide pro-drugs 
that mask the hydrophilic carboxyl group with esters are currently being 
tested as anti-stroke therapies and in other neurological  disorders, such as 
epilepsy (Töllner et al., 2014; Erker et al., 2016).  This masking facilitates 
transport into the brain, where the active molecule is released (Löscher et al., 
2013). Bumetanide due to its role in diuresis, has been widely prescribed for 
chronic conditions, such as hypertension, broncho-pulmonary dysplasia, 
nephritic syndromes and heart congestion with few side effects. In the 
treatment of neurological conditions such as autism, the only side-effect 
observed in 30% of children in a randomised trial, was hypokalaemia, which 
could be easily overcome with a potassium-containing syrup (Lemonnier et 
al., 2012).  This study showed a significant reduction in the severity of autism 
and Asperger syndrome in children. However, severe problems such as 
diuresis, hypokalemic alkalosis, and hearing loss have been related to the 
use of bumetanide in vivo (Puskarjov et al., 2014; Pressler et al., 2015); these 
effects should be critically taken into account when evaluating clinical work 
that utilises bumetanide for the treatment of neurological conditions in 
children.  
 
In low oxygen conditions, such as in brain ischaemia after stroke, a series of 
molecular cascades are activated. The most important is driven by HIF-1α, 
which triggers the transcription of a number of genes involved in cell 
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proliferation and survival, glucose and iron metabolism, and angiogenesis 
(Ke and Costa 2006, see section 1.5). A recent study has highlighted the 
involvement of NKCC1 in mediating neurogenesis after traumatic brain injury 
through the activation of CREB and the HIF-1α pathway and proposed the 
HIF-1α-mediated up-regulation of NKCC1 (Lu et al., 2015). All of the above 
information indicates that either specifically blocking the activity of NKCC1 or 
down-regulating its expression may offer a useful neuroprotective strategy in 
ischaemic stroke. However, in the long term following an ischaemic event, 
increasing NKCC1 expression/activity might be beneficial to promote 
neurorehabilitation. 
 
1.8.5 KCC2 
 
KCC2 opposes the activity of NKCC1 by extruding chloride (Figure 1.3). 
There are two splice variants of KCC2, KCC2a and KCC2b, both functional; 
the KCC2b isoform is up-regulated after birth in rodents and is considered to 
be the isoform responsible for the developmental shift in the GABAergic 
response (Rivera et al., 1999). This developmental shift in humans takes 
place at the beginning of the last trimester of gestation (Sedmak et al., 2015).  
KCC2b differs in its 5’-untranslated region and 5'-coding region compared to 
KCC2a.  Thus, the resulting protein isoform has a distinct amino-terminus 
and is 23 residues shorter than KCC2a (Uvarov et al., 2007). The two 
isoforms are generated by the use of alternate promoters, and alternate first 
exons that provide the complexity needed for the observed temporal-specific 
gene expression patterns (Uvarov et al., 2007). 
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1.8.5.1 KCC2 function and regulation 
 
KCC2 exhibits a unique feature in that it is expressed only in central nervous 
system neurons, where, alongside NKCC1, plays a crucial role in the 
regulation of neuronal excitability and development of the postnatal brain 
(Figure 1.3 ;Payne et al., 1996; Rivera et al., 1999). Furthermore, 
independent of its ion transport role, it has been linked to glutamatergic 
dendritic spine formation (Li et al., 2007; Fiumelli et al., 2013; Llano et al., 
2015). KCC2 is responsible for maintaining a low [Cl-]i in neurons by 
extruding chloride ions and, thus, producing a hyperpolarising effect when 
GABA and glycine bind to their cognate receptors, resulting in inhibition of 
synaptic transmission (Figure 1.3; Rivera et al., 1999; Blaesse et al., 2009). 
The restricted expression pattern of KCC2 is guaranteed by the presence in 
its gene sequence of a neuronal transcription factor Egr4 binding site, which 
enhances KCC2 expression, and neuron restrictive silencing elements 
(Uvarov et al., 2005; Uvarov et al., 2006). The neuropeptide oxytocin has 
recently been shown to participate in the developmental up-regulation of 
KCC2, that ultimately induces the switch in GABA-mediated function, by 
promoting KCC2 phosphorylation and insertion of the co-transporter into the 
neuronal membrane (Leonzino et al., 2016). However, projections from 
oxytocinergic nuclei have only a relatively small number of targets (Boccia et 
al., 2013), yet developmental up-regulation of KCC2 is seen in the vast 
majority of central nervous system neurons (Sedmak et al., 2015), implying 
other regulatory mechanisms. 
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Studies with mice deficient for KCC2 reveal the importance of this co-
transporter in neuronal function, because its absence leads to death after 
birth due to respiratory failure (Hübner et al., 2001). Specific deletion of the 
KCC2b isoform (KCC2b-/-) in mice produced low body weight and generalised 
seizures were observed (Woo et al., 2002). Finally, in an interesting 
investigation by Tornberg et al., (2005), a reduction in the expression of both 
isoforms to 17% of their normal values, led to increased anxiety, difficulty in 
spatial learning, and impaired sensitivity to thermal and mechanical stimuli. 
RNA interference, using short-hairpin RNAs, has also been used to knock 
down KCC2 expression in the rat (Pellegrino et al., 2011). Suppression of 
KCC2 function reduced neuronal resistance to toxic insults such as 
lipofectamine-mediated oxidative stress and NMDA receptor activation. On 
the contrary, over-expression of KCC2, in the mouse, increased neuronal 
resistance to these insults (Pellegrino et al., 2011). Although the other 
members of the KCC family are not predominant in the brain, following NMDA 
treatment, over-expression of KCC3 also increased neuronal survival, 
indicating the importance of potential compensatory mechanisms exerted by 
other KCC members (Pellegrino et al., 2011). KCC3 has also been shown to 
participate in cell volume homeostasis (Adragna et al., 2015), and its deletion 
leads to locomotor deficits (Ding and Delpire 2014).  KCC4-deficient mice are 
deaf due to a rapid degeneration of hair cells within the ear (Boettger et al., 
2002). These data suggest the importance of KCCs as potential 
neuroprotective targets; this is underscored by the neurological phenotypes 
of transgenic, particularly for KCC2, KCC3 and KCC4 (Gagnon and Delpire 
2013). 
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BDNF and its receptor tropomyosin-related kinase B/tyrosine receptor kinase 
B (TrkB) are thought to be involved in the regulation of the mRNA that 
encodes KCC2b (Ludwig et al., 2011). For the down-regulation of KCC2, two 
different intracellular TrkB signalling cascades are required: src homology 2 
domain-containing transforming protein (Shc) and phospholipase Cγ 
(Puskarjov et al., 2012). Interestingly, when only the Shc pathway is 
activated, up-regulation of KCC2 occurs. However, mice deficient for BDNF 
showed that this molecule is not necessary for the developmental up-
regulation of KCC2 expression, but is essential for the triggering of neonatal 
seizures (Puskarjov et al., 2015). Calcium and BDNF are responsible for the 
activation of calpain, which mediates the cleavage of a fragment from KCC2 
that is essential for its’ function (Puskarjov et al., 2012). Its regulation is 
important for the changes in neuronal plasticity, mediated by KCC2, in 
different pathological states and during development. 
 
1.8.5.2 KCC2 role in different neuropathologies 
 
Changes in the expression of KCC2 have been observed in different 
neuropathologies, such as schizophrenia (Hyde et al., 2011), epilepsy 
(Huberfeld et al., 2007), and traumatic and ischaemic brain injury (Kahle et 
al., 2008).  In post-mortem samples from schizophrenic patients, down-
regulation of KCC2 mRNA was observed by Hyde et al. (2011); in contrast, 
others have not found any difference, but did observe up-regulation of the 
transcripts for the kinases, WNK3 and OXSR1 (Arion and Lewis 2011). For 
temporal lobe epilepsy, the data derive from biopsies and relate to mRNA 
levels of KCC2 as detected by in situ hybridisation (Huberfeld et al., 2007).  
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In animal models of traumatic and ischaemic brain injury, KCC2 mRNA and 
protein have been reported to be down-regulated (Bonislawski et al., 2007; 
Jaenisch et al., 2010; Wu et al., 2016). 
 
Stimulation of the AMPA/BDNF signalling pathway promotes motor recovery 
after stroke (Clarkson et al., 2011). It is conceivable that this recovery is aided 
by down-regulation of KCC2 expression via BDNF. The effect of this might 
be to produce a switch in GABAAR-mediated signalling, and promote 
neuronal depolarisation. This possibility is supported by another investigation 
(Clarkson et al., 2010) that found that reducing extrasynaptic GABAergic 
tonic inhibition promoted post-stroke functional recovery (Figure 1.4). Type II 
ampakines bind to AMPA receptors producing slow deactivation and 
desensitisation, increasing the expression of BDNF and inducing its release 
(Simmons et al., 2009). Prolonged AMPA receptor activation via glutamate, 
and the action of BDNF, both promote neuronal remodelling and LTP 
(Clarkson et al., 2011).  BDNF binds to the TrkB receptor and, via the CREB 
pathway, down-regulates KCC2 gene expression (Figure 1.5). This modifies 
the chloride balance across the membrane, decreasing extracellular levels of 
chloride and causing a decrease in GABA-mediated inhibition that further 
contributes to LTP and neuronal remodelling.  Finally, L655,708 specifically 
targets α5-subunit-containing GABAA receptors and might, therefore, 
decrease the elevated tonic inhibition in extra-synaptic circuits of cortical 
neurons in the peri-infarct zone (Clarkson et al., 2010). 
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Figure 1.5. Post-stroke neurorehabilitation model in the penumbra.  Two 
potential molecular pathways could promote long term potentiation (LTP), 
and neuronal remodeling, in the peri-infarct zone (penumbra) through 
treatment with type II ampakines and the 5-specific GABAAR inverse 
agonist, L655,708. BDNF: brain-derived neurotrophic factor; TrkB: 
tropomyosin-related kinase B/tyrosine receptor kinase B; Shc: src homology 
2 domain-containing transforming protein; PLCγ: phospholipase Cγ; 
GABAAR: γ-Aminobutyric acid type A receptor. 
 
1.8.5.3 KCC2 in stroke 
 
Following six hours of the 4-vessel occlusion model of ischaemic stroke in 
mice, KCC2 protein was shown to be increased in the dendritic regions of 
pyramidal cells in the cornu Ammonis 1 (CA1) region of the hippocampus, 
showing no morphological signs of damage (Lin et al., 2015). In the same 
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tissue, 48 hours after stroke induction, the CA1 pyramidal cells begin to 
degenerate, and a progressive down-regulation of both KCC2 and HSP72 
(heat shock protein 72) expression is observed. An increase or decrease of 
HSP72 expression has been found to exacerbate or attenuate hypothalamic 
neuronal death respectively (Lin et al., 2015), and is considered a biomarker 
of the penumbra (Agulla et al., 2014). Interestingly, parvalbumin-containing 
interneurons, which possess strong KCC2 gene expression, and 
glutamatergic input, readily survive even in regions of complete pyramidal 
cell loss (Papp et al., 2008). The high expression of KCC2, together with 
extremely low expression of NMDA receptors (Nyíri et al., 2003), and the high 
number of extrasynaptic GABAA receptors, may explain the extraordinary 
resistance of parvalbumin-containing interneurons to ischemia in CA1 
pyramidal cells (Papp et al., 2008). Furthermore, there is an up-regulation of 
KCC2 in the hippocampus of patients with temporal lobe epilepsy (Karlócai 
et al., 2016). These data suggest that up-regulation of KCC2 might 
participate in the protection against cell death, at least in the hippocampus. 
 
A study by Jaenisch and colleagues (2010), showed a decrease in KCC2 
expression following transient focal cerebral ischemia in rats. The 
investigation showed that the long-term survival of neurons in the ischaemic 
core required a maintained expression of KCC2; these cells were identified 
as GABAergic parvalbumin-expressing interneurons. The identification of 
either KCC2 specific activators or allosteric modulators, that reduce [Cl-]i, 
could have a critical impact on neurorehabilitation strategies. Optimisation of 
the first-in-class arylmethylidine family of compounds resulted in the 
identification of a KCC2-selective analogue (CLP257) that lowers [Cl-]i. 
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Furthermore, CLP257 restored impaired chloride transport in neurons with 
diminished KCC2 activity, and alleviated hypersensitivity in a rat model of 
neuropathic pain (Gagnon and Delpire 2013). CLP257 has recently been 
used in an in vitro model of ictogenesis, together with the non-specific KCC2 
inhibitor VU0240551, to demonstrate the role of KCC2 in modulating the 
epileptic response (Hamidi and Avoli 2015).  However, VU024055 has 
serious off target effects, which limit its usefulness for studies on KCC2 
(Delpire et al., 2012).  A specific KCC2 antagonist, VU0463271, has been 
developed (Delpire et al., 2012), and used to induce epileptiform discharges 
(Sivakumaran et al., 2015).  It has also been used to demonstrate the critical 
role of KCC2 in regulating seizure event duration (Kelley et al., 2016). 
 
1.9 Spatial and temporal vulnerability to ischaemia 
 
Ischaemia affects the brain in a differential manner. The most susceptible 
areas are the neocortex, the dorsolateral striatum, and the CA1 region of the 
hippocampus (Baron et al., 2013). The hippocampus has long been known 
to present a selective vulnerability to ischaemia, and there the CA1 layer 
seems to be the most sensitive region, while the dentate gyrus appears to be 
the most resistant (Schmidt-Kastner 2015). However, in contrast to cortical 
cell death, which is rapid in onset, neuronal loss in CA1 is delayed (occurring 
three to five days after insult). This delayed neuronal death, and its molecular 
basis, are not yet fully understood.  Interestingly, this vulnerability appears to 
be age-dependent, because older animals suffer a greater neuronal loss after 
ischaemia than younger animals (Llorente et al., 2013; Lalonde and Mielke 
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2014). Finally, it is important to acknowledge that the use of KCC2 as a 
therapeutic target in stroke could be challenging due to the differential 
expression timing between the chronic and recovery phase, as increasing 
KCC2 expression could protect against injury, but decreasing KCC2 levels 
could promote recovery in the days following injury. 
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1.10 Summary and general aims  
 
The penumbra is recruited in the hours to days following stroke into the 
ischaemic core. Therefore, reducing the penumbral tissue at risk of infarction 
increases recovery of stroke patients. However, to understand how the 
penumbra can be salvaged, we need to understand how it evolves after 
stroke. Recent studies have highlighted the potential of cation chloride co-
transporters as targets for the development of neuroprotective strategies in 
stroke both in the short term, to reduce the excitotoxic effect observed in the 
development of the penumbra, and in the long term, to promote functional 
recovery. KCC2 is thought to be down-regulated following an ischaemic 
insult, whereas NKCC1 is suggested to be up-regulated. The reversal of the 
chloride gradient decreases GABAAR-mediated inhibition contributing to the 
excitotoxic effect described above. Increasing KCC2 and decreasing NKCC1 
expression/activity seems to be an obvious neuroprotective strategy.  
However, KCC2 inhibition also seems to provide a novel strategy to promote 
axonal growth and neuronal remodeling in the long term. Therefore, 
understanding the timing of these changes, in detail, using well characterised 
models, could play a pivotal role in future therapeutic strategies.   
 
In order to study the impact of CCC expression on neuronal loss following 
ischaemic stroke, two different models were developed:  
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1. An in vitro model of hypoxia with the neuron-like PC12 and NT2 cells. This 
model was created to mimic the effect of a stroke in neurons in order to study 
the mechanisms that lead to neuronal adaptation after hypoxic insult.  
 
2. An in vivo model of photothrombotic stroke (PTS). This model was created 
to characterise the evolution of tissue damage in the mouse PTS model of 
ischaemic stroke and for the first time quantify the spread of the glial scar 
and the penumbra in the days following PTS in order to physically and 
molecularly establish the parameters of the peri-infarct zone. 
 
Aim 1: To investigate molecular mechanisms of neuronal adaptation to acute 
hypoxic stress in neuronal-like cells in vitro. 
 
Aim 2: To characterise the penumbra following photothrombotic stroke in 
mice by establishing appropriate markers to study the extent and evolution 
of the penumbra. 
 
Aim 3: To investigate the impact of ischaemic stroke on the expression 
profile of the CCCs and assess their role as potential neuroprotective targets. 
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2. Materials and Methods 
 
Reagents and chemicals: All reagents and chemicals were obtained from 
Sigma Aldrich (Gillingham, UK) or Thermo Fischer Scientific (Paisley, UK) 
unless otherwise specified. 
 
2.1 Cell lines 
 
Cells were obtained from the American Type Culture Collection (ATCC). The 
PC12 cell line is derived from a transplantable rat pheochromocytoma of the 
adrenal medulla (Greene et al., 1976). The NTERA-2 cl.D1 (NT2) cell line is 
derived from a pluripotent human testicular embryonal carcinoma. MCF-7 
cells were a generous gift from Dr Jenny Fraser at passage number 5. MCF-
7 is a human breast adenocarcinoma cell line that was used as a positive 
control for hypoxia experiments as previous studies have shown they display 
a strong response to hypoxic insult (Bando et al., 2003). 
 
2.2 Cell culture media and conditions 
 
Dulbecco’s modified Eagle’s media (DMEM) was supplemented with 10% 
(v/v) heat-inactivated foetal bovine serum (FBS), penicillin (10 units/mL) and 
streptomycin (10 µg/mL) (P/S) (complete culture media). Cells were grown 
at 37 °C in 5% (v/v) CO2 atmosphere under high humid conditions. Medium 
was changed twice per week and cultures were passaged at a ratio of 1:6 
once per week or when they reached confluence. Cells were maintained 
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under these conditions unless otherwise specified. PC12 cells were cultured 
in complete culture media plus 5% (v/v) horse serum. All experiments were 
performed with cells at passage number 2 to 20. 
 
2.2.1 Passaging cells 
 
When cells reached approximately 90% confluency, they were washed with 
phosphate buffered saline (PBS) and incubated for 5 minutes with 3 mL 
trypsin/ethylenediaminetetraacetic acid (EDTA) 0.05% (v/v,) at 37ºC. 
Following detachment, the enzymatic activity of trypsin was neutralised by 
adding 6 mL of complete culture media. Cell pellets were collected by 
centrifugation at 170g for 3 minutes at room temperature (Hettich 
Zentrifuggen, Tuttlingen, Germany; Universal 230R). The cell pellet was 
resuspended in 10 mL of complete cell culture media. A ratio of 1:10 cells 
were then reseeded into a new T75 flask (Corning, Wiesbaden, Germany). 
 
2.2.2 Cryopreservation of cells 
 
In order to freeze cells, confluent flasks were harvested by trypsinisation and 
collected by centrifugation as previously described (section 2.2.1). The cell 
pellet was resuspended in freezing media (10% (v/v) dimethyl-sulfoxide 
(DMSO) in 90% (v/v) FBS) and 3x106 cells were aliquoted in 1.5 mL cryovials 
(Simport, Beloeil, Canada, PK/100). Vials were transferred to -80ºC wrapped 
in standard blue tissue roll in order to decrease the freezing rate. Vials were 
then transferred into liquid nitrogen for long-term storage. 
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2.2.3 Cell counting 
 
A Neubauer improved bright line haemocytometer (Marienfeld, Lauda-
Königshofen, Germany) was used to determine cell number and 
concentration. Following trypsinisation, cell pellets were resuspended in 
complete media and 100 µL of the cell suspension was transferred into a 1.5 
mL microfuge tube, diluted 1:1 (v/v) with Trypan blue and 10 µL was pipetted 
onto the haemocytometer. Trypan blue is a dye exclusion method as it stains 
non-viable cells by traversing their damaged membrane while living cells, 
with an intact membrane, are not stained (Strober 2001). Four 4x4 grids on 
the haemocytometer were counted and a viable:non-viable ratio recorded 
and averaged. This was multiplied by the dilution factor and by 104 (volume 
of a grid is 1 mm2 surface area x 0.1 mm depth = 10-4 cm3 or 10-4 mL), giving 
the total viable cells/mL. 
 
2.2.4 Poly-L-lysine coating 
 
Cell vessels for the PC12 cell line were coated with poly-L-lysine. A 0.1 
mg/mL solution was prepared in dH2O and surfaces were coated with 1 mL 
of the solution per 25 cm2. Flasks or plates were incubated for 5 minutes at 
37ºC before the solution was removed and surfaces thoroughly rinsed with 
dH2O and allowed to dry for at least 2 hours at room temperature.  
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2.3 Differentiation of cell lines 
 
2.3.1 PC12 cells 
 
PC12 cells differentiate into a neuronal like phenotype following treatment 
with nerve growth factor (NGF) with a reversible loss of mitotic activity 
(Greene et al., 1976).  
 
Cells were seeded in 6-well plates at a density of 2x106 cells/well in a final 
volume of 2 mL and cultured under standard conditions for 24 hours prior to 
treatment. The media was removed and differentiation media (200 nM NGF, 
1% (v/v) horse serum and 1% (v/v) penicillin-streptomycin on DMEM) was 
added to the cultures. Differentiation media was changed every 2-3 days over 
7-8 days. Cell morphology was analysed at different time points during 
differentiation via bright field microscopy and images were captured using an 
inverted microscope and camera (Zeiss, Primovert and Axiocam) at 20X 
magnification. 
 
2.3.2 NT2 cells 
 
Human NT2 cells can be induced to differentiate into neuron-like cells 
following retinoic acid (RA) treatment (Andrews, 1984). NT2 cells were 
differentiated into a neuronal population following the method described by 
Pleasure et al. (1992). Cells were seeded at a density of 1 x106 into a T75 
flask. Complete culture media supplemented with all-trans-retinoic acid 
(ATRA, 10-5 M) was added to the culture after 24 hours. Cells were grown for 
4 weeks and ATRA-enriched media was changed twice per week. After 4 
48 
 
weeks of ATRA treatment, cells were passaged at a ratio 1:6 into new culture 
flasks. This was done by incubating in trypsin for 30 seconds to dislodge the 
cells. Cells were then washed, centrifuged and replated into a new flask. 
When the cells were replated, the culture media was supplemented with the 
mitotic inhibitor cytosine arabinoside (1 µM) and 10 μM fluorodeoxyuridine 
and cells were incubated for 2 weeks with media changes every 3-4 days.  
 
 2.4 Harvesting cells 
 
In order to harvest cells, flasks were incubated on ice and washed twice with 
cold PBS. Cells were then detached with a cell scraper into 10 mL of PBS 
and cell pellets collected by centrifugation at 170g for 3 minutes at 4°C. Cell 
pellets were stored at -80 °C or immediately used.  
 
2.5 Induction of hypoxia in vitro 
 
A modular hypoxia chamber (Billups-Rothenberg, Inc. Del Mar, CA, USA) 
provides an excellent platform to simulate hypoxic conditions. Following 
differentiation (section 2.3), culture media was replaced with fresh 
differentiation media and flasks were placed into the modular chamber. The 
lid was attached and a gas mixture of 1% O2 and 99% N2 at (BOC, 230 bar, 
121852-V, Cambuslang, Glasgow, UK) was used to flush the chamber at a 
flow rate of 20 L/minute for 10 minutes. The chamber containing the cells 
was placed into the incubator at 37°C. After 1 hour, the chamber was 
removed and purged with 1% O2 and 99% N2 for a further 10 minutes in order 
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to remove any oxygen released by the media. Finally, the chamber was 
returned to the incubator for the desired experimental exposure. 
 
2.6 Cell viability assays 
 
2.6.1 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) 
 
Mitochondrial metabolic activity was assessed through the MTT colorimetric 
assay (Mosmann 1983). This method is based on the reduction of tetrazolium 
into the purple product formazan by active dehydrogenases present in 
mitochondria. The increase in formazan product is therefore proportional to 
the amount of metabolically active cells. Briefly, cells were seeded at a 
concentration of 105 cells/well in 100 μL of complete culture media in a 96-
well plate 24 hours prior to the experiment. MTT was prepared as a 5 mg/mL 
stock solution in PBS. Media was removed and fresh complete culture media 
was added to each well with 10 μL/well of the stock MTT (0.5 mg/mL). 
Negative controls contained media only without any cells.  As a positive 
control, 10 μL of 0.5% (v/v) triton X-100 solution was added to kill the cells. 
Triton X-100 is a strong detergent that can be used to lyse cells and obtain a 
controlled value of 100% cell death.  The 96-well plate was then incubated 
for 4 hours at 37°C. The converted MTT product was solubilised by adding 
100 μL of 0.01M HCl in isopropanol into the media. Absorbance was 
measured at 570 nm and 680 nm using a plate reader (Elisa Reader LT-
5000MS, LabTech International Ltd., Uckfield, UK) and data analysed using 
Labtech Manta Lite software (LabTech International). Absorbance was 
normalised by subtracting the 680 nm reference readings and the blank 
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readings to the 570 nm values of the samples. Normoxic cells were 
considered to represent 100% in viability and results were expressed as a 
percentage in viability compared to normoxic conditions.  
 
2.6.2 Alamar blue® 
 
Alamar blue® can also be used to determine cell viability. It is based on the 
same principle as the MTT as it relies on the conversion of resazurin to the 
fluorescent molecule, resorufin by mitochondrial dehydrogenases (Fields 
and Lancaster 1993). It presents the advantage of being non-toxic to cells 
and thus, it can be readily added during the experimental exposure. Cells 
were seeded at 105 cells/well in a 96-well plate in 100 μL of complete culture 
media and incubated under standard conditions. After 24 hours media was 
removed and 100 µL of fresh complete culture media was added to each 
well. Alamar blue® was added at a final concentration of 10% (v/v) to each 
well. Negative controls were included containing media only without any 
cells.  As a positive control, 10 μL of 0.5% (v/v) triton X-100 solution was 
added to lyse the cells. AlamarBlue® can be detected by absorbance. 
Absorbance was monitored at 550 nm, using 600 nm as a reference 
wavelength to normalise using a plate reader (Elisa Reader LT-5000MS, 
LabTech International), and data analysed using Labtech Manta Lite 
software (LabTech International). 
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 2.7 Isolation of RNA  
 
2.7.1 Diethylpyrocarbonate (DEPC) treatment of distilled water 
 
DEPC is a nonspecific inhibitor of RNases. It is typically used to treat water 
and solutions before working with easily degraded RNA. In order to prepare 
a 0.1% (v/v) DEPC solution in distilled water the desired volume, solution 
was incubated overnight at room temperature and subsequently autoclaved 
(2150 mBar, 121°C) in order to inactivate any trace of DEPC. DEPC-treated 
water was used for all subsequent RNA/DNA analyses. 
 
2.7.2 Isolation of total RNA 
 
Cells were harvested as previously described (section 2.4) and cell pellets 
homogenised by resuspending in Tri® reagent (Ambion®, Paisley, UK) at a 
ratio of 1 mL per 1 x106 cells. To ensure complete dissociation of 
nucleoprotein complexes, samples were incubated 5 minutes at room 
temperature. Following this, 100 µL of 1 bromo-3-chloropropane per mL of 
Tri® used was added to the sample. Samples were vortexed and incubated 
at room temperature for 5 minutes prior to centrifugation at 12,000g 
(Centrifuge 5415R, Eppendorf®, Stevenage, UK) for 15 minutes at 4°C. The 
aqueous phase, containing RNA, was transferred to a fresh tube and 500 µL 
of 2-propanol per mL of Tri® was added and samples incubated 5 minutes at 
RT. After centrifugation at 12,000g for 10 minutes at 4°C, the supernatant 
was removed and the pellet was washed by adding 1 mL of 75% (v/v) ethanol 
per mL of Tri® reagent. A final centrifugation at 7,500g for 5 minutes at 4°C 
was performed before the RNA pellet was air dried for 10 minutes and 
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resuspended in an appropriate volume of 0.001% (v/v) DEPC 
(diethylpyrocarbonate) treated H2O (DNase- and RNase-free H2O).  
 
2.7.3 Determining the integrity and purity of extracted RNA 
 
The purity and integrity of extracted RNA was assessed by fluorescence 
using the Agilent 2100 Bioanalyzer (Agilent Technologies Ltd., Stockport, 
UK). This gives the concentration of the RNA, absorbance ratios at 
A260/280, indicates any protein contamination, and provides an RNA 
integrity number (RIN). All samples were prepared according to the 
manufacturer’s protocol with the Agilent RNA600 Nano Kit (Agilent 
Technologies Ltd, 5067-1511). Briefly, each sample was analysed on an 
RNA chip which contains an interconnected set of microchannels that is used 
for separation of nucleic acid fragments based on their size as they are driven 
through it electrophoretically. Values were calculated by the 2100 Expert 
Software (Agilent Technologies Ltd). All samples used in further experiments 
had an A260/280 ratio above 1.8 and a RIN above 7.5 to ensure the quality 
of the extracted RNA. 
 
2.8 DNase treatment of RNA samples prior to real-time 
quantitative polymerase-chain-reaction (qPCR) 
 
To eliminate genomic DNA from the extracted RNA sample, DNase digestion 
was performed containing 1 µg of RNA in DEPC-H2O, 1 μL of RQ1 RNase-
free DNase 10 X reaction buffer, 1 U/µg of RNA RQ1 RNase-free DNase 
(Promega, Huntingdon, UK) and DEPC-treated water in a final volume of 10 
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μL. Samples were incubated at 37°C for 30 minutes and 1 µL of RQ1 DNase 
Stop Solution was added to terminate the reaction. Samples were incubated 
at 65 °C for 10 minutes in order to inactivate the DNase.  
 
2.9 Reverse transcription (RT) of RNA to generate 
complementary cDNA  
 
RNA samples were reverse transcribed in order to synthesise cDNA for 
subsequent use in quantification of gene expression via qPCR. The 
nanoScript 2 Reverse Transcription (RT) premix kit (Primer Design, 
Southampton, UK) was used in all experiments. This kit contains an 
optimised blend of random nonamer and oligo dTs. Following the 
manufacturer’s protocol, 20 μL of RT premix was dispensed into thin-wall 
tubes together with 1 μg of RNA in a final volume of 25 μL per reaction. 
Reactions were incubated at 42°C for 20 minutes and then at 72°C for 10 
minutes in order to heat inactivate the enzyme. Negative controls included 
reactions containing cDNA from a reaction without reverse transcriptase. 
Reactions were performed using a thermal cycler (2720 Thermal Cycler, 
Applied Biosystems ®, UK) and cDNA was either used immediately in qPCR 
or stored at -20°C. 
 
2.10 Quantification of gene expression 
 
2.10.1 Oligonucleotides design and preparation 
 
54 
 
All oligonucleotides were designed according to the general criteria for qPCR 
(Thornton and Basu, 2011): 40-60 G+C % (guanine and cytosine), Tm 
(melting temperature) between 58-64°C, 18 to 24 nucleotides in length, and 
produce a 80-250 base pair (bp) product (Table 2.1). Oligonucleotide pairs 
were designed to include exon boundaries either in the oligonucleotide itself 
or the sequence amplified and thus, avoid genomic amplification. 
Oligonucleotides were designed using rat and human sequences from the 
National Centre for Biotechnology Information (NCBI) gene database 
(www.ncbi.nlm.nih.gov/). To verify that the amplicon was present in the 
different isoforms of each transcript, some of the oligonucleotides were 
aligned with human sequences of the different human isoforms if they have 
not yet been described in rat. When genes were highly conserved between 
species, it was assumed that rat present the same isoforms as human. All 
alignments were performed with an online DNA alignment tool from JustBio 
software and mRNA sequences were obtained from NCBI. Oligonucleotides 
were synthesised by Eurofins MWG Operon (Ebersberg, Germany). 
 
Each lyophilised oligonucleotide was pulse-centrifuged to collect the material 
at the bottom of the tube and resuspended in H2O to a stock concentration 
of 100 µM and stored at -20C. All oligonucleotide were diluted to 6 µM in 
DEPC water prior to qPCR analyses. 
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Table 2.1. PCR oligonucleotides designed for specific amplification of 
specific gene transcripts. Forward (F) and reverse (R) oligonucleotides 
used for mRNA expression.  
Target gene Sequence 5’-3’ 
Species 
specificity 
CA9 
F: AGGGTGTCATCTGGACTGTG 
R: TGTGTGGCTCGGAAGTTCAG 
Human/Rat 
Caspr1 
F: TGACTCTGAACTTGGAGGGTCGTG 
R: TATAGCGCATCCATGTGCCAGTCT 
Human/Rat 
CD44 
F: GGATCAGGCATTGATGATGATGA 
R: TTGGGTTCCACTGGGTCC 
Human/Rat 
CHOP 
F: AGCTGGAAGCCTGGTATGAGG 
R: GTGCTTGTGACCTCTGCTGG 
Human/Rat 
Grp78 
F: TATGGTGCTGCTGTCCAGG 
R: CTGAGACTTCTTGGTAGGCAC 
Human/Rat 
HIF-1α 
F: GTACCCTAACTAGCCGAGGAAGAA 
R: GTGAATGTGGCCTGTGCAGT 
F: GCATCTCCACCTTCTACCC 
R: CTCTTTCCTGCTCTGTCTG 
Human1 
 
Rat2 
HIF-2α 
F: ACCTGGAAGGTCTTGCACTGC 
R: TCACACATGATGATGAGGCAGG 
Human/Rat 
HIF-3α 
F: AGGATTGCAGAAGTGGCTGG 
R: ATACTGCCCTGTTACTGCCTG 
Human/Rat 
NEFH 
F: AGGAGTGGTTCCGAGTGAG 
R: GGAGATAACTGAGTACCGGC 
Human/Rat 
Nrn1 
F: GCATCTGGTGAATAATCGCTCACG 
R: ACTGAAGGAGGCGACGACAATAGC 
Human/Rat 
PDI 
F: TGCCCAAGAGTGTGTCTGAC 
R: CTGGTTGTCGGTGTGGTC 
Human/Rat 
Ptbp2 
F: TTTGTCCGGTTCGGCAATGG 
R: GGACTACTGAGAACACTGCCTG 
Human/Rat 
SLC2A1 
F: GCTGTGCTTATGGGCTTCTC 
R: CACATACATGGGCACAAAGC 
F: CCTTGCCTGAGACCAGTTGAA 
R: ACAGCAGGGCAGGAGTGTC 
Human 
 
Rat3 
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Table 2.1 continued. 
Target gene Sequence 5’-3’ 
Species 
specificity 
SLC2A3 
F: CAATGCTCCTGAGAAGATCATAAAGG 
R: GAATTGCGCCTGCCAAAG 
F: CGCCTGATTATTGGCATCTT 
R: TCCAAACCAAAGACCTGAGC 
Human 
 
Rat4 
SLC12A2 
F: TTTAGTGAGAACTTTGGACCG 
R: AAGAGCGTTCCTTTGGGTATG 
Human/Rat 
Tmod1 
F: GCTCTTGCTGAAATGCTGAA 
R: AAGGCTGGCTCTGGTTGTC 
Human/Rat 
Vimentin 
F: AGATTCAGGAACAGCATGTCC 
R: AGCCTCAGAGAGGTCAGC 
Human/Rat 
 
References: 1Dales et al., 2010, 2Zhao et al., 2014, 3Campen et al., 2016, 4Weisova 
et al., 2009 
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2.10.2 qPCR 
 
qPCR was carried out in 20 L reactions containing 300 nM oligonucleotides, 
1X PrimerDesign Precision qPCR Mastermix containing SYBR green, and 
25 ng of cDNA in RNAse/DNAse free DEPC-H2O. Negative controls included 
reactions containing cDNA from a reaction without reverse transcriptase 
(negative control) and cDNA replaced with nuclease-free water (template 
negative). Reactions were performed in triplicate in 96-well bright white 
plates (Primer Design) sealed with adhesive optical seals (Applied 
Biosystems). The reaction was performed in a thermal cycler, StepOneTM 
Real Time PCR system (Applied Biosystems). Instrument settings were as 
follows: 10 minutes at 95°C for enzyme activation plus 40 cycles of 15 sec at 
95°C for denaturation and 1 minute at 60°C for the data collection. An 
additional step was performed in order to produce a melt curve of the 
amplicon by reading fluorescence as the temperature increased by 0.3 °C 
from 60 to 95 °C. This allowed the identification of single and specific 
amplified products. Data was analysed using StepOneTM Software V2.2 
(Applied Biosystems, USA) 
 
2.10.3 Relative quantification of mRNA levels 
 
The mean cycle threshold (Ct) determined for the reference gene was used 
to normalise relative mRNA expression levels of the genes of interest 
following the 2–[delta][delta]Ct method (Livak and Schmittgen, 2001), where: 
 
[delta][delta]Ct = [delta]Ct,sample - [delta]Ct,reference 
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This value represents the fold change in gene expression of a particular gene 
of interest in the experimental conditions that the cells were exposed to. 
Three repetitions per primer set and mRNA sample utilised and at least three 
independent experiments (n=3) were carried out. Ct values above 35 were 
excluded for data analysis, as they imply low efficiency (Bustin et al., 2011). 
Primer specificity was assessed by melting curves, and primer sets that 
produced more than one product were excluded and redesigned as 
previously explained.  
 
2.10.4 Identification of reference genes 
 
GeNorm (Primer Design) experiments were carried out in order to select 
stable reference genes; a gene where expression remain stable across 
different samples over time and that shows a robust and similar expression 
between sample tests. This information was necessary in order to normalise 
the results obtained in the qPCRs.  
 
In total, 12 genes from each species (human and rat) were tested against 
cDNA from the 3 cell lines. All oligomers and reagents were provided by 
GeNorm primer kit (Primer Design, ge-SY-12) (Table 2.2).  
 
The qPCR mix and amplification conditions for each reaction was prepared 
as previously stated in section 2.10.2. Analysis of reference gene stability 
was performed with qbase+ software (Biogazelle, Zwijnaarde, Belgium).  
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Table 2.2. Candidate reference genes tested in this study.  Reference 
genes from GeNorm (Primer Design) kits specific to either rat (Rattus 
norvegicus) or human (Homo sapiens) were used. 
Gene symbol Gene target Species 
18S 18S Ribosomal RNA, mRNA. Human/Rat 
ACTB actin, beta, mRNA. Human/Rat 
ATP5B ATP synthase, mRNA. Human/Rat 
B2M beta-2 microglobulin, mRNA. Human/Rat 
CANX calnexin, mRNA. Rat 
CYC1 cytochrome c-1, mRNA. Human/Rat 
EIF4A2 
eukaryotic translation initiation factor 
4A2, mRNA. 
Human 
GAPDH 
glyceraldehyde-3-phosphate 
dehydrogenase, mRNA. 
Human/Rat 
MDH1 malate dehydrogenase 1, mRNA. Rat 
RPL13 ribosomal protein L13, mRNA. Human/Rat 
SDHA succinate dehydrogenase, mRNA. Human 
TOP1 topoisomerase I, mRNA. Human/Rat 
UBC ubiquitin C, mRNA. Human/Rat 
YWHAZ tyrosine 3-monooxygenase, mRNA. Human/Rat 
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2.11 Immune detection of proteins  
 
2.11.1 Protein Extraction 
 
A lysis buffer containing 50 mM Tris, pH 8, 150 nM NaCl, 5 mM EDTA, 1% 
NP40 and 1% protease inhibitor cocktail (4-(2-Aminoethyl) benzenesulfonyl 
fluoride hydrochloride 1 mM, aprotinin 800 nM, bestatin 50 µM, E64 15 µM, 
leupeptin 20 µM, pepstatin A 10 µM, Thermo Scientific) was prepared and 
chilled on ice before use. Cell pellets were harvested according to section 
2.4 and resuspended in approximately 3X the volume of the pellet (60-100 
µL) and incubated on ice for 30 minutes. The samples were centrifuged at 
16000g for 5 minutes at 4°C. The supernatant containing the soluble proteins 
was transferred to sterile 1.5 mL microcentrifuge tubes and immediately 
quantified or stored at -80° C until further use. 
 
2.11.2 Bicinchoninic acid (BCA) assay 
 
Proteins were quantified using the bicinchoninic acid assay (BCA) according 
to the manufacturer’s protocol. Briefly, the BCA working reagent was 
prepared by mixing BCA and 4% (w/v) copper (II) sulphate pentahydrate in a 
50:1 ratio. Twenty five μL of diluted protein sample (1:20 in protein lysis 
buffer) were mixed with 200 μL of BCA working reagent and added into a 96-
well plate. All the samples were tested in triplicate. Bovine serum albumin 
was used to construct a standard curve of known concentrations with a range 
of 200-1000 µg/mL. The absorbance was measured at 562 nm in a plate 
reader (ELISA Reader LT-5000MS, LabTech International) and data 
analysed using Labtech Manta Lite software (LabTech International) 
61 
 
2.11.3 Sodium dodecyl sulphate - polyacrylamide gel electrophoresis 
(SDS-PAGE) 
 
Protein samples were prepared in 2x Laemmli buffer (4% SDS, 20% glycerol, 
10% 2-mercaptoethanol, 0.004% bromophenol blue and 0.125 M Tris HCl, 
pH 6.8).  Samples were diluted to a final concentration of 1 μg/μL in 2 x 
Lammli buffer and boiled at 100 °C in a heating block for 5 minutes prior to 
use.  
 
Acrylamide resolving gels ranging from 8-15% (w/v) were used depending 
on the size of the protein of interest. The composition of the gel was as 
follows: 8-15% (w/v) acrylamide (30% (w/v) stock acrylamide); resolving Tris 
solution (0.375 mM Tris-HCl, 0.1% (w/v) SDS adjusted to pH 8.8 with 1N HCl) 
and 10% (w/v) ammonium persulphate. Finally, 0.1% (v/v) of the 
polymerising agent N,N,N’,N’-tetramethylethyenediamine was added to the 
mixture in order to promote polymerisation. The mixture was carefully mixed 
to avoid creating bubbles and poured between two glass plates of the casting 
module, leaving a 3 cm gap of the top. A 1mL overlay of isopropanol was 
layered on the top of the resolving gel to create an even surface and minimise 
contact with air. After 30 minutes polymerisation, the isopropanol was 
carefully decanted, the top of the gel was rinsed with dH2O and blotted dry 
with filter paper. 
 
The composition of the stacking gel was as follows: 5% (v/v) polyacrylamide, 
stacking Tris solution (37.5 mM Tris HCl, 0.1% (v/v) SDS adjusted to pH 6.8 
with 1 N HCl) and 10% (w/v) ammonium persulphate. TEMED 0.1% (v/v) was 
added to the mixture to promote polymerisation.  
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The stacking gel solution was added directly on top of the resolving gel, a 
comb was inserted and the gel left to polymerise for a further 30 minutes at 
room temperature. When the gel was completely set, the comb was removed 
and any un-polymerised material was removed from the wells by rinsing with 
Tris-glycine electrophoresis buffer (5 mM Tris-base; 50 mM glycine, pH 8.3; 
0.02 % (w/v) SDS).  
 
2.11.4 Resolving SDS-PAGE gels 
 
 
The gel was removed from the casting chamber, placed into the 
electrophoresis tank and submerged in Tris-glycine electrophoresis buffer. 
Samples were loaded into the wells together with a pre-stained broad range 
protein marker (PageRuler™ Prestained Protein Ladder, 10 to 180 kDa, 
Thermo Fischer). The gel was resolved at 50 V for 15 minutes then the 
voltage was increased to 100 V and the gel was resolved until the dye front 
had reached the bottom of the gel. 
 
2.11.5 Staining and visualization of the protein gel 
 
Gels were rinsed in dH2O for 15 minutes and submerged in IRDye blue stain 
(LI-COR Biosciences, Cambridge, UK) for 1 hour. Destaining was carried out 
by removing the stain and adding dH2O for 30 minutes under agitation. Gels 
were scanned at 700 nm using the LiCOR imaging system (Odissey-3074, 
LI-COR, Cambridge, UK) and Image Studio v2.0 software. 
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2.12 Immunoblotting 
 
Proteins resolved on SDS-PAGE were transferred onto nitrocellulose 
membranes using the method of Towbin (1979). Nitrocellulose membrane 
(0.2 μm, Optiran BA-S 83) and 2 mm thick filter paper (Whatman International 
Ltd., UK) along with two fibre pads, were pre-soaked for 15 minutes in 1 X 
continuous transfer buffer (25 mM Tris; 192 mM glycine; 20 % (v/v) methanol; 
pH 8.3). Using forceps throughout, the blot sandwich was assembled under 
transfer buffer to minimise air bubbles.  Sandwiches were prepared by 
arranging them in the following order: two layers of filter paper, the gel, the 
pre-soaked nitrocellulose membrane and another 2 layers of filter paper with 
the gel facing the negative pole. The electrophoresis tank was filled with pre-
chilled transfer buffer and the gel was transferred by electrophoresis at 100 
V for 60 minutes. 
 
In order to assess for equal loading between different protein samples, 
nitrocellulose membranes were ink-stained with 0.1% (v/v) India Ink (Pelikan, 
Fount India Black) in 1X Tris-buffered saline (TBS; 50 mM Tris-HCl pH 7.4; 
0.9 % (w/v) NaCl) /0.1 % (v/v) Tween®20 (TBS-T) for 5 minutes.  Unbound 
sites in the nitrocellulose membrane filter were saturated by incubating the 
blot in 50 mL 3% (w/v) non-fat dry milk (Marvel) in 1 X TBS-T for 1 hour with 
gentle rotation at room temperature. 
 
Primary antibodies (see table 2.3) were diluted 1:1000 unless otherwise 
specified, in 3% (w/v) non-fat dry milk containing TBS-T and poured into the 
membrane. This was incubated at room temperature for 30 minutes to 1 hour 
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at 50 rpm to allow the antibody to bind, and then overnight at 4oC. Any 
unbound primary antibody was removed the following day by washing the 
membrane in TBS-T 3 times for 5 minutes. 
 
Fluorescence-conjugated secondary antibodies (LI-COR® see table 2.3) 
were diluted 1:10000-20000 in 3 % (w/v) non-fat dry milk in 1 X TBS, 0.01 % 
(w/v) SDS and incubated on the membrane with gentle agitation (50 rpm) for 
1 hour at room temperature in the dark. Any unbound secondary antibody 
was removed and the membrane was washed with TBS-T for 3 x 5 minutes 
with gentle agitation. Membranes were scanned at 700 or 800 nm 
wavelength using the LI-COR imaging system (Odissey-3074, LI-COR, 
Cambridge, UK) and Image Studio v2.0 software. 
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Table 2.3. Primary antibodies used in this study. Western blotting (WB) 
and immunohistochemistry (IHC). 
Target 
species 
Host species 
Application 
/dilution 
Supplier and catalogue 
number 
Actin Goat WB Santa Cruz, #SC-1615 
Capase-3 Rabbit WB, IHC CST, #9661 
CD44 Mouse WB CST, #5640 
GFAP Mouse IHC abcam, #10062 
GLUT-3 Rabbit WB 1:400 abcam, #ab15311 
GLUT-1 Rabbit WB EMD Millipore, #07-1401 
GRP78-
BIP 
Rabbit WB abcam, #ab21685 
HIF-1 Mouse WB abcam, #ab1 
HIF-2 Goat WB 1:500 R&D Systems, #AF2886 
HIF-3 Rabbit WB 1:750 
Acris antibodies, 
#AP20606PU-N 
HSP70 Rabbit IHC, WB abcam, #ab181606 
HSP70 Goat IHC Santa Cruz, #sc1060 
KCC1 Goat WB 
Aviva Systems, 
#OAEB01912 
KCC2 Rabbit 
WB, 
IHC 1:200 
Merck Millipore, #07-432 
KCC3 Rabbit WB 1:200 Abgent, #AP12382a 
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Table 2.3 continued 
Target 
species 
Host species 
Application
/Dilution 
Supplier and catalogue 
number 
NeuN Rabbit IHC abcam, #ab177487 
KCC4 Rabbit WB 1:200 Abgent, #AP12392a 
NKCC1 Mouse IHC DSHB, T4-s 
NKCC1 Goat WB Santa Cruz, #sc-21547 
NKCC1 Rabbit WB 1:400 Aviva Systems, #ARP43805 
NSE Mouse WB abcam, #AB16808 
PDI Mouse WB abcam, #ab2792 
Vimentin Mouse WB BD Sciences, #550513 
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Table 2.4. Secondary antibodies used in this study. Western blotting 
(WB) and immunohistochemistry (IHC). 
Target 
species 
Host 
species 
Fluorochrome 
Application/
Dilution 
Supplier and 
catalogue number 
Goat IgG Donkey 680LT IRDye 
WB 1:10000-
1:20000 
LI-COR, #925-68024 
Rabbit 
IgG 
Goat 680LT IRDye 
WB 1:10000-
1:20000 
LI-COR, 
#925-68021 
Mouse 
IgM 
Goat 800CW IRDye 
WB 1:10000-
1:20000 
LI-COR, 
#925-32280 
Rabbit 
IgG 
Goat Alexa fluor 488 IHC 1:500 
Thermo Fischer, 
#A-11008 
Rabbit 
IgG 
Mouse Alexa fluor 564 IHC 1:500 
Thermo Fischer, 
#A11011 
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2.13 In vivo experiments 
 
2.13.1 Animal and tissue samples 
 
Thirty six Swiss mice weighting 35-40 g (Mus musculus 3 months-old), were 
obtained from León University (Spain). Animals were kept under a controlled 
temperature environment (22 ± 2 ºC), relative humidity (55 ± 10%), ventilation 
(12 to 15 air changes per hour), photoperiod (12 h light/12 h darkness) and 
fed ad libitum (Pellet, Panlab, Spain). All experimental procedures were 
carried out following the Guidelines of the European Union Council 
(86/609/EU) and Spanish regulations (RD 53/2013, BOE 8/2/2013) for the 
use of laboratory animals, and were approved by the Ethics Committee of 
the University of Leon. All efforts were made to minimize animal number and 
suffering. 
 
2.13.2 Photothrombotic model of stroke 
 
Mice were placed in a transparent induction chamber and anaesthetised with 
a 3.5% (v/v) isofluorane in a 100% (v/v) oxygen gas mixture. When deep 
anaesthesia was reached, the mice were removed from the chamber and 
placed on a heating pad in order to maintain the body temperature at 37°C. 
A face mask was immediately placed on the mouse and isofluorane levels 
reduced to 1.5% (v/v).  The animals were placed in the prone position and 
the scalp was shaved with a razor. The skin was disinfected with 70% (v/v) 
ethanol. An incision was made along the midline from the eye level to the 
neck using a scalpel and skin retractors were used to expose the skull. An 
opaque mask was fixed with cyanoacrylate onto the skull over the bregma 
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point of the left parietal bone. This mask delimits the area of the lesion and 
presents an aperture which allows the laser to irradiate exclusively a 1.5 mm 
diameter area. The diaphragm was located 2 mm caudal to the bregma point 
and 2 mm lateral to the sagittal suture, which includes a large part of the 
sensorimotor cortex (Franklin 1997).  
 
Mice were injected with 50 mg/kg Rose Bengal solution intraperitoneally with 
a 1 mL syringe. After 5 minutes, photothrombosis was induced by illuminating 
the left hemisphere of the mouse with a green light laser (532 nm and 5 mW) 
for 15 minutes. At this point a second dose of Rose Bengal was injected and 
the region illuminated for another 15 minutes. Following illumination and 
photothrombosis, the mask and skin retractors were removed and the 
incision closed with 2 chirurgical staples (Fine Science Tools, Canada). The 
mouse was returned to its cage and kept in the dark for 24 hours in order to 
allow complete elimination of any circulating Rose Bengal and avoid 
unwanted photothrombosis and secondary damage. Animals were kept 
under the standard conditions previously mentioned until euthanised.  
 
2.13.3 Drug Administration 
 
The effect of modulating chloride transport after stroke was analysed by 
treating mice with specific cation-chloride cotransporter (CCC) modulators. 
The NKCC1 antagonist, Bumetanide (10 mg/kg), and KCC2 agonist CLP257 
(100 mg/kg; both Tocris Bioscience, UK) were dissolved in 0.1% DMSO in 
NaCl and administered intraperitoneally 1 and 24 h after PT. Dosage was 
70 
 
based on previous literature (Gagnon et al., 2013; Loscher et al., 2013). 
Vehicle and naïve mice were included as controls. 
 
2.13.4 Perfusion and sampling 
 
Following the different exposure times after photothrombosis, mice were 
anaesthetised with an intraperitoneal injection of pentobarbital (200 mg/kg) 
(Euta-Lender, Normon Laboratories, Spain). Mice were perfused through the 
left ventricle with 100 mL saline solution (NaCl 0.9%) at room temperature 
followed by 100 mL 4% paraformaldehyde in PBS (50 mM, pH 7.4) at 4 ºC. 
The brain was extracted and transferred to a 4% paraformaldehyde in PBS 
solution and postfixed for 24 hours. The brain was transferred to a 
cryoprotective solution containing 30% sacarose in PBS (50 mM, pH 7.4) at 
4 ºC for 48 hours. Brains were imbibed in an optimum cutting temperature 
solution (Tissue-teck, Sakura Finetek, EEUU) in PBS 50 mM, pH 7.4, 30% 
sacarose (1:1) for 30 minutes to maintain tissue integrity during the slicing 
process. 
 
2.13.5 Tissue slicing 
 
The brain was divided into two hemispheres, the ipsilateral hemisphere 
where the injury occurred and the contralateral hemisphere, which was not 
directly affected by phothrombotic stroke. Forty micron-thick brain sagittal 
sections were cut with a microtome for free floating processing (Microm 
HM450, Microm Laborgerate GmbH, Alemania). Sections were washed in 
PBS and endogenous peroxidases were inhibited with 3% H2O2 and 3% 
methanol in PBS, pH 7.4, for 20 minutes. Endogenous biotin was inhibited 
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with Blocking Kit (Vector Laboratories, Burlingame, CA, USA). Samples were 
stored on PBS with 0.025% (v/v) sodium azide in order to prevent fungal 
growth.  
 
2.13.6 Cresyl Violet staining 
 
From each animal, 3 sections were stained with Cresyl Violet in order to 
confirm the existence of the injury. This method uses a basic aniline dye to 
stain RNA blue, and is used to highlight important structural features of 
neurons (Kluver and Barrera 1953). The Nissl substance, which is located in 
the rough endoplasmic reticulum, appears dark blue due to staining of 
ribosomal RNA, giving the cytoplasm a mottled appearance. Individual 
granules of extra-nuclear RNA are named Nissl granules (ribosomes). DNA 
present in the nucleus stains a similar colour.  
 
Sections were washed in water in order to eliminate the presence of salts. 
Slides were immersed through 2x 3 minutes changes of 100% ethanol and 
the tissue was defatted by 3 immersions in 10% xylene for 15 minutes. 
Following this, sections were immersed for 10 minutes in 100% ethanol and 
finally washed with water. Sections were stained with 0.5% (v/v) Cresyl Violet 
in water for 10 minutes and quickly rinsed with water to remove the excess. 
Next, the sections were immersed in 70% ethanol and dehydrated with 2x 3 
minutes changes of 100% ethanol. Finally, sections were cleared in xylene 
and mounted on positively charged slides and air dried. A drop of 1,4-
diazabicyclo[2.2.2]octane (DABCO) 3% in glycerol:PBS (1:1) was added on 
top of each section and finally a cover slip was added. The slides were 
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imaged using a Zeiss Primovert inverted microscope at a 20X magnification 
and images captured with a Zeiss Axiocam camera. 
 
2.14 Immunohistochemistry 
 
Tissue sections were washed 3 times for 10 minutes in 50 mM PBS pH 7.4 
at room temperature to eliminate the sodium azide from the tissue. Antigen 
retrieval was performed by incubating the samples in preheated sodium 
citrate buffer (10mM sodium citrate, 0.05% (v/v) Tween-20, pH 6.0) for 30 
minutes at 80°C. Non-specific binding was blocked by incubating the sections 
in 0.2% Triton X-100, 20% serum in PBS for 1 hour and 15 minutes. The 
species-specific serum used varied according to the secondary antibody 
host. Immunolabelling was performed using a variety of primary antibodies 
at specific concentrations (see Table 2.3). The sections were incubated 
overnight at 4°C with the primary antibody diluted in 0.2% Triton X-100, 2% 
serum in PBS. Labelling was detected by incubating sections for 1 h with a 
fluorescence-conjugated secondary antibody (see Table 2.3) followed by 
incubation for 20 minutes with 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (DAPI) diluted 1:1000. Sections were washed 3 times for 10 
minutes after each incubation. Sections were mounted on positively charged 
slides and air dried before 3% (v/v) DABCO in glycerol:PBS (1:1) was added 
to improve the lifetime of the dye. Finally a cover slip was added. The 
specificity of the immune reactions was controlled by omitting either the 
primary and/or secondary antibodies. Imaging of the slides was performed 
using a Zeiss LSM 800 (Carl Zeiss Microscopy) confocal microscope. 
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2.15 Data Analysis  
 
Analysis of the .czi image files obtained with confocal microscopy was carried 
out with ZEN 2 (blue edition) software (Carl Zeiss Microscopy GmbH, 2011) 
and/or ImageJ Fiji 1.51g.  
 
2.15.1 Calculating the Mean fluorescence intensity of antibody staining 
in brain slices 
 
The mean fluorescence intensity was measured within a given area 
surrounding the photothrombosised brain. The mean intensity value was 
measured up to 600 μm from the border of the necrosised area with ZEN 2 
blue using the measure tool on the ZEN blue software. Stained sections from 
three different mice from each time point post photothrombotic stroke (days 
1, 3 and 5 days) were analysed for each mouse, three different slices were 
analysed.  
 
2.15.2 Assessing the decay in fluorescence intensity across the 
infarcted zone 
 
The decay in fluorescence in the area surrounding the photothrombotic 
stroke was also analysed. This allowed the extent of the damage and its 
evolution 1, 3 and 5 days following photothrombotic stroke induction to be 
defined. In order to do this, fluorescence was measured up to 500 μm from 
the infarcted zone at regular intervals as shown in figure 2.1. The profile 
function of ZEN 2 blue was used in order to plot intensity of the fluorescence 
signal against the distance from the border of the injury. A table with the 
intensity of each channel at each distance was exported into Microsoft Excel 
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to construct the graphs. The fluorescent signal across the brain section from 
the infarcted zone was normalised against DAPI intensity. This was repeated 
twice per section, in 3 different mice per time point studied and represented 
as normalised fluorescence intensity over time.
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Figure 2.1 Schematic representation of the method used to analyse the decay in fluorescence intensity across the 
infarcted zone. An area of 500 μm length and 200 μm wide from the infarcted zone (white box, A) was drawn at each side of 
the injury. The intensity of the fluorescence signal against the distance was also analysed. A representative trace showing the 
fluorescence intensity is shown (B).
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2.15.3 Counting the number of positively stained cells within the 
infarcted zone. 
 
In order to calculate the number of cells staining positive with a specific 
antibody, sections were analysed. Three different fields of view of the cortex, 
200 and 400 μm from each side of the ischaemic core were taken under x 63 
magnification (Figure 2.2). The total number of cells within each field of view 
was calculated by measuring nuclear staining using DAPI. The images were 
exported to ImageJ Fiji 1.51g, where the different channels were split and 
then transformed into black and white images. Using the counter tool, the 
number of antibody-positive cells were counted and the data was exported 
into a Microsoft Excel spreadsheet. Finally, the number of positively stained 
cells were represented as ratios of expression or normalised to the total 
number of DAPI stained cells within the field of view. 
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Figure 2.2 Schematic representation of the method used to analyse the 
number of positively stained cells. A representative image of a section 
stained with KCC2 (green) and NKCC1 (red) and various regions highlighted.  
The different fields of view that were analysed 100 and 200 M from the edge 
of the photothrombotic injury are indicated by red and green boxes 
respectively. 
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2.16 Statistical analysis 
 
All analyses were conducted using GraphPad Prism v7.0 (GraphPad 
Software Inc). Results are shown as the mean of three independent 
experiments ± SEM. Significance was determined using unpaired Student’s 
t-test where only single comparisons were made or one/two-ways ANOVA 
with different correction for multiple comparisons that were specificied for 
each particular case. Data was deemed significant if *:p<0.05; **: p ≤ 0.01, 
***: p ≤ 0.001. 
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3. Establishing an in vitro neuronal-like model 
of brain hypoxia to investigate the importance 
of the HIF-mediated adaptation to hypoxic 
stress. 
 
3.1 Introduction  
 
Occlusion of cerebral arteries causes irreversible neuronal damage as 
disrupted blood flow starves neurons of oxygen and glucose. The resultant 
failure in energy synthesis perturbs the ability to maintain ionic gradients, 
triggering a cascade of events leading to apoptotic cell death and irreversible 
neuronal loss (Lipton 2006). The penumbra is the moderately perfused region 
surrounding the blockage. Here, blood flow and oxygen availability are 
restricted, yet sufficient to maintain ATP synthesis to sustain ionic gradients 
(Liu et al., 2010). Cells in the penumbra are highly stressed and extremely 
vulnerable and must adapt in order to survive such harsh conditions. 
Adaptation is central to neuronal recovery. 
 
Oxygen homeostasis is essential to maintain the energy demands of cells, as 
it is ultimately responsible for the production of ATP. Brain injury after an 
ischaemic stroke is a result of a disruption in the blood flow and subsequent 
energetic homeostasis failure. Reduced levels of oxygen activate a variety of 
protective and adaptive cellular responses that if sustained can lead to 
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neuronal apoptosis (Bossenmeyer et al., 1998). Hypoxia inducible 
transcription factors (HIFs) respond to a decrease in oxygen by promoting 
the transcription of genes involved in cell survival, proliferation and apoptosis 
(Baranova et al., 2007, Barteczek et al., 2016, Shi 2009).   
 
3.1.1 HIFs as key regulators of hypoxic adaptation 
 
HIFs are responsible for the transcription of a large number of genes, most 
of them involved in promoting and increasing oxygen delivery, cell survival 
and proliferation, as an adaptive response to low levels of oxygen (Figure 
3.1) (Giaccia et al., 2003, Semenza et al., 2003, Koh and Powis, 2012). HIFs 
are heterodimers comprising an oxygen-dependant  subunit (HIF-1,HIF-
2, and HIF-3)and a constitutively expressed HIF-1subunit which when 
associated conform the HIF-1, HIF-2 and HIF-3 transcriptional factors. HIF-
1 and HIF-2 are the best-characterised subunits, whereas HIF-3function 
remains unclear. HIF-1is rapidly (< five minutes) degraded in the presence 
of oxygen (Berra et al., 2001). Under normoxia, HIF- subunits are 
hydroxylated at conserved proline residues. The hydroxylation of two proline 
residues in HIF-1α and HIF-2α by prolyl hydroxylase domain proteins (PHD) 
is regulated by O2 availability (Kaelin and Ratcliffe, 2008) and it is required 
for the binding of the von Hippel–Lindau protein (pVHL), which leads to HIF-
α ubiquitination and proteasomal degradation (Ohh et al., 2000). Under 
hypoxia, PHD activity is diminished, as O2 and -ketoglutarate are cofactors 
required for its activity, and stabilized HIF proteins translocate into the 
nucleus where they can recognise hypoxia responsive elements (HRE) in the 
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genome promoting the transcription of hypoxia-responsive genes 
(Majmundar et al., 2010).  
 
Although HIF-1 and HIF-2 share some common gene targets such as the 
vascular endothelial growth factor (VEGF) to promote angiogenesis (Koh and 
Powis, 2012; Figure 3.1), they also promote specific adaptations to hypoxia. 
HIF-1 preferentially promotes glycolytic enzymes such as glucose transporter 
1 (GLUT1) and lactate dehydrogenase A (LDHA), genes involved in pH 
regulation such as carbonic anhydrase 9 (CA-IX) and genes that promote 
apoptosis or the unfolded protein response (UPR) such as glucose-related 
proteins 94-76 (Grp94-76), C/EBP homologous protein (CHOP) or the protein 
disulfide isomerase (PDI) (Keith et al., 2012).  
 
HIF-1 mRNA has a very short half-life as it is rapidly degraded or translated 
into its protein form (Ke and Costa, 2006). HIF-1 mRNA stability is regulated 
by RNA-binding proteins (RBPs) such as the polypyrimidine tract-binding 
protein 2 (Ptbp2), micro RNAs (miRNAs) and antisense RNAs (Galbán and 
Gorospe, 2009). Antisense levels of HIF-1 (aHIF) are increased after 
prolonged hypoxia and triggers the downregulation of HIF-1 mRNA (Uchida 
et al., 2004). This rapid and tightly regulated HIF-1 mRNA kinetics makes it 
difficult to detect changes in HIF-1 mRNA under hypoxic conditions 
compared to normoxia by qPCR. Thus, the protein stability of HIF-1 is a 
better approach to detect HIF-1 induction.  
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HIF-2 is now considered the main regulator of erythropoietin (EPO) 
production (Rankin et al., 2007, Barteczek et al., 2016), which is an important 
adaptation to hypoxia as EPO promotes red blood cells production and thus, 
increases tissue oxygenation. HIF-2has also been associated with the 
maintenance of stem cell characteristics (Koh and Powis, 2012). The 
maintenance of neuroblastoma cells in an undifferentiated state requires the 
expression of HIF-2 (Pietras et al., 2009).  CD44 is a transmembrane 
glycoprotein implicated in cell–matrix adhesion and matrix-mediated cell 
signalling. It is considered a cancer stem cell marker (Keysar and Jimeno, 
2010) and it has recently been shown to be widely expressed in several  
precursor cells during cerebellum development (Naruse et al., 2013). 
Vimentin, an intermediate filament protein, is another neuronal precursor 
marker as its expression essential for neuritogenesis and it is substituted by 
neurofilaments in the adult brain (Yabe et al., 2003). 
 
Finally, the function of HIF-3α in the hypoxic response remains unclear. It has 
been generally recognised to inhibit HIF-1α translocation to the nucleus 
(Heikkil et al., 2011).However recent studies have shown the ability of some 
HIF-3 variants to act as an oxygen regulator transcription factor (Duan, 2016).  
 
3.1.2 Modelling hypoxia in neuronal-like cell lines in vitro 
 
Several methods have been developed in order to simulate the physiological 
conditions of low oxygen levels that occur during an ischaemic event. Some 
metals are known to act as chemical hypoxia-mimicking agents including 
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cobalt chloride, nickel chloride and desferrioxamine (Goldberg et al., 1988). 
Cobalt chloride (CoCl2) induces hypoxia-inducible factor 1 alpha (HIF-1) 
and HIF-3 stabilisation (Wang et al., 2006), but in addition, it has recently 
been shown to inhibit HIF-2-dependent gene expression (Befani et al., 
2013). It is therefore a good method to induce HIF-1 and the molecular 
mechanisms it triggers, but it does not induce an overall physiological 
response to hypoxia. Hypoxic modular chambers allow the control of 
atmospheric oxygen in order to mimic the low oxygen concentration that 
neurons suffer after a stroke. This model has been extensively used in a large 
number of studies (Papers et al., 2001, Gao et al., 2004, Wu and Yotnda, 
2011) and offers a more realistic approach to the hypoxic conditions of an 
ischaemic stroke. Pluripotent cell lines such as PC12 and NT2, can be 
differentiated into neurons and have previously been used as a model to 
study hypoxia and other neurodegenerative diseases (Dalen et al., 2009, 
Darbinian, 2013, Grau and Greene, 2012, Lahiani et al., 2015, Leiser et al., 
2011, Lan et al., 2011, Hill et al., 2012). Their availability to grow in large 
numbers and their homogeneity makes them ideal candidates to study 
signalling pathways.  
 
The establishment of an in vitro model of stroke complements in vivo and ex 
vivo models in order to study the effects of cerebral ischaemia in neurons. 
Such models permit further manipulation of the experimental conditions, 
which can lead to a better understanding of the molecular processes involved 
in triggering neuronal death.  
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Culturing primary neuronal cells is challenging as mature neurons do not 
undergo cell division and there is a high economic cost in maintaining an 
animal availability. To overcome this difficulty, several secondary sources 
derived from tumours have been made available and recognised as valid 
models to study neuronal differentiation and neurodegenerative diseases 
(Datta et al., 2013). Different neuronal cell lines have been used as an 
inexpensive and easy to maintain source of cultured neuronal-like cells. The 
most widely used cell lines are PC12 and NT2 cells, although other cell lines 
such as SH-SY5Y, or the murine embryonic stem cells F9 and P19, are also 
employed in different research fields (Resende et al., 2007, Lopes et al., 
2010, Kovalevich and Langford, 2013). 
 
PC12 cells treated with nerve growth factor (NGF) differentiate into 
dopaminergic-like neurons, developing neurites, synapse-like junctions (Jeon 
et al., 2010) and release the neurotransmitters acetylcholine (Hirsch et al., 
1993), dopamine and glutamate (Kumar et al., 1998). NGF is a neuropeptide 
that plays a role in the differentiation and maintenance of neurons and it has 
long been considered a method for developing neuron-like cells (Greene et 
al., 1976). In PC12 cells exposed to NGF, cell proliferation stops, neurite 
outgrowth is induced and the acquisition of biochemical and morphological 
characteristics of sympathetic neurons is stimulated.  
 
NT2 cells stop dividing and differentiate into post-mitotic neuron-like cells 
upon treatment with retinoic acid (RA) (Andrews, 1984). Retinoic acid-
differentiated NT2 cells display elaborate processes that differentiate into 
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axons and dendrites (Pleasure et al., 1992). In addition, these differentiated 
cells elaborate classic synaptic contacts and express GABAergic (Neelands 
et al., 1998), glutamatergic (Haile et al., 2014), dopaminergic (Zigova et al., 
2000) cholinergic, catecholaminergic (Guillemain et al., 2000) and 
serotoninergic markers (Podrygajlo et al., 2009).  
 
3.1.3 HIFs as modulators of the hypoxic response following stroke.  
 
Despite the limited regenerative capacity of the nervous system, a degree of 
spontaneous recovery occurs following ischaemic stroke (Carmichael, 2016). 
Studies suggest HIF mediated angiogenesis and neurogenesis are central to 
this process. Neuron-specific knockout of HIF-1α dramatically increases 
ischaemic damage caused by transient cerebral artery occlusion and HIF-1α 
loss significantly increases infarct volume and mortality (Baranova et al., 
2007). Indirect induction of HIF signalling via genetic ablation of Phd2 also 
reduces infarct size and dramatically improves sensorimotor function 
following transient ischaemic insult (Reischl et al., 2014).  
 
HIF-α’s role in the pathophysiology of ischaemic insult is however 
complicated as HIF-1α and -2α signalling display temporal differences (Koh 
and Powis, 2012); HIF-1α appears to be involved in the acute response whilst 
HIF-2α mediates the response to chronic hypoxic stress (Holmquist-
Mengelbier et al., 2006). The timescale of HIF signalling is critical for effective 
recovery from ischaemic insult as whilst genetic targeting of neuronal HIF-1α 
and HIF-2α was beneficial in acute stages, loss of HIF-1α and -2α correlated 
with increased apoptosis and reduced sensorimotor function at later stages 
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(Barteczek et al., 2016). This may be due to HIF-2α tuning VEGF signalling 
and the importance of angiogenesis in post-stroke neurogenesis (Li et al., 
2016). Together, these studies indicate the intricacies of HIF signalling, their 
neuroprotective role and importance in recovery from ischaemic damage. 
 
In this chapter, the responses and adaptations following hypoxia of the 
neuronal-like cell lines PC12 and NT2 were analysed. A reliable system to 
induce PC12 and NT2 cells differentiation into neuron-like cell was achieved. 
The effect the cell viability, gene and protein expression of chemically-
induced and atmospheric hypoxia was assessed. Specifically, the importance 
of HIF-2α signalling in neuronal adaptation and survival following hypoxic 
stress was further studied as a novel strategy to reduce the damage 
associated with stroke and promote neurorehabilitation in a more effective 
manner than currently available therapies. 
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Figure 3.1 The HIF family of proteins promote different adaptations to hypoxia. Under normal physiological levels of 
oxygen HIF-1/2 are hydroxylated by specific prolil hydroxylases (PHD) on conserved proline residues. This hydroxylation 
promotes the binding of von Hippel-Lindau protein (pVHL) which forms the substrate for the recognition and ubiquitination 
of the complex facilitating proteosomal degradation.  Under hypoxia, PHD activity is inhibited and HIF-1/2 can bind to the 
HIFβ subunit and translocate into the nucleus promoting the transcription of different hypoxia-responsive genes. HIF-1 
promotes different adaptations like glycolytic metabolism, the glucose transporter 1 (GLUT1) and glucose transporter 3 
(GLUT3) being major regulators; activates the unfoldedprotein response through glucose-related proteins 94-76 (Grp94 and 
Grp76), C/EBP homologous protein (CHOP) or the protein disulfide isomerase (PDI); regulates intracellular pH homeostasis 
through carbonic anhydrase 9 (Ca9); and promotes angiogenesis via the vascular endothelial growth factor (VEGF). HIF-2 
shares some of these adaptations with HIF-1α like angiogenesis but it also promotes specific ones like survival through the 
regulation of erythropoietin (EPO) and stem cell characterisitics like CD44 and vimentin. HIF-3 is considered a negative 
regulator of HIF-1 and has oxygen independent functions although its role is not yet fully comprehended. 
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3.2 Aims  
 
Aim 1. To create an in vitro model of hypoxia in neuronal-like cell lines in 
order to mimic the effect of a stroke in neurons. 
  
Aim 2. To study the mechanisms that lead to neuronal adaptation after a 
hypoxic insult produced by a shortage of oxygen following a stroke-like event 
in this model. 
 
3.3 Research Questions 
 
RQ1. Are PC12 and NT2 cell lines valid to study neuronal ischaemia? 
 
RQ2. How does hypoxia affect the viability of neuronal-like cells? 
 
RQ3. Which adaptive response does hypoxia trigger in neuronal-like cells? 
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3.4 Results  
 
3.4.1 Neuronal differentiation in pluripotent cell lines 
 
3.4.1.1 Morphological assessment of the directed differentiation of 
PC12 and NT2 cells via microscopy 
 
PC12 cells were treated with NGF (500 nM) and differentiation into neurons 
was assessed using visual, immune-based and gene-based techniques. As 
expected, NGF treatment rapidly initiated signs of PC12 differentiation 
(Figure 3.2). Untreated cells presented round cell bodies, however, after 24 
hours of treatment, PC12 cells started producing projections, which became 
thicker and longer on days two and three reaching  more than two-fold the 
length of the cell body at five days post-treatment (Figure 3.2). After eight 
days, the cells displayed a typical neuronal morphology with long projections 
and interlaced axons and dendrites. This was assessed by bright field 
microscopy (Figure 3.2). 
 
The Molecular Probes® Neurite Outgrowth Staining Kit was used in order to 
assess neurite outgrowth and thus confirm the visual observations previously 
made in Figure 3.2. Neurite outgrowth was monitored via bright orange-red 
staining of outer cell membrane surfaces during the 8 days of NGF treatment 
(Figure 3.3). This immunostaining reported the same pattern of neurite 
elongation: projections started to appear one day following NGF treatment, 
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becoming longer and with more ramifications after three days of treatment 
and displaying a neuronal-like morphology after eight days.   
 
 
Figure 3.2 Neurite growth factor (NGF) promotes differentiation of PC12 
into neuron-like cells. Representative bright-field microscopy images of 
PC12 cell morphology after one, two, three, five and eight days in the 
presence of NGF (20 x magnification). Typical differentiated neurons 
displayed bright cell bodies (white arrows) and neurites (black arrows).
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Figure 3.3. NGF promotes PC12 differentiation into neuron-like cells. Representative fluorescence microscopy images 
of PC12 cell morphology after one, two, three, five and eight days in the presence of NGF (20 x magnification). Cells were 
stained for the membranes of neurite extensions (red) and DNA (DAPI, blue).
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Neurite length is considered to be indicative of neural differentiation and it 
has been reported in many studies that a neurite length of twice the length of 
the cell body is an indicator of a fully differentiated neuron (Blackman et al., 
1993; Das et al., 2004). In order to determine the extent of differentiation the 
number of neurites and their length was quantified. After two days of NGF 
treatment, most cells presented at least one neurite (Figure 3.4A). Two 
neurites were observed following three days of the start of the treatment, with 
many cells presenting up to three neurites at the end of the eight days of 
treatment (Figure 3.4A). The length of these neurites was measured along 
the differentiation process. The average length of the cell bodies was 12 μm 
(Figure 3.4B, dotted line). NGF-treated PC12 cells contained neuronal 
processes longer than two times the length of the cell body (24 μm) after 
three days of NGF treatment (Figure 3.4 B). The length of the neurites was 
significantly different from two times the diameter of the cell body after eight 
days, reaching 60 μm. Finally, cells bearing at least two neurites with a length 
equal to, or greater than, two times the diameter of the cell body were 
considered differentiated and expressed as a percentage of the total number 
of cells in a field of view (Figure 3.4 C.). Considering the two parameters, 
18% of the cells were differentiated after two days, 23% after three days, 57% 
after five days and 91% after eight days of NGF treatment. Therefore, eight 
days of NGF treatment induced PC12 differentiation according to the 
parameters previously mentioned. 
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Figure 3.4 The number and length of neurites define the percentage of 
differentiated cells. PC12 cells were cultured in the absence or presence of 
500 nM NGF for up to eight days. The number of neurites (A) and neurite 
length (B) were used as a measure to identify differentiated cells (C). The 
dotted line represents the mean of the cell diameter. Results are represented 
as mean ± SEM (n=3). One-way ANOVA with Dunnett’s multiple comparisons 
test. 
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3.4.1.2 Morphological assessment of the directed differentiation of 
PC12 and NT2 cells via microscopy 
 
Human NT2 cells can be induced to differentiate into neuron-like cells 
following RA treatment. After one week of RA treatment (10 μM), NT2 cells 
started producing axons and dendrites, becoming thicker and longer, > two-
fold the length of the cell body after one week (Figure 3.5). Four weeks after 
RA treatment cells displayed longer projections and a typical neuronal 
morphology, interlaced axons and dendrites (white arrow) and ganglion like 
clusters (black arrow), as observed with primary neuronal cultures. In order 
to produce homogenous population of neuron-like cells, they were treated 
with the mitotic inhibitor cytosine β-D-arabinofuranoside (C-Ara), for a further 
two weeks to remove any non-differentiated cells from the culture. 
 
Figure 3.5. Retinoic acid (RA) promotes differentiation of NT2 into 
neuron-like cells. Representative bright-field microscopy images following 
NT2 differentiation. NT2 cells were treated with 10 μM RA for four weeks (RA 
4w) and the mitotic inhibitor cytosine arabinoside (1 µM) for two weeks (RA 
4w + 2w Ara-C). Typical differentiated neuron-like cells displayed ganglion-
like clusters (black arrow) and interlaced axons (white arrow). 
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3.4.1.2 Gene expression assessment of the directed differentiation of 
PC12 and NT2 cells via qPCR 
 
During differentiation, the PC12 and NT2 cells gene expression profile is 
modified (Lee et al., 2005). Specific genes are up-regulated or down-
regulated in order to confer cells with a neuron-like phenotype. Neuritin 
mRNA is involved in promoting neurite outgrowth in the differentiating fields 
of the developing CNS and in regions associated with neural plasticity (Naeve 
et al., 1997, Cappelletti et al., 2007). Tropomodulin binds at the pointed end 
of actin filaments and regulates their length, being implicated in neuronal 
organisation and plasticity (Rao et al., 2014). Contactin associated protein 1 
(Caspr1) is an axonal transmembrane molecule primarily localised at the 
paranodal junctions that flank the node of Ranvier and its expression is 
greatly reduced during myelination (Einheber et al., 1997). The neuron 
specific enolase (NSE) is a well-characterised and widely used marker of 
neuroendocrine and neuronal cells (Marangos and Schmechel, 1987). KCC2 
is another neuron-specific marker with a restricted expression pattern 
guaranteed by the presence, in its gene sequence, of a neuronal transcription 
factor Egr4 binding site, which enhances KCC2 expression, and neuron 
restrictive silencing elements (Uvarov et al., 2005, 2006). 
 
Quantitative RT-PCR (qPCR) was subsequently used to analyse relative 
changes in the gene expression of neuronal markers during PC12 and NT2 
cells differentiation. mRNA quantification showed a modified gene expression 
profile of neuritin 1 (Nrn1), tropomodulin 1 (Tmod1) and contactin-associated 
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protein 1(Caspr1) during differentiation that further indicated the phenotypic 
and genotypic characteristics of neurons (Figure 3.6 and Figure 3.7). In PC12 
cells, a 2.6-fold increase in Nrn1 expression was observed after one day of 
treatment with NGF, maintained over following days and reached a seven-
fold change eight days after starting the treatment (Figure 3.6 A). The gene 
expression of Tmod1 increased 10-fold after one day of NGF treatment and 
remained relatively stable during the rest of the differentiation process (Figure 
3.6 B). Unlike Nrn1 and Tmod1, Caspr-1 displayed a 2.9-fold decrease in 
expression after one day of NGF treatment (Figure 3.6 C). This decrease was 
less pronounced three and five days after treatment reaching the maximum 
down-regulation after eight days of differentiation with a 3.3-fold decrease in 
gene expression (Figure 3.6 C). 
 
NT2 cells displayed a similar pattern of variation in gene expression following 
RA treatment. Nrn1 expression was significantly modified by a 2.1-fold 
increase after four weeks and a 3.2-fold change after six weeks (Figure 3.7 
A). Tmod1 expression was significantly increased by a 9.1-fold after four 
weeks and a 12.2-fold after six weeks (Figure 3.7 B). Finally, Caspr1 
displayed a 1.2–fold decrease four weeks following RA treatment and a 
significant 1.8-fold decrease after six weeks (Figure 3.7 C). 
 
These findings show that expression of neuritin and tropomodulin is up-
regulated in NGF-treated PC12 cells and RA-treated NT2 cells compared to 
untreated cells and that the up-regulation reaches a significant change after 
eight days and six weeks of treatment in PC12 and NT2 cells respectively. 
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Up-regulation of these genes is as characteristic of neuronal differentiation 
(Cappelletti et al., 2007; Rao et al., 2014). Furthermore, down-regulation of 
Caspr-1 gene expression is in agreement with previous studies (Lee et al., 
2005). NGF-treated PC12 cells display an increase in myelinisation and 
Caspr-1 expression is reduced during this process (Einheber et al., 1997).  
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Figure 3.6. NGF triggers neuron-like gene expression in PC12 cells.  
PC12 cells were treated with 500 nM NGF for 8 days. Relative Ntn1, Tmod1 
and Caspr1 mRNA expression in differentiated PC12 cells was analysed by 
qPCR. Results are expressed as the mean ±SEM (n=3). One-way ANOVA 
with Dunnett’s multiple comparisons test. 
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Figure 3.7 RA triggers neuron-like gene expression in NT2 cells.  NT2 
cells were treated with 10 μM RA for 4 weeks (4w) and a further 2 weeks 
with 1 µM Ara-C (6w). Relative Ntn1, Tmod1 and Caspr1 mRNA expression 
in differentiated NT2 cells was analysed by qPCR. Results are expressed 
as the mean ±SEM (n=3). One-way ANOVA with Dunnett’s multiple 
comparisons test. 
101 
 
3.1.4.3 Protein expression assessment of the directed differentiation of 
PC12 and NT2 cells via immunoblotting 
 
The expression of the different neuronal specific markers NSE and KCC2 
was assessed by immunoblotting in differentiated PC12 and NT2 cells 
(Figure 3.8). An increase in the intensity for the neuron-specific enolase 
(NSE) band was observed in differentiated PC12 and NT2 cells compared to 
undifferentiated lysates, where a low basal level was detected. This change 
was even more evident when protein lysates were analysed for the neuron 
specific chloride co-transporter KCC2. The changes observed in protein 
expression following differentiation show that treatment with NGF and RA 
induces the expression of neuron-specific protein markers in PC12 and NT2 
cells.      
 
Overall, the morphological, genetic and protein data of this study indicates 
that the treatment of PC12 cells with NGF for eight days and of NT2 cells with 
RA for four weeks and a further two weeks with 1 µM Ara-C induces a 
differentiation consistent with a neuronal-like phenotype.  
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Figure 3.8 Analysis of the neuronal markers NSE and KCC2 following 
differentiation of PC12 and NT2 cells. Representative immunoblot analysis 
showing NSE and KCC2 protein expression. PC12 and NT2 cells were left 
untreated (U) or differentiated (D) with either 500 μM NGF for eight days or 
10 μM RA for four weeks and a further two weeks with 1 µM Ara-C.  
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3.4.2 Cell viability following the induction of hypoxia in differentiated 
PC12 and NT2 cells 
 
A hypoxic chamber provides an excellent platform to investigate neuronal 
responses to hypoxia. Neuronal-like cells were incubated inside a modular 
chamber containing a 1% O2, 99% N2 gas mixture in all hypoxic experiments. 
MCF7, a breast cancer cell line, was also used as a control as it is known to 
produce robust induction of HIF-1 upon chemically-induced hypoxia (An et 
al., 1998) 
 
3.4.2.1 Assessing the impact of hypoxia on mitochondrial activity 
 
The viability of PC12 and NT2 cells were analysed in order to determine a 
suitable exposure time to hypoxia. The mitochondrial activity of differentiated 
PC12, NT2 and MCF7 cells was analysed using the Alamar blue assay after 
subjecting them to two, four, eight and 24 hours of hypoxia (Figure 3.9). 
Alamar blue was used to measure cell viability as it can be incorporated 
during the hypoxic exposure while the MTT assay needs post-hypoxia time 
for development and that would involve reoxygenation of the cultured cells.  
 
As can be seen in Figure 3.9, a hypoxic insult of two hours did not produce a 
decrease in cell viability of MCF7, PC12 and NT2 cells. MCF7 cells showed 
a strong decrease in cell viability after four hours of hypoxia, with only 35% 
of the cells being viable, 18% after eight hours and only 13% after 24 hours. 
PC12 cells also showed an intense decrease in mitochondrial respiration: 
44% after four hours, 24% after eight hours and 7% after 24 hours. Finally, 
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NT2 cells displayed a strong resistance to moderate hypoxia; at four hours 
68% of the cells were viable, 34% after eight hours and 14% after 24 hours.  
 
 Figure 3.9. Mitochondrial activity is significantly compromised by 
hypoxia. MCF7, PC12 and NT2 cells viability was analysed using Alamar 
blue two, four, eight and 24 hours after exposure to hypoxia (1% O2). Viability 
is expressed as a percentage of normoxic cell viability. Results are expressed 
as the mean ±SEM (n=3). One-way ANOVA with Tukey’s multiple 
comparisons test.  
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3.4.2.2 Assessing the impact of hypoxia on cell viability 
 
HIF-1 stabilisation during hypoxia leads to the inhibition of mitochondrial 
activity by affecting the production of NAD(P)H  (Papandreou et al., 2006) 
which is needed for reducing agent-based assays like MTT and Alamar blue. 
Thus, it is possible that the reduction observed in cell viability is actually 
reflecting a decrease in mitochondrial respiration. Therefore, an alternative 
assay was used in order to analyse the effect of hypoxia on cellular viability. 
Trypan blue is a dye exclusion test that allows the assessment of cell viability 
as it is able to enter the damaged membranes of dead cells whereas it does 
not interact with viable cells possessing intact cell membranes. Cells were 
treated for eight hours under hypoxic conditions and then the cell viability was 
analysed by the Trypan blue exclusion dye (Figure 3.10). Eight hours of 
hypoxic insult significantly decreased cell viability in MCF7 cells by 30%, 26% 
in PC12 cells and 55% in NT2 cells. At longer exposure times (24 hours) a 
large number of floating cells was observed. Eight hours of hypoxia produced 
a change in the colour of the media and this increase in the pH acidity of the 
media is thought to reflect a change in the metabolism in the cells. Therefore, 
eight hours of hypoxia was subsequently used in further experiments (unless 
otherwise stated) as it provided with a sufficient hypoxic insult yet it produced 
sufficient viable cells to analyse.   
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Figure 3.10. Cell viability was significantly reduced after 8 hours of 
hypoxia. MCF7, PC12 and NT2 cells were exposed to hypoxia (1% O2) for 
eight hours. Trypan blue was employed to record a viable:non-viable ratio. 
Results are represented as mean percentage of viable cells ± SEM of three 
independent experiments. Two-tailed unpaired Student’s t test.  
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3.4.3. HIF-1-3α changes in gene and protein expression following 
hypoxia 
 
In order to study the impact of hypoxia upon the neuronal-like PC12 and NT2 
cell lines, the expression of the HIF family of genes and proteins was 
assessed. 
  
3.4.3.1 Identifying suitable housekeeping genes 
 
In order to find a candidate reference gene that showed a stable expression 
after hypoxia, the stability of a panel of reference genes (GAPDH, CYC1, 
MDH1, B2M, ACTB, YWHAZ, 18S, CANX, UBC, RPL13A, TOP1 and ATP5B) 
was investigated. The Ct values were analysed with the geNorm algorithm, 
which selects an optimal reference gene out of a larger set of candidates. 
The so called M-value describes the variation of a gene compared to all other 
candidate genes, selecting the pair of genes with the lowest M-value as the 
optimum pair of reference genes (Vandesompele et al., 2002). Values lower 
than 1.5 are arbitrarily suggested as stable genes, with increased gene 
stability as the M-value gets smaller. The reference genes selected under our 
experimental conditions were TOP1 for PC12 and ACTB for MCF7 and NT2. 
 
3.4.3.2 HIF-1-3α changes in gene expression following hypoxia 
 
Neuronal-like PC12 and NT2 cell adaptation to hypoxic stress was 
investigated by assessing HIF-1, 2 and-3α gene expression The fold change 
in HIF-1-3 gene expression was assessed in each cell line 8 hours after 
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exposure to hypoxia (Figure 3.11). Unexpectedly, HIF-1 was not induced 
following the insult in PC12 cells and just a 1.8-fold increase was observed 
in NT2 cells. These results are in contrast with the strong 12-fold increase of 
HIF-1 transcript observed in MCF-7 cells. Surprisingly, hypoxia triggered a 
significant increase in HIF-2α mRNA expression in differentiated PC12 and 
NT2 cells (2.4- and 2.6- fold respectively, Figure 3.14) whilst HIF-2α 
expression in hypoxic MCF7 cells was significantly decreased. HIF-3α mRNA 
showed relatively stable levels of expression in PC12 and NT2 cells and was 
relatively unchanged in response to hypoxia (Figure 3.11). By contrast, HIF-
3α mRNA was dramatically up-regulated in MCF7 cells by hypoxic insult. 
These results were particularly striking, as a strong HIF-1 response was 
expected for the three cell lines. However, the robust response observed in 
MCF7 cells and the fact that all exposures were conducted in parallel for the 
different cell lines, validate the use of a modular chamber as a platform to 
induce hypoxic adaptation.  
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Figure 3.11. Hypoxia triggers up-regulation of the mediators of the 
hypoxic response, HIF-2α and HIF-3α, in neuronal-like cell lines.  
Relative HIF1-3α mRNA expression was analysed in MCF7 and differentiated 
PC12 and NT2 cells exposed to eight hours of hypoxia by qPCR. The dotted 
line represents basal gene expression. Data is expressed as mean ± SEM 
(n=3). Two-tailed unpaired Student’s t test.   
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Previous studies in endothelial cells have shown that sustained hypoxia 
progressively decreases HIF-1 mRNA expression with its level peaking after 
three hours of hypoxia and decreasing by 50% after six hours (Chamboredon 
et al., 2011). Endothelial cells are, however, the primary sensors of oxygen 
levels in the blood so a different behaviour in neuronal-like cells was 
expected. This means that eight hours of hypoxia might be a late stage to 
detect HIF-1 expression. However, the up-regulation of HIF-2 and HIF-3 
and absence of HIF-1might also suggest that neuronal cell response to 
hypoxia differs to that of endothelial cells. 
 
3.4.3.3 HIF-1-3α changes in protein expression following hypoxia 
 
HIF-1 mRNA was not induced in PC12 cells and only a small activation 
could be detected in NT2 cells; however, hypoxia causes HIF-1 stabilisation 
and it was expected that a clear induction of HIF-1 would be seen at the 
protein level. Protein expression was therefore analysed to determine 
whether transcriptional changes corresponded to translational expression of 
HIF-1 
 
MCF7, PC12 and NT2 cells were exposed to hypoxia for one, two, four, eight 
and 24 hours before HIF-1 expression was analysed by immunoblotting. 
Antibodies corresponding two different epitopes of HIF-1 were used at 400-
550 and 610-727 aa (Table 2.3, Figure 3.12). Surprisingly, HIF-1 protein 
induction was not detected in either neuronal-like cell line at any time point 
(Figure 3.13). A variety of conditions and antibody dilutions were tested in 
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order to determine whether the lack of induction was due to a technical error, 
but HIF-1 remained undetectable. By including MCF7 cells as a positive 
control for HIF-1α induction the experimental conditions of the chamber and 
validity of the antibodies was confirmed. In MCF-7 cells HIF-1 induction was 
detected two hours following the hypoxic insult as evident by two bands at 
~120 and ~115 KDa. This reached a maximum intensity at four-eight hours 
and HIF-1protein was still detected at 24 hours. MCF7 cells at eight and 24 
hours after hypoxia were then used as positive controls for the rest of the 
experiments.  
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Figure 3.12 alignment of the human and rat HIF-1 protein sequences. 
The sequences were aligned using ClustalW version 2 (Larkin et al., 2007) 
and BoxShade for the  output format .The location of epitopes bound by HIF-
1 antibodies #H1alpha67 (Abcam) corresponding to amino acids 400 to 550 
(black dotted line) and #610958 (BD Biosciences) corresponding to amino-
acids 610 to 727 (grey dotted line) are highlighted.   
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Figure 3.13. Analysis of HIF-1 protein expression in PC12 and NT2 
neuronal-like cell lines following hypoxia.  Representative immunoblots 
of HIF-1 protein expression in MCF7 and differentiated PC12 and NT2 cells 
in normoxic conditions (N) 1, 2, 4 (i), 8 or 24 (ii) hours after exposure to 
hypoxia. Immunoblotting with actin was used to check equal protein loading. 
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Bands corresponding to HIF-2 were readily detected in PC12, NT2 and 
MCF7 cells and their intensity increased after four hours of hypoxia 
(Figure3.14 A). HIF-3 expression was evident in both neuronal-like cell lines 
under normoxic conditions (Figure 3.14 B), however, a differential response 
to hypoxia was observed between PC12 and NT2 cells. HIF-3 expression 
was initially induced by hypoxia in PC12 cells yet reduced below basal 
expression at 8 hours (Figure3.14 B). By contrast, the intensity of HIF-3 
expression progressively decreased in NT2 cells after four hours of hypoxia. 
HIF-3 expression was not detected in MCF7 cells under either normoxic or 
hypoxic conditions. 
 
These results remarkably suggest that HIF-1 is not stabilised under the 
experimental conditions tested here. The up-regulation observed in the gene 
and protein expression of HIF-2 and HIF-3suggested an alternative 
adaptation to hypoxia mediated by different regulators. Apoptosis and HIF 
downstream targets were analysed in order to determine a potential minimal 
activation of HIF-1 that immunoblotting could not detect but sufficient to 
induce a transcriptional response.   
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Figure 3.14. Analysis of HIF-2 and HIF-3 protein expression in PC12 
and NT2 neuronal-like cell lines following hypoxia.  Representative 
immunoblots of HIF-2 (i), HIF-3 (ii) protein expression in MCF7 and 
differentiated PC12 and NT2 cells in normoxic conditions (N) and four, eight 
or 24 hours after exposure to hypoxia. Immunoblotting with actin was used to 
check equal protein loading (iii).  
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3.4.4 Analysis of caspase-3 –mediated apoptosis following hypoxia 
 
Differential cellular responses to hypoxia can range from adaptation of gene 
expression to apoptotic cell death under severe/prolonged hypoxia (Figure 
3.1). Caspase-3 is cleaved as a result of mitochondrial signalling and other 
pro-apoptotic factors (Porter and Jänicke, 1999); it is therefore active when 
cells are undergoing severe stress, orchestrating apoptotic signalling. Thus, 
the activation of caspase-3 in neuronal-like cell lines PC12 and NT2 was 
experimentally tested by immunoblotting after hypoxia in order to assess 
whether apoptotic death was occurring rather than adaptation. 
 
Uncleaved caspase-3 (35 kDa) is present in cell lysates after eight and 24 
hours of hypoxia and under controlled conditions of normoxia (C), however 
the active and cleaved form (17-19 kDa) was not detected under our 
conditions (Figure 3.15). The lack of cleaved caspase-3 indicates that 
caspase-3 mediated apoptosis is not occurring. The results from the gene 
and protein expression profile of HIF-1-3 (Figures 3.11, 3.13 and 3.14) 
suggest that adaptation to hypoxia is occurring in PC12 and NT2 cells, yet 
that cellular death is not taking place or at least not via caspase-3-mediated 
apoptosis.  
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Figure 3.15. Hypoxic insult does not trigger apoptosis in neuronal-like 
cells. Representative immunoblot of caspase-3 protein expression in PC12, 
NT2 and MCF7 cells following exposure to hypoxia (1% O2) for 8 and 24 
hours or left untreated under normoxic conditions (C).  
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3.4.5 Analysis of HIF-1α and HIF-2α activation via downstream target 
expression 
 
To further analyse potential differences in hypoxic adaptation in neuronal-like 
cells, regulators of HIF-1α and HIF-2α signalling were investigated. Ptbp2, 
stabilises HIF-1 mRNA promoting its translation, thus playing an essential 
role in HIF-1 protein up-regulation during hypoxia (Schepens et al., 2005). 
Ptbp2 interacts with the internal ribosome entry site (IRES) in the 5′-
untranslated region (5′-UTR) of the HIF-1 mRNA allowing its efficient 
translation during hypoxic conditions and serum starvation (Schepens et al., 
2005). Carbonic anhydrase isoform 9 (Ca9) is a transmembrane isozyme of 
the CA family that catalyses the reversible hydration of CO2. Ca9 is one of 
the most hypoxic-sensitive genes with a hypoxia-responsive element in its 
promoter region, while HIF-1 but not HIF-2α activates Ca9 transcription 
(Kaluz et al., 2009). Slc2A1 and Slc2A3, encode the glucose transporters, 
GLUT1 and 3, and their expression is regulated by HIF-1α and HIF-2α (Zhang 
et al., 2009).  
 
The fold change in Ptbp2, Ca9, Slc2A1 and Slc2A3 gene expression was 
analysed after eight hours of hypoxia in PC12, NT2 and MCF7 cells (Figure 
3.16). Ptbp2 showed a 4 and 7.6-fold change in gene expression in the 
neuronal-like cell lines PC12 and NT2 respectively, while little change was 
observed in MCF7 cells expression. Surprisingly, Ca9 expression remained 
unchanged after hypoxia in PC12 cells with a slight 1.2-fold upregulation in 
NT2 cells, whereas a 4.3-fold change in gene expression was observed in 
MCF7 cells. Slc2A1 expression was significantly increased in neuronal-like 
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PC12 and NT2 cells, and MCF7 cells in response to hypoxia (Figure 3.16). A 
small but significant increase in Slc2A3 expression was also detected in 
neuronal-like PC12 and NT2 cells following hypoxia (Figure 3.16) however 
Slc2A3 expression was not detected in MCF7 cells or induced by hypoxic 
insult (Figure 3.16). This is in keeping with the fact GLUT3 is a neuronal 
glucose transporter (Vannucci et al., 1997). 
Figure 3.16. Hypoxia triggers the up-regulation of HIF-1α dependant 
genes in neuronal-like cell lines. Relative expression of HIF-1α related 
target genes (Ptbp2, CA9, SLC2A1 and SLC2A3) were analysed in MCF7 
and differentiated PC12 and NT2 cells, eight hours after hypoxia, using 
qPCR. The dotted line represents basal gene expression. Data is expressed 
as mean ± SEM (n=3). Two-tailed, unpaired Student’s t test. 
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Cerebral hypoxia alters glucose metabolism and the expression of glucose 
transporters such as GLUT1 and GLUT3 (Vannucci et al., 1998, Maurer et 
al., 2006). Levels of GLUT1 and GLUT3 are known to be increased through 
both HIF-1α and HIF-2α -dependent mechanism under these conditions in 
the brain (Zhang et al., 2009). Here, the effect of hypoxia on GLUT1 and 3 
was assessed as a marker of hypoxia. Heat shock protein 70 (HSP70) is an 
inducible molecular chaperone, which is activated under different stress 
conditions. HSP70 is up-regulated during ischaemia in the brain (De La Rosa 
et al., 2013). The induction of HSP70 was studied in neuron-like cells after 
different treatments of hypoxia.  
 
The results displayed in Figure 3.17 show a small increase in the intensity of 
staining of the band corresponding to GLUT1 after eight hours of hypoxia in 
MCF-7 cells. However, induction of GLUT1 was not observed in PC12 or NT2 
cells following the insult.  Higher molecular weight bands were detected by 
the human anti-GLUT1 antibody. These are thought to represent post-
translationally modified forms (Kitagawa et al., 1995). GLUT3 expression was 
detected in the neuronal-like cell lines PC12 and NT2 as opposed to MCF-7 
cells, where no expression was observed. This is in agreement with previous 
studies indicating that GLUT3 is an almost exclusively neuronal glucose 
transporter (Simpson et al., 2008). Increased GLUT3 expression was not 
observed in either cell line after the hypoxic insults. HSP70 is constitutively 
expressed but up-regulated in response to different stress situations such as 
hypoxia (Giffard et al., 2008). The immunoblot for HSP70 suggests an 
activation and a minor up-regulation of HSP70 protein under our hypoxic 
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conditions in NT2 cells after four hours of hypoxia (Figure 3.17). However, 
induction was not observed in PC12 cells after four, eight or 24 hours of 
hypoxia or in MCF7 cells. 
 
 
Figure 3.17. Activation of HIF-1 related targets after hypoxia in the 
MCF7, PC12 and NT2 cell lines. Representative immunoblot of GLUT1, 
GLUT3 and HSP70 protein expression in PC12, NT2 and MCF7 cells 
following exposure to hypoxia (1% O2) for four and eight hours or left 
untreated under normoxic conditions (N). Immunoblotting with actin was used 
to check equal protein loading.  
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Despite the lack of a strong HIF-1α induction in PC12 and NT2 cells, acute 
hypoxia was achieved. MCF7 cells were used as a positive control throughout 
and hypoxia was induced simultaneously with NT2 and PC12 cells. HIF-1α 
stabilisation was rapidly detected in MCF7 cells and intense activation of HIF-
1α signalling was observed (Figure 3.16). Marked induction of Ptbp2 and 
Slc2A1 was observed in hypoxic PC12 and NT2 cells; genes thought to be 
specifically regulated by HIF-1α (Chen et al., 2001). However, many HIF-1α 
specific genes have more recently been shown to be regulated by HIF-2α, 
including Slc2A1 (GLUT-1)(Harvey et al., 2007), underscoring the importance 
of HIF-2α signalling in hypoxic adaptation of neuronal-like cells. 
 
3.4.6 Analysis of the unfolded protein response (UPR) after hypoxia 
 
Hypoxic stress triggers accumulation of misfolded proteins in the 
endoplasmic reticulum (ER) (Roussel et al., 2013). The unfolded protein 
response (UPR) serves to redress ER homeostasis by fine-tuning protein 
translation and enhancing folding capacity (Ron, 2002). Growing evidence 
suggests HIF and UPR dependent pathways interact to coordinate gene 
expression, metabolism and cell survival (Pereira et al., 2014). The unfolded 
protein response (UPR) serves primarily to restore ER function by decreasing 
the quantity of misfolded proteins that must be correctly processed in the ER 
and enhances ER protein processing capacity. There are several key 
proteins induced to protect from this damage. Amongst them, the chaperones 
glucose related protein (GRP78) (also known as BIP) and protein di-sulfide 
isomerase (PDI) are induced in order to restore the correct folding of proteins. 
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GRP78 is strongly induced by perturbations in ER protein homeostasis 
following hypoxia via HIF-1α (Paris et al., 2005).  
 
The UPR can also induce transcription of the pro-apoptotic transcription 
factor CCAAT-enhancer-binding protein homologous protein (CHOP) and 
following GRP78 release from ER stress receptors, caspase 7 and caspase 
12 are activated, thereby triggering apoptosis (Oyadomari and Mori 2004; 
Nishitoh, 2012). Thus, the UPR regulates the balance between survival and 
cell death in stressed cells, and the up-regulation of the GRPs represents a 
major adaptive protective action.  
 
Expression of UPR markers, Grp78, PDI and CHOP, was measured via 
qPCR in neuronal-like PC12 and NT2 cells, eight hours after hypoxic insult 
(Figure 3.18). Grp78 expression was unchanged by hypoxia in PC12 and 
NT2 cells yet was significantly increased in MCF7 cells (Figure 3.18). CHOP 
expression was also unchanged by hypoxia in NT2 cells yet was significantly 
reduced in hypoxic PC12 cells and increased in hypoxic MCF7 cells (Figure 
3.18). PDI expression was relatively unchanged in hypoxic PC12 cells but 
showed a small but significant reduction in hypoxic NT2 cells (Figure 3.18).  
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Figure 3.18 UPR response after hypoxia. Relative expression of UPR 
related genes Grp78, CHOP and PDI were analysed in MCF7 and 
differentiated PC12 and NT2 cells, eight hours after hypoxia, using qPCR. 
The dotted line represents basal gene expression. Data is expressed as 
mean ± SEM (n=3). Two-tailed, unpaired Student’s t test.  
 
In addition, the protein expression of the UPR markers GRP78, PDI and 
CHOP was analysed following 8 hours of hypoxia (Figure 3.19). The band 
corresponding to GRP78 was detected in PC12, NT2 and MCF7 cells 
although no changes in the intensity of the staining were detected following 
hypoxia. Strong immunostaining for CHOP was found in MCF7 and PC12 
cells and a faint band corresponding to the molecular weight of CHOP in 
NT2 cells, although changes in expression were not observable in either 
cell line. Finally, and in agreement with our previous results, PDI expression 
was detected in PC12, NT2 and MCF7 cells with no induction following 
hypoxia. Overall, this data suggests neuronal-like cells present a higher 
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resistance to ER stress following hypoxia under our experimental 
conditions. 
 
Figure 3.19. Analysis of the UPR response elements CHP, PDI and 
GRP78 protein expression in PC12 and NT2 neuronal-like cell lines 
following hypoxia. Representative immunoblot of Grp 78, CHOP and PDI 
protein expression in PC12, NT2 and MCF7 cells following exposure to 
hypoxia (1% O2) for four and eight hours or left untreated under normoxic 
conditions (N).  
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3.4.7 Characterisation HIF-2 signalling in neuron-like cells after 
hypoxia 
 
Whilst HIF-2 shares some target genes with HIF-1, it also promotes 
different adaptations to hypoxic stress (Figure 3.1, (Koh and Powis, 2012; 
Jochmanova et al., 2013). HIF-2 is responsible for the activation of EPO 
(Chavez et al 2006) which in turn regulates hematopoiesis in order to 
increase the oxygen supply. EPO has also been reported to play an important 
role during neurogenesis (Tsai et al., 2006), promoting cell proliferation, 
survival and differentiation. HIF-2α regulates expression of stem cell markers 
(Li et al., 2009) and maintains the undifferentiated state via expression of 
neural crest and stem cell-associated genes (Pietras et al., 2009). Vimentin 
and CD44 are highly expressed in neuronal precursor cells (Sanin et al., 
2013; Naruse et al., 2015), however expression declines during development 
as neurons become post-mitotic. In post-mitotic neurons, vimentin is replaced 
by neurofilaments (Arvidsson et al., 2002). 
 
Neurofilament heavy polypeptide (NEFH), vimentin, and CD44 expression in 
hypoxic neuronal-like PC12 and NT2 cells by qPCR. Neuronal marker, NEFH 
(Usoskin et al., 2014) expression was evident in differentiated PC12 and NT2 
cells yet undetected in MCF7 cells (Figure 3.20); basal expression was also 
unaffected by hypoxic insult in PC12 and NT2 cells. Vimentin expression was 
significantly up-regulated in PC12 and NT2 cells following hypoxia (Figure 
3.20). CD44 expression was also dramatically increased in hypoxic PC12 
cells, whilst expression was only modestly effected in hypoxic NT2 cells (1.6-
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fold increase, Figure 3.20). Vimentin and CD44 expression were not 
significantly altered in hypoxic MCF7 cells (Figure 3.20). 
 
 
Figure 3.20. Hypoxia triggers the up-regulation of HIF-2α dependant 
genes in neuronal-like cell lines. Relative expression of HIF-2α related 
target genes NEFH, Vimentin and CD44 were analysed in MCF7 and 
differentiated PC12 and NT2 cells, eight hours after hypoxia, using qPCR. 
The dotted line represents basal gene expression. Data is expressed as 
mean ± SEM (n=3). Two-tailed, unpaired Student’s t test. 
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The induction of HIF-2, vimentin and CD44 was also investigated by 
immunoblot (Figure 3.21). HIF-2 was induced in both PC12 and NT2 cells 
after eight and 24 hours and four and eight hours of hypoxia respectively. 
However, MCF7 cells showed a different pattern as HIF-2 was not induced 
after hypoxia. This result is in agreement with the down-regulation in the HIF-
2 gene expression following hypoxia in MCF7 cells (Figure 3.11). CD44 was 
markedly activated in NT2 cells after four hours and a strong expression was 
still present after eight hours. MCF7 showed again a different behaviour to 
PC12 and NT2 cells, as a faint activity was detected in normoxia, which was 
further down-regulated after 24 hours of hypoxia. Finally, a strong band at 50 
kDa corresponding to the molecular weight of vimentin was detected in NT2 
cells and an up-regulation was observed after four and eight hours of hypoxic 
insult. Vimentin was not detected in either MCF7 cells, suggesting no 
expression of this protein, or PC12 cells. CD44 and vimentin were not 
detected in PC12 cells due to a lack of epitope availability for the human-
specific CD44 and vimentin antibodies in rat PC12 cells. 
 
Together these findings show strong induction of HIF-2α regulated genes in 
hypoxic neuronal-like cells and suggest the HIF-2α dependant cellular 
regeneration arm of the adaptive hypoxic response predominates over the 
HIF-1α arm in neuronal-like cell lines following acute hypoxia. 
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Figure 3.21. Activation of the HIF-2 response after hypoxia in MCF7, 
PC12 and NT2 cells. Representative immunoblot of Cd44 and vimentin 
protein expression in PC12, NT2 and MCF7 cells following exposure to 
hypoxia (1% O2) for four and eight hours or left untreated under normoxic 
conditions (N). Immunoblotting with actin was used to check equal protein 
loading.  
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3.4.8 Hypoxia promotes a regression to undifferentiated states in 
neuronal-like cells 
 
NSE and KCC2 are dramatically induced following neuronal differentiation of 
PC12 and NT2 cells (Figure 3.8). NSE and KCC2 expression was assessed 
by immunoblotting to determine whether hypoxia could reverse neuronal-like 
differentiation. The dramatic increase in NSE expression was attenuated 
following hypoxia in differentiated PC12 cells, whereas NSE expression 
remained unchanged by hypoxia in differentiated NT2 cells (Figure 3.22). The 
striking induction of KCC2 expression observed following differentiation was 
also dramatically reversed in hypoxic PC12 cells after as little as 8 hours of 
hypoxic insult and severely reduced in hypoxic NT2 cells (Figure 3.22). 
 
Differentiated PC12 and NT2 display neurite-like processes and gangliar 
structures (Figures 3.2, 3.3 and 3.5). The neuronal-like morphology was 
dramatically modified in as little as 8 hours of hypoxic insult (Figure 3.23); the 
number of PC12 and NT2 cells presenting with neurites was dramatically 
reduced and the length of neurites was evidently shortened. 
 
These results combined with the observed HIF-2α dependant induction of 
neural progenitor cell markers (Figures 3.20 and 3.21) suggest adaptations 
promoted by HIF-2α following hypoxic insult could drive neuronal-like cells 
into a more undifferentiated and potentially stem-like phenotype. 
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Figure 3.22 Hypoxia induces the loss of neuronal markers in PC12 and 
NT2 cells. Representative immunoblot of NSE and KCC2 protein expression 
in PC12 and NT2 cells undifferentiated (U), differentiated (D) or differentiated 
cells following exposure to hypoxia (1% O2) for eight hours (H). 
Immunoblotting with actin was used to check equal protein loading.  
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Figure 3.23. Hypoxia induces the change in the morphology of neuron-
like cells into undifferentiated-like states. Representative bright-field 
microscopy images of differentiated PC12 and NT2 morphology after 
exposure to 8 hours of normoxia or hypoxia (20 x magnification). Scale bar 
represents 50 μm. White arrows indicate interlaced axon-like structures and 
black arrows indicate ganglion-like clusters. 
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3.5 Discussion 
 
3.5.1 PC12 and NT2 cells as a model of neuronal-like cells 
 
Morphological analysis, membrane staining and the analysis of the changes 
in gene and protein expression of PC12 and NT2 cells during differentiation, 
showed the methodology used offered a confident source of post-mitotic and 
fully differentiated neuron-like cells. The neuronal characteristics of these 
differentiated cell lines have been extensively covered in the literature (Haile 
et al., 2014, Jeon et al., 2010, Kumar et al., 1998, Neelands et al., 1998, 
Podrygajlo et al., 2009). In this study, the morphological changes observed 
and the neurite extension over time, indicated a neuron-like phenotype 
(Figures 3.2 to 3.5). Furthermore, the changes in the gene expression of 
neuritin, tropomodulin and Caspr-1 and protein expression of NSE and KCC2 
further indicated the differentiation into a neuron-like genotype (Figures 3.6 
to 3.8). 
 
PC12 and NT2 cells have been extensively used as a model for studying 
neuronal differentiation and neurological pathologies such as stroke 
(Tabakman et al., 2002, Pedersen et al., 2007, Angelica and Fong, 2008, Lan 
et al., 2011, Chiu et al., 2014). NT2 cells have undergone phase one and two 
clinical trials as cell grafts for stroke patients (Kondziolka et al., 2005, Manley 
et al., 2015). Therefore, it can be concluded that differentiated PC12 and NT2 
cells are a valid source of neuronal-like cells in order to study molecular 
responses to hypoxia very similar to those encountered in vivo after a stroke. 
Furthermore, the advantage of in vitro models of cerebral ischemia is that 
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they can provide information at a cellular and molecular level on the 
mechanisms behind the insult that are not possible in vivo. However, our 
model represents a neuronal-like cell culture, whereas the brain is composed 
of a great number of different cellular types, with astrocytes playing a major 
role in regulating neuronal behaviour and the response to ischaemic insults 
(Takano et al., 2009) and this should be considered when extrapolating 
results. 
 
3.5.2 HIF-1 – mediated response to hypoxia in neuronal-like cell lines 
 
Many studies have addressed the involvement of HIF-1α in neuronal 
adaptation to hypoxia (Sharp and Bernaudin 2004; Ratan et al., 2007) and 
point to HIF-1α as the major regulator of the hypoxic response (Figure 3.1). 
HIF-2α, HIF-3α and their downstream pathways have received far less 
attention, however more recent work shows HIF-2α signalling is an essential 
component of hypoxic adaptation. HIF-1α is preferentially activated under 
severe (≤ 1% O2) or acute (≤ 24 hours) hypoxia whilst HIF-2α activation 
occurs under more physiological hypoxia (≤ 5% O2) and persists under 
chronic (≥ 24 hours) insult (Koh and Powis, 2012, Koumenis, 2006). In reality, 
these pathways are complimentary and co-ordinated signalling, and both 
HIF-1α and HIF-2α are required to promote survival and adaption following 
hypoxic insult (Figure 3.1). To our knowledge, this is the first study to dissect 
the importance of HIF dependant adaptation and downstream signalling in 
neuronal-like cells following hypoxia. 
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HIF-1α expression and induction following hypoxia has previously been 
reported in PC12 and NT2 cells (Frøyland et al., 2008; Zhdanov et al., 2013) 
therefore our observed lack of HIF-1α induction and signalling was surprising. 
However, closer scrutiny reveals fundamental methodological differences 
which account for this; employing undifferentiated cells (Hui et al., 2006; 
Koumenis, 2006), cells cultured on uncoated plates (Naranjo-Suárez et al 
2003), using different exposure times (Li et al., 2015) or oxygen 
concentrations conferring mild hypoxia (Zhdanov et al., 2013). Our model 
utilises fully differentiated post-mitotic neuronal-like cells, therefore is more 
representative of neuronal cell function than undifferentiated cells. 
 
Despite the lack of HIF-1 induction in PC12 and NT2 cells, it was clear that 
the methodology and hypoxic conditions were appropriate. The drop in the 
pH of the media (seen through the change of colour in the media) and MCF7 
cells hypoxic induction, performed in the same chamber at the same time, 
indicated that hypoxia was taking place (Figure 3.16, A and C), so there was 
no methodological problem. However, the induction of Ptbp2 (Figure 3.16), 
which is specifically controlled at a transcriptional level by HIF-1(Chen et 
al., 2001), indicates that the activation of this transcription factor takes place 
but might not be detected with our experimental approach. 
 
HIF-1 regulation is complex and factors other than oxygen might contribute 
to the activity of this transcription factor (Koh et al., 2008). It is important to 
know that both neuroprotective and detrimental effects of HIF-1 have been 
observed in different models of ischemia (Helton, 2005; Baranova et al., 
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2007). A more recent study with knockout mice, has revealed that the 
combined loss of HIF-1 and HIF-2 is detrimental for functional recovery 
after stroke but surprisingly beneficial in the early acute phase of stroke 
(Barteczek et al., 2016). Thus, the spatial, temporal and severity-dependent 
role of HIF-1and the molecular mechanisms involved in its actions are in 
need of further research.  
 
PC12 and NT2 cell lines subjected to hypoxic insults appear to be resistant 
to the activation of HIF-1. Data shown here indicates that neuronal-like cells 
might use an alternative method of adaptation to hypoxia mediated by an 
interplay of the different members of the HIF family of transcription factors 
rather than the general conception of HIF-1 as the major regulator of the 
hypoxic response. Interestingly, we show how HIF-2 and HIF-3 transcripts 
are up-regulated following hypoxia and how this response seems to be 
dominant over the HIF-1 mediated response.  
 
3.5.3 HIF-2 as a novel mediator of the hypoxic response in neuronal-
like cell lines  
 
Many studies have addressed the involvement of HIF-1 in neuronal 
adaptation to hypoxia. The involvement of HIF-2 and specially HIF-3 and 
their downstream pathways has on the other hand been generally 
disregarded by the scientific community. To our knowledge, this is the first 
study that combines the different HIF-mediated responses and their 
downstream metabolic counterparts on neuronal-like cells following hypoxia. 
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The major finding of this study was that hypoxia activates the pro-proliferative 
HIF-2α pathway in PC12 and NT2 cells (Figure 3.20) and that this response 
seems to be dominant over the HIF-1pathway. Furthermore, up-regulation 
of the stem cell marker, CD44, and the early progenitor neuronal marker, 
vimentin, indicates a regression of this cells to pro-proliferative states after 
hypoxia. NGF mediates the down-regulation of HIF-2 at a protein level in 
PC12 cells (Naranjo-Suárez et al., 2003). However, under our experimental 
conditions, both hypoxic and normoxic PC12 cells had been treated with NGF 
and HIF-2protein expression was detected.  
 
Surprisingly, neuronal-like PC12 and NT2 cells are resistant to HIF-1α 
stabilisation in response to acute hypoxia (Figures 3.11 and 3.13) and 
activation of HIF-1α dependant downstream signalling was absent (Figures 
3.16 to 3.20). Instead, significant induction of HIF-2α mRNA and stabilisation 
of HIF-2α and HIF-3α protein was evident in hypoxic PC12 and NT2 cells 
suggesting the HIF-2α arm of the hypoxic adaptive response may 
predominate over HIF-1α dependant mechanisms in neuronal-like cells. 
 
HIF-2α regulates several target genes involved in cell proliferation and 
regeneration, including OCT4; a transcription factor which maintains stem-
cell-like characteristics (Nichols et al., 1998) and human embryonic and adult 
neural stem cell pluripotency (Forristal et al., 2010; Kim et al., 2009). HIF-2α 
signalling also maintains cells in an undifferentiated state. Increased 
expression of the stem cell marker, CD44 and early neuronal progenitor 
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marker, vimentin was readily observed in hypoxic neuronal like cells (Figure 
3.23 and 3.24) and was accompanied by loss of neuronal markers, NSE and 
KCC2 and neuronal morphology (Figure 3.25 and 3.26). HIF-2α dependant 
hypoxic adaptation therefore promotes regression of neuronal-like cells to a 
more undifferentiated, and potentially proliferative, state. By reverting 
neuron-like cells to a more stem cell-like state, HIF-2α dependant mechanism 
may to trigger regeneration and neuronal recovery following hypoxic insult 
(Figure 3.1). Preferentially activating the HIF-2α dependant arm of the 
hypoxic adaptive response could therefore represent a novel strategy to 
minimise damage associated with ischaemic stroke and promote 
neurorehabilitation. 
 
In the brain, adult neurogenesis takes place in the subgranular zone of the 
hippocampus and the subventricular zone (Ming and Song, 2011). It is well 
accepted that neurogenesis can also be driven by astrocytes acting as neural 
stem cells (Doetsch 2003). Neurogenesis in other adult CNS regions is 
generally believed to be very limited under normal physiological conditions, 
but could be induced after injury (Gould, 2007). Stroke induces cell 
proliferation and migration of new neurons to infarct sites, the vast majority 
of which fail to survive over long-term, presumably due to a lack of functional 
connections and trophic support (Arvidsson et al., 2002). However recent 
evidence suggest that neurogenesis can take place in areas that are normally 
non-neurogenic like striatum and cerebral cortex (Lindvall and Kokaia, 2015). 
Mild hypoxia (3 hours) has been shown to induce neuronal proliferation 
(Bossenmeyer-Pourié et al., 1999), although this study used cultured 
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embryonic rat brain cells which may have an increased resistance to hypoxia. 
Exogenous administration of EPO, a HIF-2 target, has also been shown to 
induce angiogenesis and neurogenesis after neonatal ischaemia in rats (Iwai 
et al., 2007). A recent work by Barteczeck et al. (2016) with knockout mice 
for HIF-1 and HIF-2 suggests partial compensatory mechanism between 
the two transcription factors but also reveal how specific target genes, such 
as EPO, are differentially regulated. 
 
It is crucial to understand the mechanisms that promote self-repair and how 
non-neurogenic areas in the brain can revert to neural stem/progenitor cells. 
Our results show the HIF-2 pathway predominates over the HIF-1 pathway 
and that this adaption could promote regression to proliferative states. By 
completely understanding this mechanism and translating these results to in 
vivo models, it could represent a novel therapeutic approach to stimulate 
recovery after stroke. 
 
Ischaemic neuronal injury is a multifunctional process (Martín-Aragón Baudel 
et al., 2017). Spatial and temporal factors combined with the intensity of 
ischaemic challenge will all impact upon HIF dependant adaptation and 
whether downstream signalling promotes neuroprotection, ischaemia 
induced cell death or neuroproliferation. These areas require significantly 
greater research. Specific therapeutic agents targeting HIF-1α and HIF-2α 
are needed to delineate the intricacies of HIF signalling and understand their 
therapeutic potential. Desferoximine pretreatment can reduce the neuronal 
lesion in global ischaemia in mice (Baranova et al., 2007), whilst exogenous 
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administration of HIF-2α’s target, EPO can promote angiogenesis and 
neurogenesis following neonatal ischaemia in rats (Iwai et al., 2007). 
 
Understanding the mechanisms involved in promoting self-repair and how 
non-neurogenic areas in the brain can revert to neural stem/progenitor cells 
is crucial. Our results show the HIF-2α arm of the hypoxic adaptive response 
may predominate over the HIF-1α arm and indicate this could promote 
regression to proliferative states. Therapeutic manipulation of the 
endogenous pathways driving neuronal adaptation to hypoxic stress could 
represent exciting possibilities to promote neurogenesis in the penumbra and 
enhance neuronal recovery after ischaemic stroke.  
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4. Characterising the penumbra in a 
photothrombotic model of ischaemic stroke 
 
4.1 Introduction  
 
Human neuronal tissue is rapidly and irretrievably lost in the brain as stroke 
progresses. It is estimated that a typical patient will lose 1.9 million neurons 
each minute if untreated (Saver 2006). This loss adds to the morbidity and 
disability that takes place following an ischaemic injury. It is therefore critical 
to rapidly salvage and protect the affected neuronal tissue in order to reduce 
morbidity and increase the quality of life of stroke survivors.   
 
4.1.1 The ischaemic core and penumbra in stroke 
 
The evolution of damage in stroke is a dynamic and spatiotemporal process. 
The ischaemic core is the infarct area immediately affected by the reduction 
in blood supply to the brain and occurs when blood flows is less than 30% 
(Yu et al., 2016). It is characterised by suffering from rapid and irreversible 
neuronal loss and is therefore considered as non-salvageable tissue (Olsen 
et al., 1983). The penumbra surrounds the ischaemic core in the peri-infarct 
zone, where the blood supply is sufficient to be salvaged due to collateral 
blood supply (Astrup et al., 1981). However, collateral arteries are not 
sufficient in the long term to sustain the energetic demands of this area 
subsequently it is characterised by a serious reduction of normal 
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physiological function and hypoxic adaptation (Figure 4.1). If untreated, in the 
hours and days following an ischaemic event, the penumbra develops 
towards a core-like state due to repeated deleterious events that spread out 
from the core, including excitotoxicity, peri-infarct depolarisations, oxidative 
stress and inflammatory responses that ultimately increase the volume of the 
infarct (Hartings et al., 2003). If reperfusion of the tissue takes place in a 
timely fashion, the penumbra can be salvaged and increased penumbral 
volume correlates with improved neuronal recovery. Therefore, it is of critical 
urgency to develop neuroprotective strategies targeted towards reducing 
neuronal loss in the penumbra thus, improving patient outcome (Ramos-
Cabrer et al., 2011; Martín-Aragón Baudel et al., 2017). Subsequently, this 
would alleviate the tremendous social and economic burden of stroke.  
 
Numerous studies have revealed the importance of the molecular events that 
take place in the penumbra in order to identify potential neuroprotective 
targets in this area (Del Zoppo et al., 2011; Iadecola and Anrather 2011). 
However, many of these studies fail to precisely characterise the penumbra 
in the animal model used and simply refer to this as the peri-infarct region. 
This is the first study to investigate the spatial and temporal development of 
the penumbra in mouse cortex in the five days following photothrombotic 
stroke (PTS) utilising a molecular approach (Figure 4.1). Different markers of 
the penumbra were used in order to map the molecular processes occurring 
in this area, such as apoptosis, neuronal stress and the formation of a glial 
scar. For the first time in the mouse model of PTS, the molecular 
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characterisation elucidated the precise location of the penumbra around the 
infarct in order to identify potential neuroprotective targets. 
 
4.1.2. Imaging the ischaemic core and penumbra 
 
Various approaches have been employed to locate the penumbra and 
distinguish it from the ischaemic core and adjacent healthy tissue. Imaging 
regional cerebral blood flow provided the basis for defining core and 
penumbra (Astrup et al., 1981) and thus, positron emission tomography 
(PET) was long considered as the gold standard to identify this region in 
clinical diagnosis (Baron 1996). However, the limited availability and high cost 
of this technique has recently turned attention to magnetic resonance 
imaging  (MRI) and whole brain computed tomography perfusion (CTP), 
which have allowed selection of eligible patients for reperfusion therapy 
outside the normal treatment window of 4.5 hours following the stroke onset 
(Kidwell 2013; Yu et al., 2016). Better brain imaging techniques are needed 
to select patients who can benefit most from identification of penumbral 
tissue, which would be at risk of further infarction if reperfusion of the infarcted 
zone is not achieved. 
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Figure 4.1. The ischaemic core and penumbra. Two physiologically and molecularly defined areas develop following a 
thrombus formation in the brain; the ischaemic core and the penumbra. Characteristics and adaptations are indicated. The 
ischaemic core, containing necrotic neurons, glial scar and stressed neurons in the peri-infarct zone are shown. Potential 
location of the penumbra within peri-infarct area is also indicated.
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4.1.3 Models of Ischaemic stroke 
 
In vitro models of ischaemic stroke do not fully replicate the conditions 
observed in human disease, therefore animal models are needed to study 
the mechanisms involved in development of ischaemic cell death and neural 
repair following stroke. Various animal models have been employed 
(Carmichael 2005; Casals et al., 2011), however, these models differ widely 
in their ability to simulate the conditions observed in humans following 
ischaemic stroke, and have limitations. Furthermore, poor characterisation of 
these have contributed to failure of numerous clinical trials due to low 
translational success rate from animal findings into patients (Dirnagl and 
Endres 2014).  
 
Middle cerebral artery occlusion (MCAO) remains the most widely used 
rodent model as it closely replicates the conditions of an ischaemic stroke. 
However, this model produces a very large infarct that does not relate to the 
infarction size observed in humans (Figure 4.2). MCAO also presents 
problems of reproducibility as well as local issues with surgery-derived 
trauma (MacRae 2011). Some models are best suited to study mechanisms 
of cell damage whereas others are more appropriate to study neural repair 
(Fluri et al., 2015). Choosing the appropriate model is critical in order to 
increase the translational success of bench findings. 
 
The photothrombotic stroke (PTS) model was refined in rats by Watson and 
colleagues in 1985. In this model, a light sensitive dye (Rose Bengal) is 
administered through intraperitoneal injection. When illuminated, through the 
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intact skull, with a cold light source, the dye releases singlets of oxygen, 
which in turn leads to damage of endothelial cells, platelet aggregation and 
clot formation in a defined region of the brain. The main advantages of this 
technique are that it is highly reproducible; it affects a highly delimited area 
of the brain (Figure 4.2) and is less invasive than other techniques to induce 
ischaemic damage (Carmichael 2005; Labat-gest and Tomasi 2013). 
Furthermore, in PTS, the contralateral hemisphere is not damaged, providing 
a useful control for the infarcted ipsilateral hemisphere. However, the PTS 
procedure also has limitations as it occludes a large number of vessels in the 
illuminated area; this, differs in most cases of thrombotic stroke in humans, 
where the interruption of blood flow takes place in a single terminal artery. 
Finally, the resulting penumbra in the PTS is thought to be reduced in size 
compared to MCAO (Figure 4.2; Witte et al., 2000), but it has proven sufficient 
to provide a useful platform to study the molecular mechanisms that induce 
neuronal damage and neuronal repair following ischaemic stroke. 
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Figure 4.2. Comparison of the lesion volume induced by MCAO, 
photothrombotic stroke and a typical human stroke. A: Coronal section 
of a rat brain 24 hours post-MCAO stained with triphenyl tetrazolium chloride 
(TTC) showing the infarcted area (clear stain) and the healthy tissue (red 
stain) (Image taken from Connell et al., 2013). B: TTC-stained mouse brain 
five days post-PTS, (Image taken from Bierbower et al., 2015). C: T2-
weighted MRI image from a stroke patient with an infarct more representative 
of average human stroke size (Image taken from Carmichael 2005). Stars 
indicate the location of the infarct. 
 
4.1.4. Molecular markers of the penumbra 
 
The assessment of potential neuroprotective markers within the penumbra 
requires characterisation of its extent and evolution in the days following 
ischaemic stroke, allowing identification of molecular events intrinsic to this 
region. Molecular events within the penumbra involve translational arrest 
through the unfolded protein response (UPR) (DeGracia and Hu 2007), high 
concentrations of intracellular calcium that lead to free radical release 
(Szydlowska and Tymianski 2010) and other cellular cascades that ultimately 
can ultimately activate apoptosis. These molecular events contribute to the 
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progression of the penumbra towards a non-salvageable core-like state. The 
increase in expression of several markers, such as glial fibrillary acidic protein 
(GFAP) (Hoehn et al., 2005; Huang et al., 2014), heat shock protein 70 
(HSP70) (Zhan et al., 2009; De La Rosa et al., 2013), hypoxia-inducible factor 
1 alpha (HIF-1 (Bergeron et al., 1999), caspase 3 (Deng et al., 2016)  or a 
diminished immunoreactivity of microtubule-associated protein 2 (MAP2) 
(Popp et al., 2009) have previously been used to identify the penumbra in 
both animal models and human patients. 
 
4.1.4.1 Caspase-3  
 
Neuronal apoptosis is a major factor driving the development of the 
penumbra towards a core-like state following ischaemic stroke. Neurons 
undergo apoptosis in the hours after stroke through the activation of caspase-
3 (Kim et al., 2000). Once cleaved and activated, caspase-3 is the key 
executioner of the apoptotic cascade and is upregulated by increased 
intracellular concentration of calcium (Juin et al., 1998). Caspase-3 
expression and activity are significantly increased in the brain following stroke 
(Manabat et al., 2003), and there is a correlation between increased caspase-
3 expression, infarct expansion and poorer neurological outcome in human 
patients (Rosell et al., 2008). Cleaved caspase-3, as a marker of apoptosis, 
could therefore represent a useful marker of the penumbra.  
 
Autophagy has revealed itself as another important process linked with cell 
death in the penumbra (Rami and Kögel 2008). LC-3 and Beclin-1 are both 
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well characterised markers of autophagy and are found to be increased in the 
penumbra following ischaemia (Rami and Kögel 2008; Pamenter et al., 
2012). Whether the activation of autophagy presents advantageous or 
detrimental effects on neuronal survival remains to be ascertained. Finally, 
necrotic mechanisms of cellular death have also been demonstrated 
following an ischaemic insult in the penumbra, therefore the involvement of 
either apoptosis or necrosis depends on the severity of injury and the 
presence of reperfusion (Yuan 2009). 
 
4.1.4.2 HSP70 
 
When endoplasmic reticulum (ER) function is disrupted by stress, such as 
ischaemia, the UPR is activated (DeGracia and Hu 2007). Therefore, 
following stroke there is an increase in the number of misfolded proteins in 
the penumbra (Caldeira et al., 2014). The UPR-mediated response includes 
a global decrease in protein synthesis and a concurrent increase in the 
expression of proteins involved in the UPR stress response in order to clear 
misfolded proteins and decrease the demand on ER function (Yang and 
Paschen 2016).  
 
HSP70 is a molecular chaperone. Its expression is induced under different 
cellular stress conditions (Brown 2007).  HSP70 binds to nascent 
polypeptides preventing their aggregation and supporting their proper protein 
folding and trafficking across intracellular compartments (Mayer and Bukau 
2005). HSP70 is particularly relevant in ischaemia as it is considered to have 
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neuroprotective potential (Rajdev et al., 2000).  HSP70 mRNA and protein 
expression is strongly induced in neurons of the penumbra, while HSP70 
expression is not found in neurons within the core (Zhan et al., 2009; De La 
Rosa et al., 2013).  HSP70 has also been reported to play a role in reducing 
post-stroke brain damage through anti-inflammatory mechanisms (Doeppner 
et al., 2013). 
 
The many protective roles of HSP70 in ischaemia are summarised in Figure 
4.3. HSP70 is involved in downregulating the activity of the pro-apoptotic 
agents Fas, SMAC and the Tumour Necrosis Factor Receptor (TNFR), and 
inducing the anti-apoptotic protein Bcl-2 (Giffard et al., 2008).  
Overexpression of HSP72, a member of the HSP70 family of proteins, also 
provides neuroprotection (Xu et al., 2011). Therefore, HSP70 and its family 
members play a central role in adaptation to ischaemic stress and cell death 
and are considered to be excellent markers of stressed neurons within the 
penumbra of ischaemic stroke (Popp et al., 2009). 
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Figure 4.3. HSP70 is involved in modulating distinct cell death pathways 
induced by ischaemia. Green arrows indicate increased activity or 
expression and the red barred ends indicate steps that are blocked, or 
reduced when HSP70 is overexpressed. Cyt C = cytochrome c; Casp 9: 
caspase 9; JNK: c Jun N terminal Kinase; Apaf-1: apoptosis protease 
activating factor 1; ROS: reactive oxygen species; AIF: apoptosis inducing 
factor; Bcl-2 (B-cell lymphoma 2); Bax (Bcl-2 Associated X); Smac (Second 
Mitochondria-Derived Activator Of Caspase) (adapted from Giffard et al., 
2008).  
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4.1.4.3 GFAP 
 
Glial cells is the ‘umbrella’ term that refers to microglia, oligodendrocytes and 
astrocytes. Following a stroke there is an increase in the number of glial cells 
found in the area bordering the infarct core, which is known as the glial scar 
(Figure 4.1). This scar surrounds the area of damage, and confers both 
beneficial and detrimental effects on ischaemic tissue (Liddelow and Barres 
2016). One of the hallmarks of molecular and cellular events after ischemia 
in the penumbra is astrogliosis, which is characterised by the increased 
presence of reactive astrocytes with enhanced expression of GFAP (Barreto 
et al., 2011). In addition to the activation of GFAP-positive astrocytes within 
the area, glial cells  from the subventricular zone have been shown to 
proliferate and migrate to the border of the infarcted area (Figure 4.1, Shen 
et al., 2010; Abeysinghe et al., 2014). 
 
During the acute phase of ischaemia, the glial scar prevents the spread of 
the core, stimulates revascularisation of blood capillaries, promotes axonal 
regeneration (Anderson et al., 2016) and limits the responses to 
inflammation, growth factors and free radicals (Rolls et al., 2009). However, 
the scar can interfere with the innate process of axonal sprouting, by 
secreting growth-inhibitory molecules such as chondroitin sulphate 
proteoglycans and creating a physical barrier to regenerating axons 
(Carmichael et al., 2016). Thus, the beneficial or detrimental role of the glial 
scar may be time-dependent; it appears to be beneficial in the acute phase, 
but detrimental to the promotion of recovery (Liddelow and Barres 2016). 
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Aged animals, which are more likely to suffer from a stroke, present an 
increased astrocytic and microglial reactivity in the peri-infarct zone, which 
may account for their reduced functional recovery compared to younger 
animals following ischaemic stroke (Badan et al., 2003; Anuncibay-Soto et 
al., 2014).  
 
Most research in the field of molecular adaptation in the penumbra following 
ischaemic stroke investigates responses in the peri-infarct area (which 
includes penumbra and healthy tissue), often lacking an in-depth 
characterisation of the penumbra. Therefore, the results obtained in some 
studies could potentially over/underestimate findings due to an overlap 
between penumbra and healthy tissue.  
 
The aim of this study was to fully characterise the evolving penumbra in the 
photothrombotic model of stroke, focusing on markers of adaptation to cell 
stress (HSP70), neuronal death (Caspase-3) and the glial response (GFAP). 
Careful analysis of relevant markers allows characterisation of the 
parameters of the penumbra and map the development in the days following 
PTS. It would also provide a platform to study different molecular 
mechanisms involved in the development of the injury. 
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4.2 Aims 
 
Aim 1. To characterise the evolution of tissue damage in the mouse 
photothrombotic stroke (PTS) model of ischaemic stroke. 
 
Aim 2. To assess the extent of the glial scar and the penumbra in the days 
following PTS in order to establish the parameters of the peri-infarct zone.  
 
Aim 3. To assess neuronal loss in the penumbra. 
 
4.3 Research Questions 
 
RQ1. Are any of the hypothesised biomarkers currently suggested to identify 
neuronal death, stress and glial response valid for defining the penumbra? 
 
RQ2. What is the extent of the penumbra in the days following 
photothrombotic insult? 
 
RQ3. Is there neuronal loss in the penumbra in the days following the 
photothrombotic insult contributing to the expansion of the ischaemic core? 
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4.4 Results  
 
4.4.1 Visual assessment of the region of neuronal injury surrounding 
the ischemic core 
 
The photothrombotic stroke was performed in mice two mm caudal to the 
bregma point and two mm lateral to the sagittal suture, a region that includes 
a large part of the sensorimotor cortex of the brain (Paxinos and Franklin 
2013) (Figure 4.4 A). Following PTS, the two hemispheres were separated 
and labelled as ipsilateral (damaged) and contralateral (non-damaged) and 
sectioned obtaining transversal rostrocaudal slices (following the head to tail 
axis) of 40 µm. Visual observations allowed the identification of the damage 
(Figure 4.4 B) and therefore brains that showed a similar infarcted area and 
location were used for further analysis to avoid differing extents of injury. 
 
Figure 4.4. The photothrombotic injury location. (A) Schematic 
representation of the location of the injury in the mouse brain (red dot), which 
was located two mm caudal to the bregma point and two mm lateral to the 
sagittal suture and had a diameter of 1.5 mm.  (B) Representative image of 
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a three month-old Swiss mouse brain following photothrombotic stroke 
showing the injured area (red dot).  
 
Cresyl Violet is an organic compound that stains the Nissl substance in the 
cytoplasm of neurons (Krutsay 1970). It is used to assess the damage in 
infarcted areas, as it allows morphological characterisation of different brain 
regions, and regions of proliferation showing a darker stain. The ischaemic 
core was evident following PTS in all the brains analysed as this area was 
lost following the sectioning of the brains and immunostaining procedure. 
(Figure 4.5 black arrows). Cresyl violet staining demonstrated that the 
infarcted area was located in the frontal cortex and the extent of the infarct 
was reproducible (Fig. 4.5 A, B and C). Images of brains at days one, three 
and five following PTS showed some differences in staining between the 
various time points analysed. Neuronal proliferation (red arrows) appeared at 
the edges of the damaged area (darker stain) three and five days following 
PTS (Figure 4.5 B and C) but not one day post insult (Figure 4.5 A). Figure 
4.5 A-C represent a comparison between three brains from different animals 
and further variances were attributed to differences between sections and 
during the Nissl staining procedure. The region affected by PTS consistently 
included areas of the motor and somatosensory cortex (Figure 4.5 D) 
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Figure 4.5. Damage inflicted by photothrombotic insult in mouse is 
reproducible in extent and location. Representative images of 40 μm 
transversal rostrocaudal sections of the ipsilateral brain stained with cresyl 
violet, one (A), three (B) and five (C) days after photothrombotic injury. 
Different brain regions are observed: Cx: Cortex; Hp: Hippocampus; CC: 
Corpus callosum.  Black arrows indicate the area were the injury was 
performed, red arrows indicate areas of potential proliferation. D Schematic 
representation of the ischaemic core, peri-infarct and penumbra in the 
photothrombotic model of stroke. The peri-infarct zone is located between the 
primary somatosensory cortex (SSp Cx) and primary motor cortex (MO Cx). 
Image modified from Allen Mouse Brain Atlas (2015). 
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4.4.2 Identifying markers of penumbral tissue in a model of PTS 
 
The penumbra is the partially perfused area surrounding the ischaemic core. 
It is a region where apoptotic cell death takes place, neurons undergo protein 
stress and there is an activation and migration of glial cells to form the glial 
scar. Therefore, caspase-3, HSP70 and GFAP were used as markers of 
these processes, respectively, to determine whether they would be suitable 
to analyse the evolution of the penumbra in the days following PTS. 
 
4.4.2.1 Assessment of apoptosis in the penumbra 
 
In order to determine whether apoptotic mechanisms were activated in 
response to ischaemic damage in the area surrounding the photothrombotic 
injury, cleaved caspase-3 expression was assessed via confocal microscopy. 
Immunolabelling of this protein was confined to the area immediately 
surrounding the injury (Figure 4.6 A). Specific expression of cleaved caspase-
3 was detected in single cells in the area bordering the infarcted core one, 
three and five days after the injury (Figure 4.6 C, D and E). Expression of 
cleaved caspase 3 was not detected in the contralateral hemispheres (Figure 
4.6 B). Apoptosis was therefore evident up to five days following PTS. 
However, expression of cleaved caspase-3 was low and concomitant high 
level background staining was observed in the contralateral and ipsilateral 
hemispheres (Figure 4.6). Furthermore, cleaved caspase-3 immunolabelling 
did not define a specific region with physiological relevance as expression 
was only evident in discrete cells, therefore it was deemed unsuitable as a 
marker to determine location and extension of the penumbra in this model. 
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Figure 4.6. Caspase-3-mediated apoptosis is observed in the peri-
infarct zone surrounding the ischaemic core. Representative images of 
mouse cortex following PTS immunostained for cleaved caspase 3 (green) 
and DAPI (blue). A: Tile scan representing the full extent of the damaged 
area (10 x magnification) one day following PTS in the ipsilateral hemisphere 
(ipsi). Scale bar represents 200 μm. Higher magnification (63x) representing 
single cells positive for cleaved caspase 3 (arrows) in contralateral 
hemisphere (contra) (B), one day (C), three days (D) and five days (E) 
following the insult. Scale bar represents 20 μm. 
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4.4.2.2 Assessing cell stress in the penumbra 
 
Cleaved caspase-3 staining did not allow precise definition of the extent and 
location of the penumbra, therefore, an alternative marker was employed. 
Heat shock proteins (HSPs) have a function in the adaptive response to 
hypoxic insults by participating in protein-protein interactions, such as protein 
folding, assembly, secretion, and degradation. HSP70 is expressed in all cell 
types following an ischaemic event, particularly neurons within the penumbra 
(Sharp et al., 2013). Therefore, HSP70 represents not only a suitable marker 
of the penumbra but also a potentially interesting clinical target for 
neuroprotection. 
 
The presence of HSP70 was assessed in the PTS model as a tool to measure 
the extent of the stressed region in the peri-infarct region and to assess 
whether activation of neuroprotection was taking place. Two different 
antibodies were tested in order to detect specific staining for HSP70 (Figure 
4.7). Both antibodies revealed strong HSP70 immunolabelling in the area 
surrounding the injury three days following PTS (Figure 4.7 A-C and D-F). 
Immunolabeling with the Santa Cruz anti-HSP70 antibody was highly specific 
(Figure 4.7 A-B), although specific marking was not observed in the 
contralateral hemisphere (Figure 4.7 C). Immunolabelling with the Abcam 
antibody provided a more defined marking for HSP70-induced neurons within 
the peri-infarct region (Figure 4.7 D-F) and lighter immunolabelling, 
corresponding to constitutively expressed HSP70, could be detected in the 
contralateral hemisphere (Figure 4.7 F).  
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The Abcam antibody was employed in the following experiments as it 
detected both the induced form and to a certain degree, the constitutively-
expressed HSP70. HSP70 immunolabelling showed an induction of HSP70 
expression in the border surrounding the infarct core and could therefore be 
used in subsequent experiments to analyse the development and extent of 
the penumbra following PTS.  
 
 
Figure 4.7. HSP70 localises in the peri-infarct area of the 
photothrombotic lesion. Representative images of HSP70 immunolabeling 
of mouse cortex three days following PTS, staining with HSP70 antibodies 
from Santa Cruz (A, B, C; red) or Abcam (D, E, F; green). Cell nuclei were 
stained with DAPI (blue). Tile scan of the injured area (A and D, 10 x 
magnification, scale bar represents 200 μm). Detailed image of the labelling 
in the ipsilateral (B and E) and contralateral (contra C and F) cortex (63x 
magnification, scale bar represents 20 μm).
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4.2.2.3 Assessment of the glial response 
 
The expression pattern of GFAP was determined to investigate the formation 
of the glial scar in the mouse brain following PTS (Figure 4.8). Glial cells 
migrate and seal the area surrounding the core and GFAP expression is 
enhanced in reactive astrocytes responding to injuries in the CNS (Sofroniew 
and Vinters 2010). GFAP expression is therefore considered a hallmark of 
the penumbra (Silver and Miller 2004, Cregg et al., 2014). 
 
An intense immunolabelling for GFAP was observed in the border 
surrounding the injury at the different time points analysed following 
photothrombotic insult (Figure 4.8). Three days following PTS a distinct 
border of glial cells was evident with highly reactive GFAP-positive cells 
forming a physical glial scar surrounding the infarcted core (Figure 4.8 A). 
Increased immunoreactivity was evident in the cortex around the core. At 
higher magnification, some glial processes can be observed within the 
membrane of GFAP positive cells (Figure 4.8 B arrows), a further indication 
of the presence of reactive astrocytes (Sofroniew and Vinters 2010). These 
results indicated that a distinct and detectable glial scar forms in the region 
bordering the photothrombotic injury and is clearly evident in mouse brain 
following PTS.
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Figure 4.8. Glial cells are recruited to the area surrounding the photothrombotic stroke forming the glial scar. 
Representative mouse brain images displaying GFAP (red) and (DAPI) immunolabelling three days after photothrombotic 
insult. A: General overview of the marking for GFAP at x 10 magnification (A). B: detailed x 63 magnification. Arrows indicate 
extended processes. Scale bars represent 500 μm (A) and 50 μm (B).
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4.4.3 Tracking the development of the glial scar and penumbra 
 
The identification of distinct immunolabeling for GFAP and HSP70, indicative 
of the formation of a glial scar and stressed neurons respectively in the area 
immediately adjacent to the photothrombotic injury, make GFAP and HSP70 
excellent markers to define and study the penumbra following PTS in mouse. 
The development of the penumbra was therefore assessed in the days 
following the photothrombotic insult in the motor and somatosensory cortex 
using these key markers. Serial confocal images were taken at the border of 
the ischemic penumbra for unbiased image analysis to assess the evoultion 
of the penumbra. In order to achieve this, two methodologies were utilised: 
1) quantifying the mean fluorescence intensity for GFAP and HSP70 in the 
area surrounding the injury and 2) quantifying the decay in fluorescence 
intensity of GFAP and HSP70 from the core into the adjacent healthy tissue 
through the peri-infarct zone.  
 
4.4.3.1. Assessing the mean fluorescence intensity of GFAP and HSP70 
in the peri-infarct area 
 
The mean fluorescence intensity of GFAP and HSP70 staining was 
measured up to 600 μm from the border of the infarcted area (Figure 4.9). 
This allowed a preliminary assessment of the increase in immunolabelling for 
markers of neuronal stress and the glial scar, in order to define the exact 
location of the penumbra within in the peri-infarct area.  
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Figure 4.9. Assessing the mean fluorescence intensity in the area 
surrounding the photothrombotic injury. Representative image of the 
methodology followed in order to measure the mean fluorescence intensity 
of GFAP (red) and HSP70 (green) staining in the different mouse brain 
sections one, three and five days post PTS. The mean fluorescence intensity 
within an area of approximately 600 μm from the infarcted border was 
measured and fluorescence recorded. The image shown is a 40 μm 
ipsilateral brain section three days following PTS. 
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Brains of mice were analysed, one, three and five days following PTS and 
compared to untreated mice. Furthermore, three different mice per time point 
and nine different brain slices per mouse were analysed in order to obtain 
statistical significance. A significantly greater intensity of HSP70 fluorescence 
was observed in PTS brains compared to representative matching regions in 
untreated controls (Figure 4.10 panel A; p = 0.006 at one day, p = 0.033 at 
three days and p = 0.054 at five days). In contrast, no significant differences 
in the mean fluorescence intensity of HSP70 staining were observed between 
the different time points. The significant increase in HSP70 staining indicated 
that specific neuronal stress was evident in the peri infarct zone up to five 
days following PTS. The lack of significant difference in HSP70 staining 
indicates that neuronal stress is immediately induced and then sustained in 
the peri-infarct area up to five days following the photothrombotic insult.  
 
Analysis of GFAP immunolabeling revealed a significantly higher 
immunostaining for GFAP in the penumbra up to five days following PTS 
compared to control mice (Figure 4.10 panel B; p = 0.0015 at one day, p = 
0.0162 at three days and p = 0.0189 at five days). At one day following the 
insult, GFAP showed a more robust increase in the mean fluorescence 
intensity, whereas, at three and five days post-PTS this increase was less 
pronounced yet still significant. When comparing the different days analysed 
following PTS, the increase in mean fluorescence intensity of GFAP three 
and five days following PTS was lower than one day post insult (p = 0.27 and 
p = 0.24 respectively). The decrease in the intensity of GFAP-positive cells 
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in this area indicates that the glial scar is rapidly formed following PTS, 
declining over time.  
 
Figure 4.10. Assessment of the mean fluorescence intensity for HSP70 
and GFAP staining in the peri-infarct zone of mouse brain following 
PTS. The mean fluorescence intensity was measured as stated in Figure 4.9. 
Fluorescence intensity is expressed as the mean ± SEM (n=3) normalised 
against the mean fluorescence intensity of DAPI staining in the same region. 
Statistical analysis was performed compared to control and between the 
different time points analysed. One-way ANOVA with Tukey’s multiple 
comparisons test. 
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The data provided a general overview of the abundance of glial cells and 
stressed neurons, as represented by GFAP and HSP70 staining, in the area 
surrounding the photothrombotised tissue. In order to delimit the precise 
extent of the penumbra in the PTS model, the decay in intensity of 
fluorescence for GFAP and HSP70 staining from the ischaemic core into the 
healthy tissue was analysed.  
 
4.4.3.2. Assessing the decay in fluorescence intensity of HSP70 and 
GFAP from the ischaemic core into the healthy tissue 
 
In order to understand the precise location and extent of the penumbra, the 
decay in fluorescence for GFAP and HSP70 staining from the ischaemic core 
into the adjacent healthy tissue was analysed. Regions of 500 μm length and 
200 μm width were marked on the brain cortex and aligned at the edge of the 
ischaemic core. The fluorescence across two sections at either side of the 
ipsilateral hemisphere and corresponding regions in the contralateral 
hemisphere were obtained at regular intervals (5 μm) for GFAP (Figure 4.11 
A) and HSP70 (Figure 4.11 B). Data was normalised against DAPI 
fluorescence in order to represent data independent of cellular density.  Nine 
brain sections per mouse (n=3 per time point) were analysed in order to 
obtain statistical significance and represent the injury across the z axis 
allowing the definition of the extent of the peri-infarct zone and the temporal 
changes within, one, three and five days post-injury.  
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Figure 4.11. Assessing the decay in fluorescence of HSP70 and GFAP 
from the ischaemic core into the healthy tissue. Representative images 
of mouse brain sections stained with HSP70 (A) or GFAP (C) and analysed 
by confocal microscopy.  Rectangles (500 x 200 μm) spanning the region in 
the cortex from the border of the infarcted core into the adjacent healthy 
tissue were applied to the image and the fluorescence within was measured. 
Fluorescence from DAPI staining (shown in blue) was also obtained to 
normalise for cellular density. Representative images of the fluorescent 
quantitation obtained from the zones are highlighted in micrographs showing 
HSP70 (green, B), GFAP (red, D) and DAPI (blue).
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Data collected through this method was represented as the mean 
fluorescence intensity for GFAP and HSP70 staining at five μm regular 
intervals zero to 500 μm from the ischaemic core (Figure 4.12). This data was 
normalised to DAPI fluorescence intensity in order to accommodate 
differences in cellular density in the regions analysed. Statistical analysis was 
performed at 100 μm intervals compared to a matching cortex region in the 
contralateral hemisphere.  
 
HSP70 expression was significantly higher compared to the contralateral 
hemisphere at each time point following the insult, up to 200 μm from the 
ischaemic core (Figure 4.12 A; p < 0.001 for one and five days, p = 0.03 for 
three days). These results indicate that HSP70 was concentrated into a 
region of 200 μm in the cortex region that surrounds the ischaemic core up 
to five days following PTS. 
 
The fluorescence intensity for GFAP immunolabeling in the ipsilateral 
hemisphere was significantly higher compared to the contralateral 
hemisphere up to 400 μm from the ischaemic core, one day after PTS was 
induced (Figure 4.12, B; p < 0.001). Less robust, but still significantly higher 
fluorescence intensity of GFAP staining across this region, was observed 
three and five days following the insult compared to the contralateral 
hemisphere (Figure 4.12, B; 200 μm: p < 0.001 for three and five days; 300 
μm: p < 0.001 for three days, p = 0.008 for five days; 400 μm: p = 0.02 for 3 
days, p = 0.03 for five days).  
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This data and the visual observations made through immunostaining (Figure 
4.8 and 4.11 B) clearly differentiate two distinct areas surrounding the 
photothrombotic insult, a glial scar up to 200 μm from the core and an area 
of increased glial immunoreactivity between 200 and 400 μm from the core.  
 
By combining data sets obtained with GFAP and HSP70 staining, it was 
evident that an area of neuronal stress and the formation of a glial scar, both 
hallmarks of the penumbra, represent a good strategy to define the extent 
and expansion of the penumbra in this model. Furthermore, this data clearly 
identified two distinct areas within the peri-infarct zone a penumbra 200 μm 
from the ischaemic core and an area of increased glial enrichment (IGE) 
between 200 and 400 μm from the ischaemic core (Figure 4.12 C). 
 
The immunofluorescence data displayed in Figure 4.12 was also represented 
as a continuous analysis of fluorescence from the ischaemic core into the 
healthy tissue in order to detect differences in the fluorescence decay at the 
different days studied following PTS (Figure 4.13). 
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Figure 4.12 GFAP and HSP70 immunolabelling define a neuronal stress 
and IGE area that are hallmarks of the penumbra. The mean fluorescence 
intensity values for HSP70 (A) and GFAP (B) were analysed across the 
distance from the border of the ischaemic core into the adjacent healthy 
tissue. The results displayed are normalised against DAPI mean 
fluorescence intensity and given as mean ± SEM (n=3). Two-way ANOVA 
with Tukey’s multiple comparisons test. C. Schematic summary of the 
findings dividing the peri-infarct zone into the penumbra (0-200 μm from the 
infarcted core) and increased glial enrichment (IGE) zone (200-400 μm).  
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Expression of HSP70 was marginally higher in ipsilateral sections five days 
following PTS compared to one and three days, although no significant 
differences were observed at the different time points analysed (Figure 4.13, 
A). These results were in agreement with previous results shown in Figure 
4.10. The pattern of HSP70 fluorescence decay was very similar one, three 
and five days following PTS. This implies that neuronal stress is maintained 
up to five days following photothrombotic insult in the penumbra and 
therefore, whilst stressed, this tissue still has potential to be salvaged. 
 
A significantly higher intensity of GFAP fluorescence was observed one day 
after the insult compared to three and five days post-injury at all distances up 
to 400 μm from the ischaemic core (Figure 4.13 B; p < 0.001). This is in 
agreement with previous data represented in Figure 4.10. The pattern of 
GFAP expression across the region surrounding the core three and five days 
following the insult was very similar (Figure 4.13 A). This indicates that the 
highest glial intensity was observed one day following PTS in a region 
radiating 400 μm from the ischaemic core, suggesting that the glial scar is 
rapidly formed following the insult. 
 
Overall, these results indicate that in this PTS model the penumbra is located 
up to 200 μm from the ischaemic core. A transition area is also evident 
between 200 and 400 μm from the ischaemic core, which contains a 
significant increase in glial activity, representing an increase in glial 
enrichment (IGE) zone (Figure 4.13). The area affected by PTS included 
areas of the motor and somatosensory cortex (Figure 4.4).   
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Figure 4.13. Tracking the neuronal stress and glial scar development in 
the days following PTS. The mean fluorescence intensity for HSP70 (A) 
and GFAP (B) staining were measured across the distance from the border 
of the ischaemic core into the adjacent healthy tissue as in Figure 4.11. The 
fluorescence intensity was normalised against the mean fluorescence 
intensity of DAPI staining and expressed as mean ± SEM, (n=3). Two-way 
ANOVA with Tukey’s multiple comparisons test. 
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4.4.4. Assessing neuronal loss in the defined penumbra 
 
Following the characterisation of the extent and development of the 
penumbra in mice in the days following PTS, neuronal loss was then 
assessed in this area. Serial confocal images of 200 μm x 200 μm were taken 
at the border of the ischaemic core for unbiased stereological analysis to 
quantitate the response of neurons to injury in the penumbra (as described 
in section 2.15.2). Mouse brain sections were labelled with the established 
neuronal marker NeuN (Mullen et al., 1992) to quantify the number of neurons 
in the penumbra in the days following ischaemic insult. DAPI was used to 
counterstain the total number of cell nuclei (Figure 4.14). NeuN is 
predominantly expressed in the nucleus, although some cytoplasmic staining 
was observed (Figure 4.14 B and D). Distinct areas containing neuronal cells 
(DAPI and NeuN-positive) were observed within the penumbra (Figure 4.14, 
white arrows). Other cell types were identified within the penumbra as 
revealed by DAPI-positive and NeuN-negative cells (Figure 4.14, red arrows). 
The location of these cells and the previous results shown in Figures 4.8, 4.9 
and 4.11 suggest these were most likely glial cells.  
 
NeuN positive cells in the penumbral cortex were normalised against DAPI 
positive cells one, three and five days following the insult and expressed as 
a ratio. Mice not photothrombosised presented a NeuN/DAPI ratio of 0.9, 
indicating a strong presence of neurons in the area (Figure 4.15). A significant 
decrease in NeuN-positive neurons was evident one, three and five days 
following the insult (Figure 4.15 p = 0.04 for one day and p < 0.001 for three 
and five days). The NeuN/DAPI ratio decreased to 0.66 one day following the 
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insult and further decreased to 0.59 three days after the insult. A significant 
decrease in NeuN-positive cells was observed five days post-insult when 
compared to three days (p = 0.03) reaching a NeuN/DAPI ratio of 0.42. This 
indicates significant neuronal loss occurs in the penumbra up to five days 
following PTS. 
 
Figure 4.14. Neuronal loss in the penumbra following PTS. 
Representative confocal images of NeuN staining in the penumbra at low (10 
x, A) and high magnification (63 x, B, C and D). NeuN (green) and DAPI 
(blue) positive neurons (white arrow) and non-neuronal cell types only 
positive for DAPI (red arrow) are represented in mouse brain, five days 
following PTS. Scale bar represents 200 μm (A) or 50 μm (B, C and D).
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Figure 4.15. Quantifying neuronal loss in the penumbra five days after 
photothrombotic stroke. NeuN/DAPI ratio 200 μm from the ischaemic 
core represented in untreated control and one, three and five days following 
the ischaemic insult. Results are represented as the mean  SEM (n=3). 
One-way ANOVA with Tukey’s multiple comparisons test. 
 
The aim of this study was to identify markers in order to characterise the 
penumbra in the PTS model in mice. The analysis was fundamental to 
highlight the penumbra as a therapeutically relevant region. Overall, the 
results indicate neuronal stress and glial scar formation, represented by 
HSP70 and GFAP immunolabelling, as suitable markers to study the 
penumbra in PTS. The penumbra was established as the area extending 200 
μm from the ischaemic core. The results also identified an area of increased 
glial enrichment in the area between 200 and 400 μm from the core. Finally, 
a significant neuronal loss was identified in the penumbra through NeuN 
immunolabelling, which was sustained up to five days following the ischaemic 
insult.  
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4.5 Discussion  
 
The mortality and morbidity associated with stroke is correlated with the 
ensuing expansion of cell death from the ischaemic core into the surrounding 
penumbra (Heiss 2010). The slow development of cell death in the 
penumbra, which takes place in the hours to days following the ischaemic 
onset, makes the study of this area an attractive target for the development 
of neuroprotective strategies. Cells within the penumbra have the potential 
for recovery and survival of the neurons within is associated with better 
prognosis (Del Zoppo et al., 2011), therefore, this region is an important 
therapeutic target to be considered for interventional therapy. 
 
The aims of this study were to characterise the evolution of tissue damage in 
the mouse PTS model of ischaemic stroke, to assess the spread of neuronal 
stress and glial response in the days following PTS in order to establish the 
extent of the penumbra and to assess neuronal loss in the then characterised 
penumbra. 
 
4.5.1 Photothrombosis in modelling stroke 
 
Several models have tried to simulate the conditions observed following 
ischaemic stroke. These models can be broadly categorised into three 
groups: i) in vitro hypoxia, ii) in vivo global ischaemia and iii) in vivo focal 
ischaemia. Organotypic brain slice cultures, primary cultures and neuronal 
differentiated cell cultures diminish the experimental cost and number of 
animals used in stroke research and provide a good platform to perform wide-
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spectrum analysis of the cellular responses to oxygen and glucose 
deprivation and understand basic cellular and biochemical mechanisms 
activated by ischaemic stroke (Holloway and Gavins 2016). However, in vitro 
models do not represent the complex intrinsic 3D structure and dynamics that 
exist between different cell types in the brain. In vitro models require longer 
oxygen deprivation insults, ATP depletion is less severe and glutamate 
release is delayed when compared to in vivo models (Woodruff et al., 2011). 
Global ischaemia models, which are produced by multiple vessel occlusion, 
are particularly relevant to study ischaemic events derived of cardiac arrest 
or asphyxia (McBean and Kelly 1998) but less representative of an ischaemic 
stroke in humans. MCAO, a standardised model of focal ischaemia, produces 
large infarction volumes and is therefore only representative of strokes in 
which a large artery is affected and does not present a well characterised 
infarct/peri-infarct region (Figure 4.2). Therefore, these models do not fully 
replicate the conditions observed in the penumbra following an ischaemic 
event. 
 
In this chapter, focal ischaemia was achieved through the photothrombotic 
model of stroke. Results show a reproducible and localised infarct in the 
region corresponding to the motor and somatosensory frontal cortex (Figures 
4.4 and 4.5). This was highly reproducible, facilitating comparison between 
animals. The ischaemic core was evident following PTS in all the brains 
analysed as this area was lost following sectioning of the brains (Figure 4.5). 
Therefore, this model allowed an excellent platform to characterise the 
evolution of tissue damage in the mouse PTS model of ischaemic stroke. 
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4.5.2 Neuronal death in the penumbra 
 
In ischaemic stroke, necrotic cell death takes place rapidly in the infarcted 
core (Yuan 2009). Conversely, in the ischaemic penumbra, apoptosis is the 
main mechanism regulating cell death as a result of hypoxic insult to the brain 
(Namura et al., 1998; Ferrer and Planas 2003). Caspases are central players 
in apoptosis and their role in programmed cell death in neurological diseases 
(reviewed in McLaughlin 2004). Specifically, activation of caspase-3 is 
associated with the induction of apoptosis following ischaemia (Broughton et 
al., 2009) and a direct link between caspase 3 expression and infarct growth 
is evident in ischaemic stroke (Rosell et al., 2008). Furthermore, 
pharmacological inhibition or genetic disruption of caspase-3 expression 
have been found to be neuroprotective (Ma et al., 1998; Le et al., 2002) or 
promote neuroregenerative responses (Fan et al., 2014). Data presented 
here demonstrate discrete activation of caspase-3, therefore agreeing with 
previous literature and indicating that caspase-3-mediated apoptosis occurs 
in the peri-infarct zone following PTS (Figure 4.6).   
 
The different mechanisms that promote neuronal death in the penumbra 
makes choosing a single marker, such as caspase-3, difficult to study the 
precise extent of the penumbra. Furthermore, due to the complex 
immunolabelling pattern of caspase-3, using this marker to assess the extent 
of the penumbra and its development in the following days represented a 
technical and conceptual challenge. Therefore, alternative markers of the 
penumbra were investigated. 
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4.5.3 HSP70 can define the penumbra 
 
There is a complex relationship between apoptotic and necrotic cellular death 
in the ischaemic core and penumbra, however other fundamental cellular 
adaptations, such as the activation of the UPR and HSP70, are exclusive to 
the penumbra (Sharp et al., 2013; Yang and Paschen 2016). A global 
reduction in protein synthesis and induction of HSP70 is representative of the 
early cellular response to focal ischaemia (Zhang et al., 2006). Permanent 
abolition of cerebral protein synthesis occurs in the ischaemic core and is 
associated with cell death, whereas recovery of protein synthesis is known to 
promote cell survival (Kokubo et al., 2003). The expression of inducible 
HSP70 (HSP70i or simply HSP70), which is involved in protein folding 
following stress, is therefore considered to be a biomarker of penumbral 
tissue (Brea et al., 2015).  
 
HSP70 immunolabelling in the peri-infarct zone (Figure 4.7) agree with 
previous literature in which the expression of HSP70 was localised in the 
proximity of the ischaemic core (Popp et al., 2009; Sharp et al., 2013; Agulla 
et al., 2014). In more distant areas from the infarct and the contralateral 
hemisphere, the expression was significantly reduced to basal levels. In 
neurons, HSP70 follows a time-dependent localisation as in the early stages 
following an ischaemic insult it is expressed in the cytoplasm, extending to 
dendrites and finally to axons in the later stages (Ferrer and Planas 2003). 
However, differences in region-specific HSP70 immunolabelling within the 
neuron were not observed under the conditions herein (Figure 4.7) and were 
not part of the investigation. 
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HSP70 was validated as a specific marker of stressed cells in the mouse PTS 
and expression was significantly up-regulated in the region extending 200 m 
from the ischaemic core five days following PTS (Figure 4.16). This spatial 
location of the penumbra is in agreement with a previous study by Brown et 
al. (2008) using mice and the PTS model. Here, dendritic spine length was 
used as a tool to measure neuronal stress in the peri-infarct zone and also 
identified an area of neuronal stress 200 μm from the ischaemic core. 
 
Although many studies have investigated HSP70 expression in the peri-
infarct region, this study allowed the spatiotemporal characterisation of 
HSP70 for the first time and provided an analysis of the precise extent of the 
penumbra in the PTS model and its development in the days following the 
injury. Therefore, through HSP70 immunolabeling, the penumbra was 
exclusively distinguished from healthy neuronal tissue, representing a critical 
and necessary methodology in order to identify mechanisms of neuronal 
damage specific to this region (Figure 4.16). This knowledge will allow future 
development of neuroprotective strategies to potentially target and rescue 
neuronal tissue in this region and prevent its recruitment into the ischaemic 
core.  
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Figure 4.16. Model representing the regions that surround the 
ischaemic core in mouse PTS.  The ischaemic core, in which necrosis takes 
place, is surrounded by the peri-infarct zone and healthy tissue. The peri-
infarct zone is subdivided into the penumbra (0-200 μm from the ischaemic 
core) containing stressed neurons and the glial scar. The area of increased 
glial enrichment (IGE) (200-400 μm from the ischaemic core) is composed of 
glial cells with increased reactivity and potentially cells migrating to the glial 
scar.    
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4.5.4 The glial scar as a marker of the penumbra  
 
GFAP staining allowed the identification of the glial scar surrounding the 
ischaemic core and revealed its rapid formation one day following PTS 
(Figures 4.8, 4.10, 4.11, 4.12). This is in agreement with previous findings, 
as in human patients, through PET scans, an initial microglial response was 
detected under 72 hours of a subacute ischaemic stroke and this persisted in 
the peri-infarct zone up to 30 days post-stroke (Price et al., 2006). In rats, 
microglial activation has been reported to take place within 24 hours following 
transient global ischaemia (Gehrmann et al., 1992), although phagocytic 
microglia were prominent eight to 12 weeks after stroke through electron 
microscopy in a gerbil model of MCAO (Ito et al., 2007). In the mouse model 
of PTS, elevated GFAP immunolabelling was identified one day following 
ischaemia in cortex, and then decreased from day seven through to day 60 
post-injury (Haupt et al., 2007). A more recent study of PTS in mice found a 
significant upregulation of GFAP-positive cells in the cortex two days 
following the injury, peaking at day four (Li et al., 2014). They also analysed 
proliferating glial cells (GFAP+ BrdU+) in the peri-infarct region, and indicated 
that astrogliosis mostly occurs due to upregulation of GFAP expression from 
existing and migratory glial cells rather than proliferating glial cells. A focal 
cerebral ischaemia model in mice revealed that most astrocyte proliferation 
occurs within 200 µm of the edge of the infarct (Barreto et al., 2011). 
However, the cumulative percentage of proliferating microglial cells over a 
week was modest at 11.4% and the percentage of proliferating astrocytes 
declined sharply with distance. This study indicated that only astrocytes 
within the glial boundary resume proliferation following stroke, while 
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astrocytes further out display reactive changes but largely without 
proliferation. Overall, these previous findings are in agreement with the 
results of this chapter, indicating that the glial scar forms rapidly following 
stroke and that its presence is sustained in the days following the insult.  
 
The investigation of glial scar formation incorporated a spatial analysis that 
complemented the previously well documented time-dependent formation 
analysis of the glial scar (Li et al., 2014). The temporal analysis is in 
agreement with previous studies that indicated rapid glial scar formation 
following stroke and extends this investigation by incorporating spatial 
dynamics of glial reactivity. Two distinct areas of glial reactivity were 
observed in the PTS model (Figure 4.16); i) a well-defined glial scar with a 
significant increase in GFAP immunolabelling, representing reactive 
astrocytes, in the region up to 200 μm from the ischaemic core, and ii) an 
area with a decrease in GFAP immunolabelling and reduced level of 
structural intricacy in the area between 200 and 400 μm from the ischaemic 
core (Figure 4.12, Figure 4.13). The lack of proliferating cells in this region 
shown by others (Barreto et al., 2011) and the fact that neural stem cells can 
migrate to the peri-infarct region where they can differentiate into reactive 
astroglia (Faiz et al., 2015) suggest that this area could represent a migratory 
zone to the area surrounding the injury.  
 
The exact role of the glial scar is still under debate as both beneficial and 
detrimental roles have been observed (Carmichael et al., 2016). However, 
current thinking suggests that the glial scar is beneficial in the early 
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responses to ischaemic injury to seal and confine the damage (Rolls et al., 
2009), but it is detrimental in the long term as it prevents axonal regeneration 
in the area (Carmichael et al., 2016). 
 
The analysis of HSP70 spatiotemporal immunolabelling and acknowledging 
the glial scar as a marker of the penumbra (Zamanian et al., 2012; Li et al., 
2014), provide strong evidence for the existence of penumbral tissue located 
up to 200 μm from the ischaemic core in mouse brain following PTS under 
the aforementioned experimental conditions (Figure 4.16). In summary, this 
research provided evidence for the molecular subdivision of the peri-infarct 
zone into the penumbra and an area of increased glial enrichment (IGE) and 
precisely characterise the extent of each region. 
 
4.5.5. Neuronal loss in the penumbra 
 
Brain ischaemia induces selective neuronal loss in the penumbra, being 
particularly relevant in the cortex, striatum and CA1 layer of the hippocampus 
(Pulsinelli et al., 1982). NeuN staining is considered to be the best method to 
quantify neuronal loss although it presents some limitations as some neurons 
may still stain for NeuN yet already be dead (Baron et al., 2014). Although 
avoiding neuronal loss in the penumbra is a logical and well documented 
beneficial therapeutic strategy, some degree of neuronal loss is known to be 
beneficial in order to promote plastic reorganisation, a process that underlies 
recovery (Neher et al., 2013; Baron et al., 2014).  
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Neuronal loss takes place in the penumbra and this loss increases 
progressively in the days following the PTS (Figure 4.15). This has great 
relevance as it shows that affected penumbral areas are recruited to the 
infarct core. There is an increase in neuronal damage in the days following 
the insult, a time window that is outside the therapeutic treatments currently 
used (Green and Shuaib 2006). Therefore, this area of the brain has a 
potential to be salvaged and it is of critical necessity to understand the 
mechanisms that lead to the recruitment of this area into the infarct core. This 
will allow the development of neuroprotective strategies with a therapeutic 
window that accompanies the reality of stroke patients, which do not normally 
benefit from the strategies of revascularisation due to its limited 4.5 hours 
window (del Zoppo et al., 2009). Current strategies rely on the rapid 
revascularisation of the affected area through thrombolytic agents, such as 
recombinant tissue plasminogen activator (rt-PA) or mechanical thrombolytic 
devices (Holmes et al., 2015; Akbik et al., 2016). Neuroprotective and 
neurorehabilitation strategies are needed, especially at the sub-acute and 
chronic phases of stroke, for which no effective therapies are currently 
available, probably due to a lack of understanding and characterisation of 
penumbral dynamics. 
 
In summary, the assessment of the extent and evolution of the penumbra in 
the days following PTS, provides an excellent tool to study mechanisms of 
neuronal damage in this area and the potential for the development of 
therapeutic strategies specific to the penumbra. These results provide a 
strategy to discriminate between penumbra and healthy tissue within the peri-
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infarct zone and a method to quantify this specific response. Furthermore, 
the increasing neuronal loss observed up to five days following the insult, 
emphasises the potential of this area to be salvaged. Therefore, a platform in 
which to study penumbra-specific molecular events involved in the spreading 
of the damage was created. 
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5. Chloride co-transporters represent a valid 
therapeutic target to reduce neuronal loss in 
stroke 
 
5.1 Introduction 
 
Stroke is a leading cause of death and disability worldwide (Thrift et al., 2014; 
Mozaffarian et al., 2016). The interruption of blood flow to the brain creates 
an infarct that continues to develop in the hours and days following ischaemic 
injury (Chapter 4; Baron et al., 2014). Increasing the volume of saved 
penumbral tissue, can improve neuronal recovery (Heiss 2010). 
Furthermore, one third of patients suffer from secondary damage of 
penumbral tissue augmenting the neurological impairment for which there 
are no current therapies (Roger et al., 2011). It is therefore imperative to 
develop novel therapeutics that could ameliorate the damage caused by the 
ensuing neuronal loss in the penumbra and promote neurorehabilitation 
(Martín-Aragón Baudel et al., 2017).  
 
5.1.1 Excitotoxicity in the development of the penumbra 
 
The ischaemic core is the brain region immediately impacted by rapid and 
irreversible damage and is subsequently considered as a non-salvageable 
tissue (Astrup et al., 1981). The penumbra, area immediately surrounding the 
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ischaemic core, is only partially metabolically compromised but it can be 
readily recruited into a core-like state due to excitotoxicity (Olney 1969; 
Hinzman et al., 2015). This is a consequence of the inability of collateral 
blood supply to sustain the high glucose and oxygen demands of the 
penumbral tissue, leading to the deterioration of neuronal ionic gradients 
(Dreier and Reiffurth 2015). Ionic dysregulation results in excessive 
activation of NMDA and AMPA receptors and increased intracellular calcium, 
which ultimately leads to caspase activation and free radical formation 
(Szydlowska and Tymianski 2010) among other ionic dysfunctions (Chapter 
1). Substantial release of excitatory neurotransmitters produce continuous 
peri-infarct depolarisations (PIDs) (Nedergaard and Hansen 1993) that 
spread outwards from the ischaemic core, depleting the glucose and ATP 
pool, and preventing neurons from repolarising (Feuerstein et al., 2010; 
Dreier and Reiffurth 2015). The penumbra has the potential to be salvaged 
and it is therefore necessary to determine the underlying molecular 
mechanisms responsible for the damage that could provide novel therapeutic 
targets. 
 
In the previous chapter, molecular characterisation of the peri-infarct region 
following photothrombotic stroke in mice was performed. This provided a 
defined platform to elucidate the extent of the penumbra and assess neuronal 
loss within this region in the days following the insult. The resulting penumbra 
in this model extended 200 μm from the ischaemic core and a significant 
neuronal loss was observed within one day and continued over the five days 
monitored following the insult. The aim of the following study was to 
191 
 
investigate the pattern of expression of the cation chloride co-transporters 
(CCCs) in the penumbra in order to extend the molecular characterisation 
and discern their potential validity as neuroprotective targets. 
 
5.1.2 Chloride cotransporters mediate GABAergic inhibitory tone 
 
Synaptic activity is responsible for information processing in the CNS. 
Synaptic activation of GABAAR usually inhibits post-synaptic neuronal firing, 
whereas release of glutamate promotes action potential emission. GABAAR 
are transmembrane ligand-gated ion channels. GABAAR  activation 
generates an inhibitory post-synaptic current that depends upon the 
electrochemical gradient within the neuron relative to extracellular [Cl-] (Kaila 
1994). Cation chloride cotransporters are the key players in the regulation of 
intracellular chloride concentration in neurons (Kaila et al., 2014). The CCC 
family of proteins includes two Na+–K+–2Cl− cotransporters, NKCC1 and 
NKCC2 (encoded by Slc12a2 and Slc12a1 respectively), a Na+–Cl− 
cotransporter (NCC; encoded by Slc12a3) and four K+– Cl− cotransporters, 
KCC1, KCC2, KCC3 and KCC4 (encoded by Slc12a4, Slc12a5, Slc12a6 and 
Slc12a7 respectively).  
 
NKCC1 and KCC2 are the principal chloride cotransporters in the brain, 
mediating electroneutral chloride import and export respectively (Kaila et al., 
2014). However, the expression of KCC1, KCC3 and KCC4 has also been 
documented in neurons (Blaesse et al., 2009) and the expression of NKCC2, 
long-believed to have brain-independent functions, has recently been 
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demonstrated to be involved in neuronal osmoregulation (Konopacka et al., 
2015). In mature neurons, KCC2 activity is increased in comparison to 
NKCC1, mediating a low [Cl-]i (Figure 5.1). Therefore, upon GABAA receptor 
activation leads to chloride influx into cells, promoting hyperpolarisation.  
 
In mammalian brain during development, and the first two post-natal weeks, 
the expression pattern of the CCCs in neurons is altered, with expression of 
NKCC1 being greater than KCC2 resulting in high [Cl-]i. Upon GABA binding 
to its receptor, chloride effluxes and thus, GABAAR-ergic response is 
depolarising (Figure 5.1) (Rivera et al., 1999; Yamada et al., 2004). GABAAR-
dependent depolarisation has been shown to lead to post-synaptic neuronal 
excitation by promoting the activation of voltage-gated calcium channels, 
triggering action potentials and generating giant depolarising potentials (Ben-
Ari 2001). Such a response is observed in all neurons of the CNS although 
its precise timing can vary between different brain regions and neuronal 
subtypes (Ben-Ari et al., 2007; Wang and Kriegstein 2009). GABA-mediated 
excitation promotes neuronal proliferation, migration and targeting (Blaesse 
and Schmidt 2015). In other pathological situations, the gene expression 
patterns of CCCs also resembles early development (Figure 5.1). These 
include, cerebral oedema, traumatic and ischaemic brain injury, temporal 
lobe epilepsy, schizophrenia, Andermann syndrome, Bartter syndrome and 
cancer (Uyanik et al., 2006; Kaila et al., 2014; Kahle et al., 2015). The activity 
of NKCC1 and KCC2 is therefore important in dictating the GABAAR-
mediated response (Succol et al., 2012). 
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Figure 5.1. NKCC1 and KCC2 dictate the GABAAR response. NKCC1 is 
responsible for transport of chloride into the cell in immature neurons, 
whereas KCC2 which extrudes chloride, is up-regulated during CNS 
development and in mature neurons promoting hyperpolarising, or 
depolarising GABAAR-mediated currents respectively. In stroke and other 
pathological situations this chloride homeostasis is reversed towards a 
temporary immature-like state. 
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5.1.3 Cation chloride cotransporters as potential therapeutic targets in 
stroke 
 
 
The switch in NKCC1 and KCC2 expression might augment the excitotoxic 
damage that promotes development of the penumbra  into a core-like state 
in the days following an ischaemic event by diminishing, or even reversing, 
GABAAR-mediated inhibition (Rivera et al., 2002; Jaenisch et al., 2016; 
Martín-Aragón Baudel et al., 2017). GABA has been shown to be 
neuroprotective and able to reduce excitotoxic-derived neuronal death in the 
acute phase of stroke (Figure 5.2; Lyden and Hedges 1992; Green et al., 
2000). However, GABAAR agonists administered during the acute phase of 
stroke failed to improve the outcome of stroke patients (Lyden et al., 2002; 
Liu and Wang 2013). This could be due to the lack of suitable preclinical 
animal models (Chapter 4) and GABAAR subtype-specific compounds 
(Clarkson 2012). In contrast, reducing GABA-mediated inhibition in the long 
term following stroke (rehabilitation post-stroke), is beneficial for functional 
recovery and improves brain plasticity (Figure 5.2; Clarkson et al., 2010; Hiu 
et al., 2016). Recently, the contribution of NKCC1 and KCC2 in the spreading 
depolarisations that are responsible for post-stroke injury was revealed 
(Steffensen et al., 2015). The promising results obtained in preclinical models 
and the relative failure of GABAAR-specific compounds in clinical trials 
suggests that that therapies targeting chloride co-transporters could 
represent a potential novel strategy to reduce the damage associated with 
stroke (Figure 5.2). 
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Figure 5.2 Schematic representation of potential positive and negative 
therapeutic strategies in stroke. During the chronic phase of stroke, the 
reversal of the chloride gradient mediated by the CCCs could be targeted 
with positive (+) or negative (-) modulators of KCC2 and NKCC1 
activity/expression respectively. This would promote GABAAR-mediated 
inhibition and counteract NMDA and AMPA-mediated excitotoxicity. 
Conversely, in the long term, post-stroke, an opposed strategy could promote 
neurorehabilitation. 
 
 
It is hypothesised that after a stroke event, KCC2 is down-regulated while 
NKCC1 is up-regulated, modifying neuronal [Cl-]i balance, and rendering 
GABAA receptors excitatory (Figure 5.1). This phenomenon, coupled with the 
substantial release of glutamate, and NMDA and AMPA receptor activation, 
constitutes the excitotoxicity that ultimately leads to neuronal death 
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(Szydlowska and Tymianski 2010).  Different therapies, used after either the 
initial event, or in the long term, acting on CCCs and/or GABAA receptors 
could promote neuroprotection or neurogenesis and, subsequent, 
rehabilitation (Figure 5.2). 
 
 
5.1.3.1 NKCC1 in ischaemia 
 
NKCC1 activity has been shown to be up-regulated in peri-infarct cortex 
following middle cerebral artery occlusion (MCAO) in mice (Yan et al., 2003; 
Begum et al., 2015). In addition, NKCC1-null mice have been shown to 
exhibit less grey and white matter damage following MCAO (Chen et al., 
2005). The kinase with no lysine kinase 3 (WNK3) directly stimulates NKCC1 
activity by phosphorylating NKCC1 (Alessi et al., 2014). WNK3 knockout 
mice subjected to MCAO have been shown to present reduced brain damage 
and improved recovery after stroke (Begum et al., 2015).  
 
Bumetanide acts as an antagonist of NKCC1 channels at low concentrations 
(2-10 μM) whereas at higher concentrations it inhibits both NKCC1 and KCC2 
activity (Payne et al., 2003). At doses that solely block NKCC1 activity, 
different studies have shown that bumetanide administration following MCAO 
promotes neurogenesis and increases behavioural recovery 28 days 
following the insult (Xu et al., 2016). It also decreases oedema formation 
three hours and up to two days after the insult (Wang et al., 2014). However, 
this effect could be due to the expression of NKCC1 in the luminal side of 
endothelial cells in the blood brain barrier (BBB), which is known to decrease 
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oedema formation (O’Donnell et al., 2004). NKCC1 has a role in the 
formation of ionic oedema as it transports sodium into endothelial cells, which 
is then expelled by the Na+-K+ ATPase, therefore controlling volume 
regulation (Brillault et al., 2008). However, the implication of NKCC1 in 
neuronal loss following stroke in the ischaemic penumbra has not been 
adequately addressed. 
 
5.1.3.2 KCC2 in ischaemia 
 
KCC2 expression has been shown to be downregulated following ischaemia 
in a model of MCAO in rats (Jaenisch et al., 2010). Application of exogenous 
glutamate to cortical neurons, to mimic excitotoxicity (Figure 1.1), also 
resulted in KCC2 downregulation (Jaenisch et al., 2016). Functional 
downregulation of KCC2 in vitro was also observed following different 
neuronal stressors, such as oxidative stress, BDNF-induced stress and 
hyperexcitability (Wake et al., 2007). Little research into the change in the 
expression of KCC2 following PTS has been undertaken. In spinal 
motoneurons, KCC2 expression was downregulated seven days following 
stroke but not at three or 21 days (Toda et al., 2014). However, data was not 
in the context of KCC2 participation in the development of the penumbra. 
 
No therapeutic agents specifically targeting KCC2 that can cross the BBB 
and with a long half-life are available for human use. Bumetanide and 
furosemide can inhibit KCCs activity, however they can also inhibit NKCC1 
at higher concentrations (Austin and Delpire 2011). Therefore, specific KCC2 
inhibitors are required to further elucidate KCC2 function. KCC2-specific 
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agonists have been identified recently by Gagnon et al. (2013). The KCC2-
selective analogue CLP257, and its prodrug CLP290, lower the [Cl-]i and 
restore impaired chloride transport to alleviate hypersensitivity in a rat model 
of neuropathic pain (Gagnon et al., 2013) and modulate the epileptic 
response in an in vitro model of ictogenesis (Hamidi and Avoli 2015). A 
selective KCC2 inhibitor, VU0463271, has recently been developed (Delpire 
et al., 2012) and been shown to induce epileptiform discharges both in vitro 
and in vivo (Sivakumaran et al., 2015) and increase the duration of seizure–
like events (Kelley et al., 2016). These studies highlight the importance of 
KCC2 in regulating neuronal chloride concentration and mediating 
GABAergic activity in different pathologies and the critical necessity for 
specific compounds able to cross the BBB and specifically target KCC2. 
 
The combined effects of NKCC1 and KCC2 are thought to be involved in the 
excitotoxic events that take place rapidly after stroke (Jantzie et al., 2015, 
Beck et al., 2003) but also in promoting neurorehabilitation in the days 
following the insult (Tanaka et al., 2009). The joint assessment of KCC2 
expression, having a role opposed to NKCC1, will further the understanding 
of the chloride gradient and thus GABAAR-mediated activity in neurons after 
PTS.  Additionally, it will expand the knowledge of the molecular events that 
ultimately dictate neuronal fate during the days following stroke. In this study, 
expression of the chloride co-transporters, NKCC1 and KCC2, mediators of 
the GABAAR-mediated response was assessed in:  i) neuronal-like PC12 and 
NT2 cells following hypoxia in a modular chamber in vitro and  ii) in the 
penumbral cortex following photothrombotic stroke in mice. Neuronal loss 
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was assessed in vivo in the penumbra and compared with mice treated with 
bumetanide and CLP257.  
 
5.2 Aims 
 
Aim 1. To characterise expression of the (N)KCC family of proteins in the 
neuronal-like differentiated PC12 and NT2 cells following acute hypoxia. 
 
Aim 2. To quantify spatial and temporal expression of NKCC1 and KCC2 in 
the penumbra following PTS in mice. 
 
Aim 3. To assess the impact of NKCC1 and KCC2 modulation by 
bumetanide (NKCC1 antagonist) and CLP257 (KCC2 agonist) on neuronal 
loss in the established penumbra.  
 
5.3 Research Questions 
 
RQ1. Does an ischaemic-like episode reverse the expression of the cation 
chloride cotransporters in vitro and in vivo? 
 
RQ2. Do drugs that specifically target the cation chloride cotransporters 
prevent neuronal loss in the penumbra following ischaemic stroke? 
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5.4 Results 
 
5.4.1 The expression of CCCs in neuronal-like PC12 and NT2 cells is 
modified following hypoxia 
 
A model for generating differentiated neuronal-like cells using the pluripotent 
cell lines PC12 and NT2 was developed in Chapter 3. Using an in vitro 
hypoxic modular chamber, eight hours of acute hypoxic insult (1% O2) was 
established as the time point that induces damage and changes in hypoxic-
responsive genes and proteins. The activity of the CCCs is fundamental in 
mediating the GABAAR-mediated response (Succol et al., 2012). Following 
hypoxic insults such as stroke, the alteration in the expression of some of 
these transporters has been demonstrated (Yan et al., 2003; Jaenisch et al., 
2010; Begum et al., 2015). Therefore, an in vitro model of hypoxia with the 
neuron-like PC12 and NT2 cells, provided a platform to analyse the changes 
in expression of this family of transporters. 
 
5.4.1.1 In vitro gene expression profile of the CCCs following hypoxia. 
 
The expression of the CCCs genes, Slc12a2 (NKCC1), Slc12a4 (KCC1), 
Slc12a5 (KCC2), Slc12a6 (KCC3) and Slc12a7 (KCC4) was assessed 
following acute hypoxia in differentiated PC12 and NT2 cell lines via qPCR. 
Expression of the chloride exporter genes Slc12a4-7 showed a significant 
downregulation following hypoxic insult in both PC12 and NT2 cells. In 
contrast, the expression of the chloride importer Slc12a2 was relatively 
unchanged (Figure 5.3).  
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Following acute hypoxia in PC12 cells, a significant 7.5-fold decrease in 
Slc12a5 (KCC2) (p = 0.04) mRNA abundance and a 3.4-fold decrease for 
Slc12a6 (KCC3) (p = 0.006) were observed (Figure 5.3 A). However, Slc12a4 
(KCC1) and Slc12a7 (KCC4) mRNA was not significantly downregulated 
(Slc12a4: 6.3-fold change, p = 0.08; Slc12a7: 12.5-fold change, p = 0.12). 
 
NT2 cells showed a similar variation in mRNA for the CCCs following acute 
hypoxia (Figure 5.3 B). The expression of the chloride exporters Slc12a4-7 
(KCC4-7), was significantly downregulated following acute hypoxia, whereas 
only a small 1.3-fold decrease in the gene expression of the chloride importer 
Slc12a2 (NKCC1) was observed. A significant 1.84-fold decrease in mRNA 
(p = 0.04) was observed for Slc12a4 (KCC1), 2-fold change for Slc12a6 
(KCC3; p = 0.02), 2.2-fold change for Slc12a7 (KCC4; p = 0.004). 
Interestingly, a non-significant 1.6-fold downregulation was observed for 
Slc12a5 (KCC2; p = 0.06). 
 
In summary, the expression profile of the CCCs genes is modified following 
acute hypoxia in neuronal-like PC12 and NT2 cells. In particular, significant 
downregulation in mRNA encoding chloride exporters KCC1-4 was observed 
whilst the expression of the chloride importer NKCC1, was not significantly 
altered following the insult. Changes in mRNA levels do not always translate 
into changes in protein expression, therefore protein expression following 
hypoxia was analysed via immunoblotting. 
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Figure 5.3. Hypoxia downregulates expression of all chloride extruder 
genes but not in the chloride importer in PC12 and NT2 cells. Relative 
mRNA expression of Slc12a2 (NKCC1) and Slc12a4-7 (KCC1-4) was 
analysed in PC12 (A) and NT2 (B) cells after 8 hours of hypoxia relative to 
the reference gene; TOP1 for PC12 and ACTB for NT2. Results are 
expressed as the mean fold change ± SEM (n=3). Two-tailed unpaired 
Student’s t test. 
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5.4.1.2 Immune detection of the CCCs in response to hypoxia 
 
The neuron-specific chloride exporter KCC2 and the chloride importer 
NKCC1 are the most important members of the CCC family of proteins in the 
mammalian brain (Kaila et al., 2014) so were analysed at protein level in 
PC12 and NT2 cells following acute hypoxia. 
 
Prominent NKCC1 expression was detected  in PC12 and NT2 (Figure 5.4). 
Expression of NKCC1 was not altered by hypoxia in PC12 cells (Figure 5.4). 
Staining intensity of NKCC1 was, however, increased in differentiated NT2 
cells following 4 and 8 hours of hypoxia (Figure 5.4). Equal loading of protein, 
as shown by actin immunoblot, indicates NKCC1 is upregulated by acute 
hypoxia in NT2 cells. Note that the band corresponding to NKCC1 has an 
expected size of 130 KDa, however the band detected in PC12 cells was 
smaller (~115 KDa). This could be due to the antibody having been 
synthesised to recognise a human epitope (NT2 cells) and, therefore, not 
being specific for a rat epitope (PC12 cells). 
 
A marked basal expression of KCC2 was observed in PC12 and NT2 cells in 
normoxic conditions. KCC2 protein expression was dramatically affected by 
hypoxic insult in differentated PC12 and NT2 cells (Figure 5.5). The band 
corresponding to KCC2 was not observed in PC12 cells following hypoxia 
and an intense decrease in the expression of the chloride exporter was 
observed in NT2 cells. These results suggest that the chloride exporter KCC2 
expression is downregulated by acute hypoxia. 
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Figure 5.4. Analysis of chloride importer NKCC1 expression following 
acute hypoxia in PC12 and NT2 cells. Representative immunoblot analysis 
showing: A. NKCC1 protein expression in differentiated PC12 and NT2 cells 
under normoxic (N) or hypoxic conditions for 4 and 8 hours. B. 
Immunoblotting with actin was used to verify equal protein loading. 
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Figure 5.5 The impact of hypoxia on KCC2 expression in hypoxic 
neuronal-like PC12 and NT2 cells. Representative immunoblot analysis 
showing: A. KCC2 protein expression in differentiated PC12 and NT2 cells 
under normoxic (N) or hypoxic conditions for 8 hours. B. Immunoblotting with 
actin was used to verify equal protein loading. 
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Previous literature has focused on the expression of KCC2 and NKCC1 as 
principal mediators of the GABAAR-mediated response whereas less 
attention has been payed into the function of the remaining chloride 
exporters, KCC1, KCC3 and KCC4 in CNS pathologies and adaptation to 
hypoxic insult. mRNA quantification showed downregulation of chloride 
exporter expression following hypoxia (Figure 5.3), therefore their protein 
expression was analysed via immunoblotting.  
 
Changes in protein expression of KCC3 and KCC4 following hypoxia (Figure 
5.6) were not as obvious as for NKCC1 and KCC2 (Figure 5.4 and 5.5). The 
band corresponding to KCC3 showed no difference in intensity following 
acute hypoxia in both cell lines analysed (Figure 5.6 A). A decrease in KCC4 
immunolabeling was observed after four hours of hypoxic insult and staining 
was even less robust after 8 hours in PC12 cells (Figure 5.6 B). KCC4 
expression was not detected in NT2 cells due to a lack of human-specific 
antibody. In summary, a small downregulation in the chloride exporter KCC4 
expression in PC12 cells was observed following acute hypoxia whereas 
changes were not detected in KCC3 expression.  
 
These results suggest that chloride trafficking might be modified in neuronal-
like cells following hypoxia due to changes in the expression of the CCCs, as 
a decrease in the expression of the chloride exporters (KCC1-4) in both the 
mRNA and protein was observed. The chloride importer NKCC1 protein 
expresion was upregulated in NT2 cells, but significant changes in the mRNA 
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abundance for PC12 and NT2 cells, and PC12 cells protein expression, were 
not observed.  
 
 
 
Figure 5.6 Analysis of the chloride exporters KCC3 and KCC4 
expression following hypoxia in PC12 and NT2 cells. Representative 
immunoblot analysis showing KCC3 (A) and KCC4 (B) protein expression in 
differentiated PC12 and NT2 cells under normoxic (N) or hypoxic conditions 
for 4 or 8 hours. Ns: non-specific. Immunoblotting with actin was used to 
verify equal protein loading (C). 
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5.4.2 Analysing the expression of NKCC1 and KCC2 in vivo in the peri-
infarct region following photothrombotic stroke 
 
In Chapter 4, the penumbra was assessed and defined in a photothrombotic 
stroke (PTS) model in mouse. In the 200 μm region surrounding the 
ischaemic core, an increase in neuronal stress and recruitment of glial cells 
was identified (Figure 4.16). This was taken to define the penumbra, as 
neuronal stress and glial reactivity are two well-defined hallmarks of the 
region (Popp et al., 2009; Barreto et al., 2011). Increased glial reactivity was 
also identified in the region between 200 and 400 μm from the ischaemic 
core (Figure 4.16), which was named area of increased glial enrichment 
(IGE). Furthermore, significant neuronal loss was observed within the 
penumbra following PTS demonstrating that the damage in this tissue 
continues to increase in the days after the ischaemic insult. 
 
The goal of this study was to analyse the pattern of NKCC1 and KCC2 
expression in the now defined penumbral cortex following PTS. The results 
observed in the in vitro model indicated a decrease in KCC2 at the mRNA 
and protein levels as an adaptation to hypoxia in neuron-like cells. Thus, this 
could potentially contribute to excitotoxic neuronal injury following an 
ischaemic event. Therefore, expression of NKCC1 and KCC2, the two 
principal mediators of neuronal chloride trafficking, was assessed via 
immunostaining of brain sections encompassing the penumbra following 
PTS. 
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Immunostaining for NKCC1 and KCC2 was performed in 40 μm mouse brain 
slices in untreated mice at at one, three and five days following PTS (Figure 
5.7). Five serial images encompassing 30 μm across the z-axis were taken 
per brain slice. Regions of 200 μm length and 200 μm width were marked on 
the brain cortex and aligned at the edge of the ischaemic core representing 
the penumbra (Figure 5.7 red box). The IGE area was analysed in regions of 
200 μm length and 200 μm width aligned at the edge of the penumbral cortex 
(Figure 5.7 blue box). This procedure was repeated in matching regions of 
the contralateral hemisphere. 
 
Confocal microscopy images of the injury at low magnification (x 10) revealed 
defined NKCC1 staining in the area surrounding the ischaemic core (Figure 
5.7 A). As expected, KCC2 staining was ubiquitous in the brain (Figure 5.7 
A). Higher magnification images were taken in the penumbra and IGE area 
(Figure 5.7 B and C, red and blue box respectively). A high number of 
NKCC1-positive cells was observed in the penumbra and the staining was 
defined at the perisomatic and dendritic membrane (Figure 5.7 B, white 
arrows). In the IGE area, NKCC1-positive cells were less prominent and the 
staining intensity was decreased (Figure 5.7 C, white arrows). KCC2 staining 
was more diffuse as it stained perisomatic, dendritic and axonal membranes, 
creating higher background noise. Therefore, only perisomatic membrane 
staining, which identified individual cells was considered to be KCC2-positive 
(Figure 5.7 B and C, yellow arrows). A higher number of KCC2-positive cells 
could be visually distinguished in the IGE zone when compared to the 
penumbra in the cortex (Figure 5.7 B and C). Therefore, visual observations 
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indicated a reversal in the expression of the chloride importer NKCC1 and 
the chloride exporter KCC2 in the penumbra compared to more remote, 
healthy areas. 
 
Figure 5.7 NKCC1 and KCC2 expression is altered in the penumbra 
following PTS. Representative mouse brain images three days after PTS 
displaying NKCC1 (red) and KCC2 (green) immunolabeling. A: General 
overview of the marking for NKCC1 and KCC2 at x 10 magnification. Red 
box represents an area of the penumbra, blue box the IGE zone. B: Detailed 
(x 63) magnification of the penumbra. C: Detailed (x 63) magnification of IGE 
area. White arrows represent NKCC1-positive cells, yellow arrows represent 
KCC2-positive cells. Scale bar represent 200 μm (A) and 50 μm (B and C). 
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5.4.2.1 Analysing the expression of NKCC1 and KCC2 in the penumbra 
following PTS 
 
Brains of mice were analysed at one, three and five days following PTS and 
compared to untreated mice. Furthermore, three different mice per time point 
and nine different brain slices per mouse were analysed for statistical 
significance 
 
In the damaged ipsilateral hemisphere, the penumbra comprised a 
significantly higher number of NKCC1-positive cells compared to KCC2-
positive cells at at one, three and five days following PTS (Figure 5.8 A). One 
day post-PTS, 58.7% of DAPI-positive cells were NKCC1-positive compared 
to 25.5% KCC2-positive cells (p < 0.001). Three days following PTS, 53.1% 
of the cells were NKCC1-positive and 26.5% KCC2-positive (p = 0.004) and 
five days after the insult 58.6% were NKCC1-positive and 21.6% KCC2-
positive (p <0.001). 
 
In the undamaged contralateral hemisphere, regions of cortex that matched 
the location of the penumbra in the ipsilateral hemisphere were analysed. In 
this area, the expression of NKCC1 and KCC2 was reversed, with a 
significantly higher number of KCC2-positive cells than NKCC1-positive cells 
at one, three and five days following the insult (Figure 5.8 B, p < 0.001). At 
days at one, three and five days 63.5 ± 1 % of the cells were KCC2-positive 
and NKCC1-positive cells remained unchanged at 24 ± 0.5 %.  
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Figure 5.8 NKCC1 expression is more abundant than KCC2 in the 
penumbra following the injury. The expression of NKCC1 and KCC2 was 
analysed in the penumbra in the ipsilateral (A, ipsi) and contralateral (B, 
contra) hemispheres. Results were normalised as a percentage of total 
DAPI-positive cells for each marker and represented as the mean ± SEM 
(n=3). Two-way ANOVA with Sidak’s multiple comparisons test. 
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This data strongly indicate that there was a higher number of NKCC1-positive 
cells in the penumbra compared to KCC2 positive cells and that this pattern 
opposes that of the contralateral hemisphere, where the population of KCC2-
positive cells is significantly greater than the amount of NKCC1 positive cells. 
However, no temporal changes were observed indicating that the reversal in 
the expression of these transporters takes place before one day following 
PTS and is maintained beyond five days following the insult. 
 
In order to compare expression of NKCC1 and KCC2 independently between 
the ipsilateral and contralateral hemispheres, a different analysis was 
performed (Figure 5.9). Here, expression of each transporter in the ipsilateral 
penumbra was compared to matching regions in the contralateral 
hemisphere. This permitted a clear distinction between the ipsilateral and 
contralateral hemispheres and provided a tool to examine differences 
created by the injury with a matching control without damage but within the 
same animal. This approach negates variation between individuals. Figure 
5.9 panel A, revealed highly significant differences (p < 0.001) in the 
expression of NKCC1 between the ipsilateral penumbra, where a high 
percentage of cells were NKCC1-positive, and the cortex of the contralateral 
hemisphere where, in comparison, the number of NKCC1-positive cells was 
reduced. Highly significant differences (p < 0.001) in KCC2 expression 
between ipsilateral and contralateral hemispheres were also observed in the 
penumbra following PTS (Figure 5.9 B). However, the pattern of KCC2 
expression was reversed, with a significantly higher number of KCC2-positive 
cells in the contralateral hemisphere compared to the ipsilateral hemisphere. 
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The results indicate that there was a reversal in the expression of the CCCs, 
NKCC1 and KCC2 in the penumbra following PTS. 
 
Figure 5.9 Distinct differences in NKCC1 and KCC2 expression in the 
penumbra following PTS. The expression of NKCC1 (A) and KCC2 (B) was 
analysed in the penumbra in the ipsilateral and contralateral hemispheres. 
Results were normalised as a percentage of total DAPI-positive cells for each 
marker and represented as the mean ± SEM (n=3). Two-way ANOVA with 
Sidak’s multiple comparisons test.  
215 
 
5.4.2.2 Analysis of NKCC1 and KCC2 expression in the IGE area 
following PTS 
 
In chapter 4 a region displaying increased glial reactivity, referred to as the 
increased glial enrichment (IGE) area was identified between 200 and 400 
μm from the ischaemic core. In order to analyse the expression of the cation 
chloride cotransporters, NKCC1 and KCC2, in this transitional area and 
further understand chloride homeostasis within it, an identical analysis as per 
section 5.4.2.1 was performed in the IGE zone. 
 
In the IGE zone, significant differences between NKCC1- and KCC2-positive 
cells were observed in both the ipsilateral and contralateral hemispheres 
(Figure 5.10). In the IGE zone of the ipsilateral hemisphere (Figure 5.10 A), 
one day following PTS, 32.9% of DAPI-positive cells were NKCC1-positive, 
whereas 54% were KCC2 positive (p = 0.02). Three days following the insult 
23.5% of DAPI-positive cells were NKCC1-positive and 65% KCC2-positive 
(p < 0.001) and after five days 24% NKCC1-positive and 64.4% KCC2-
positive (p < 0.001).  
 
Similar results were obtained in the contralateral hemisphere: at day one, 
26% of cells were NKCC1-positive and 63.1% KCC2-positive, at day three 
the percentage of NKCC1-positive cells decreased to 22.5% and 65.1% 
KCC2-positive and at five days 25.1% NKCC1-positive and 66.2% KCC2-
positive. The differences between NKCC1 and KCC2 expression were highly 
significant at all time points following the injury (p < 0.001). KCC2-positive 
cells were therefore significantly more abundant than NKCC1-positive in the 
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IGE area in the ipsilateral hemisphere compared to matching regions in the 
contralateral hemisphere cortex. 
 
Figure 5.10 KCC2 expression is more abundant than NKCC1 in the IGE 
area following PTS. Expression of NKCC1 and KCC2 was analysed in the 
penumbra in the ipsilateral (ipsi) and contralateral (contra) hemispheres at at 
one, three and five days post-injury. Results were normalised as a 
percentage of total DAPI-positive cells for each transporter and represented 
as the mean ± SEM (n=3). Two-way ANOVA with Sidak’s multiple 
comparisons test. 
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Transporter-specific differences between the ipsilateral hemisphere and 
matching regions of the contralateral hemisphere were assessed in the IGE 
zone (Figure 5.11). Differences were not observed in the percentage of 
NKCC1-positive cells in the IGE zone between the ipsilateral and 
contralateral hemispheres (Figure 5.11 A). Furthermore, time-dependent 
differences were not observed in the expression pattern of NKCC1 in the 
days following the injury. The percentage of KCC2-positive cells was also 
very similar in the ipsilateral and contralateral hemisphere and significant 
differences were not observed (Figure 5.11 B). As for NKCC1 time-
dependent differences were not observed in the days following the PTS. 
Therefore, expression of NKCC1 and KCC2 between the IGE area was very 
similar in the damaged (ipsilateral) and healthy (contralateral) hemispheres. 
 
Interestingly, the results shown in Figures 5.10 and 5.11 reveal that, in 
contrast to the penumbra, the expression of the CCCs, NKCC1 and KCC2, 
is not affected in the IGE zone. Furthermore, the pattern of expression of 
these transporters is very similar to healthy areas of the brain (contralateral 
hemisphere). Therefore, this area is further confirmed as a non-penumbral 
region where there is an increase in glial reactivity but where potential ionic 
imbalance is not extended to, or at least not mediated by changes in the 
expression of the chloride transporters NKCC1 and KCC2. 
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Figure 5.11 NKCC1 and KCC2 expression is not affected by PTS in the 
IGE area when compared to healthy tissue. The expression of NKCC1 (A) 
and KCC2 (B) was analysed in the IGE area in the ipsilateral and 
contralateral hemispheres at one, three and five days post-PTS. Results 
were normalised as a percentage of total DAPI-positive cells for each 
transporter and represented as the mean ± SEM (n=3). Two-way ANOVA 
with Sidak’s multiple comparisons test. 
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In summary, analysis of NKCC1 and KCC2 expression in the area 
surrounding the ischaemic core following PTS indicated: i) a strong induction 
of NKCC1 expression in the penumbra following the injury; ii) A concurrent 
decrease in the number of neurons expressing KCC2 in the penumbra; iii) 
The zone with increased glial reactivity (IGE), hypothesised to be a glial 
migration zone, displays an almost identical pattern of NKCC1 and KCC2 
expression in matching, unaffected contralateral hemisphere; iv) Expression 
of NKCC1 or KCC2 was unchanged in the days following the injury in any of 
the areas analysed. Together, this indicates rapid (before one day) and 
sustained reversal in NKCC1 and KCC2 expression occurs in the penumbra 
following PTS. The striking differences in NKCC1 and KCC2 expression 
induced by ischaemia strongly suggest that chloride trafficking is modified 
and could be contributing to an ionic imbalance in neurons of the penumbra 
up to five days and beyond following the injury. 
 
The clear alteration in expression of NKCC1 and KCC2 in the penumbra after 
PTS might represent a reversal in the chloride trafficking across neuronal 
membranes, therefore modifying neuronal [Cl-]i (Figure 5.1). This shift could 
modify GABAAR-mediated activity rendering it depolarising (Succol et al., 
2012) and, therefore, contributing to the excitotoxicity that terminates in 
neuronal damage in the penumbra (Szydlowska and Tymianski 2010). In light 
of the data, NKCC1 and KCC2 represented very attractive neuroprotective 
targets for modulation in order to rescue the salvageable penumbral tissue 
at risk of infarction following PTS. Accordingly, the next study was aimed to 
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investigate whether the modulation of CCCs channel function, using CCCs-
specific ligands, would impact on neuronal loss following PTS. 
 
5.4.3 Modulation of NKCC1 and KCC2 activity reduces neuronal loss in 
the penumbra following PTS 
 
Specific drugs that target NKCC1 and KCC2 are needed in order to modulate 
their activity and test their validity as neuroprotective targets in different 
pathologies. The neuroprotective potential of NKCC1 and KCC2 was 
analysed by treating mice with transporter-specific modulators and 
measuring subsequent neuronal loss in the defined penumbra following PTS. 
 
5.4.3.1 CLP257 as a neuroprotective modulator of KCC2 activity 
 
CLP257 is a specific KCC2 agonist (Gagnon et al., 2013) and has been 
shown to strengthen KCC2 activity and recover loss of neuronal inhibition as 
well as pain hypersensitivity in a rat model of neuropathic pain (Gagnon et 
al., 2013). It therefore represents a novel strategy to restore the normal 
chloride gradient in the penumbra after PTS. KCC2 mRNA and protein were 
downregulated in neuronal-like PC12 and NT2 cells following acute hypoxia 
in vitro (Figures 5.3 and 5.5) and a substantial decrease in the number of 
neurons expressing KCC2  was observed in the penumbra following PTS in 
vivo (Figure 5.8 and 5.9).  
 
CLP257 was administered intraperitoneally to mice at 100mg/kg 1 hour 
following the photothrombotic insult as described previously (Gagnon et al., 
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2013). For days three and five post PTS, a second dose was administered 
to mice 24 hours following the PTS insult. In Chapter 4, NeuN 
immunostaining following PTS revealed neuronal loss taking place in the 
penumbra increasing up to 5 days following the insult (Figure 4.15). Brain 
slices were immunostained with NeuN and DAPI and images obtained as 
explained in section 5.4.2.1. Untreated, vehicle and CLP257-treated mice 
were examined. The vehicle used with the drug treatments (0.1% DMSO in 
NaCl) was used as a control to eliminate any possible interference of the 
solvent on the drug effects.  
 
Analysis of NeuN-positive staining of cells in the penumbra (Figure 5.12, A, 
red boxes), healthy cortex in the peri-infarct region (Figure 5.12, A, yellow 
boxes) and an area matching the location of the penumbra in the 
contralateral hemisphere (Figure 5.12, C) was analysed at one, three and 
five days following PTS (Figure 5.12). NeuN immunolabeling was 
homogeneous in the brain (Figure 5.12, A, top panel), although a decrease 
in the total number of cells, as well as an increase in DAPI-positive NeuN-
negative cells, was observed in the penumbral cortex at all time points 
following the PTS (Figure 5.12, A, red boxes).  
 
NeuN- and DAPI-positive cells were counted in the different regions and 
analysed to quantify neuronal loss in the penumbra and contralateral 
hemisphere following PTS and were expressed as a ratio of NeuN/DAPI. One 
day following the insult the NeuN/DAPI ratio was 0.66 in untreated mice, 0.60 
in vehicle control and increased to 0.74 in CLP256-treated animals (Figure 
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5.12 B, p = 0.74). Three days after PTS the ratio in untreated animals was 
0.59, 0.58 in vehicle-treated and 0.55 in CLP257-treated mice (Figure 5.12 
B). Finally, five days following PTS, the NeuN/DAPI ratio was 0.42 in 
untreated mice, 0.46 in vehicle-treated and 0.53 in CLP257-treated (Figure 
5.12 B). The vehicle used for the drug administration did not induce any 
changes on neuronal loss (Figure 5.12 B). Significant changes in neuronal 
loss were not observed following CLP257 treatment. A small increase in 
neuronal numbers was observed at one and five days following the insult 
compared to the vehicle and untreated animals in CLP257-treated mice. 
Therefore, this result indicates that CLP257, under the conditions of this 
investigation, did not decrease neuronal loss in the penumbra up to five days 
following PTS in mice.  
 
In the contralateral hemisphere, changes in neuronal loss were not observed 
following vehicle or drug treatment (Figure 5.12 C). Furthermore, the 
NeuN/DAPI ratio was very similar, 0.87 ± 0.02, indicating that the 
contralateral hemisphere did not suffer from any effect following the drug 
treatments and therefore functioned as a valid control.  
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Figure 5.12 CLP257 treatment following PTS does not affect neuronal 
loss in the penumbra. A. Representative images of untreated, vehicle-
treated and CLP257-treated mice analysed for NeuN (green) and DAPI (blue) 
staining in the penumbra (red boxes), healthy cortex (yellow boxes). Scale 
bar represents 500 μm (top panel) and 50 μm (bottom panels). The 
NeuN/DAPI ratio was represented in the penumbra (B) and contralateral 
hemisphere (C) at one, three and five days following PTS. Results are 
represented as the mean ± SEM (n=3). Two-way ANOVA with Sidak’s 
multiple comparisons test.  
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5.4.3.1 Bumetanide as a neuroprotective modulator of NKCC1 activity 
 
Bumetanide is an NKCC1-specific antagonist at low concentration (< 10 μM) 
(Dzhala et al., 2005). The results shown earlier in this chapter indicate that 
NKCC1 and KCC2 expression was modified following ischaemic insults. In 
the hypoxic in vitro model, NKCC1 levels were not modified at mRNA level 
(Figure 5.3) but there was an increase in the protein levels following acute 
hypoxia in NT2 cells (Figure 5.4). In the in vivo PTS model, the ischaemic 
penumbra revealed a significant increase in NKCC1-positive cells in the days 
following the insult (Figures 5.8 and 5.9).  Bumetanide has been shown to be 
effective in reducing neonatal seizures in different animal models (Kahle and 
Staley 2008) and to be protective in preterm hypoxic brain injury (Jantzie et 
al., 2015), situations in which high expression of NKCC1 was observed. 
Hence, given the over-expression of NKCC1 observed in the penumbra 
(Figures 5.8 and 5.9), bumetanide was postulated to be effective in reducing 
excitotoxicity by facilitating GABAAR-mediated hyperpolarisation. It was 
hypothesised that the antagonising actions of bumetanide would inhibit 
NKCC1-mediated chloride import and therefore, upon GABAAR activation, 
the higher concentrations of extracellular chloride would lead to chloride 
influx in the cell. This could eventually induce hyperpolarising action 
potentials, mitigating the excitotoxic effect that ensues in the penumbra 
following stroke. 
 
Untreated, vehicle and bumetanide-treated mice were analysed by NeuN 
immunostaining of brain sections following PTS. Analysis of the number of 
NeuN-positive cells in the penumbra (Figure 5.13, A, red boxes), healthy 
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cortex in the peri-infarct region (Figure 5.13, A, yellow boxes) and an area 
matching the location of the penumbra in the contralateral hemisphere 
(Figure 5.13, C) was assessed at one, three and five days following PTS 
(Figure 5.13). NeuN immunolabeling was, as expected, homogeneous in the 
brain (Figure 5.13, A, top panel), although a decrease in total number of cells, 
and an increase in DAPI-positive NeuN-negative cells, was observed in the 
penumbral cortex at one, three and five days following PTS (Figure 5.13, A, 
red boxes).  
 
By counting the number of NeuN and DAPI-positive cells in the penumbra 
and contralateral hemispheres, neuronal survival following PTS was 
determined (Figure 5.13 B and C). In the penumbra, one day following PTS, 
the NeuN/DAPI ratio was 0.66, 0.60 in the vehicle control and 0.71 in the 
bumetanide-treated mice (Figure 5.13 B). Three days following PTS the ratio 
of neurons in the penumbra was reduced to 0.59 in untreated mice, 0.58 in 
vehicle control and a significantly higher 0.76 ratio (p = 0.01) was observed 
in bumetanide-treated animals. Five days after PTS, the ratio of NeuN/DAPI 
in untreated mice in the penumbra was reduced to 0.42, 0.46 in the vehicle 
control and a significantly higher 0.68 ratio (p < 0.001) in bumetanide-treated 
mice. The vehicle control had no effect on untreated mice indicating that the 
vehicle did not interfere with the drug effects. However, treatment with 
bumetanide promoted neuronal survival three and five days following PTS 
(Figure 5.13 B).  
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An interesting observation was that the ischaemic core is always lost during 
the tissue handling, however, one of the bumetanide-treated mice analysed 
one day following the ischaemic insult did not lose the ischaemic core during 
the sample preparation (Figure 5.13 A). Whether this was an isolated event 
or produced by maintenance of tissue integrity due to reduced neuronal loss 
could not be ascertained. 
 
In the contralateral hemisphere, changes in neuronal loss were not observed 
following vehicle or drug treatment (Figure 5.13 C). Furthermore, the 
NeuN/DAPI ratio was very similar in the different groups analysed, 0.88 ± 
0.04, indicating that, as expected, the contralateral hemisphere did not suffer 
from any effect following the drug and vehicle treatments and therefore 
functioned as a valid control. 
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Figure 5.13 Bumetanide treatment reduces neuronal loss in the 
penumbra following PTS. (A) Representative images of untreated, vehicle-
treated and bumetanide-treated mice at one, three and five days following 
PTS were analysed for NeuN (green) and DAPI (blue) staining in the 
penumbra (red boxes), healthy cortex (yellow boxes). Scale bar represent 
500 μm (top panel) and 50 μm (bottom panels). The NeuN/DAPI ratio was 
represented in the penumbra (B) and contralateral hemisphere (C). Results 
are represented as the mean ± SEM (n=3). Two-way ANOVA with Sidak’s 
multiple comparisons test. 
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In summary, the analysis of KCC2 and NKCC1 modulation on neuronal loss 
following PTS revealed two main findings: i) there is a reversal in the 
expression of the CCC family of proteins following hypoxic insults in both in 
vitro and in vivo models. The expression of the chloride exporters was 
downregulated at both the mRNA and protein level following hypoxic insults 
while the expression of the chloride importer NKCC1 was upregulated; ii) 
Treatment with bumetanide, an NKCC1 antagonist reduced neuronal loss 
three and five days following the insult in a photothrombotic model of stroke 
in mice.  
 
The aim of this study was to assess the impact of NKCC1 and KCC2 
modulation on neuronal loss in the established penumbra following treatment 
with the NKCC1 antagonist bumetanide and the KCC2 agonist CLP257. 
Treatment with bumetanide resulted in an increase in neuronal survival in the 
penumbra following PTS in mice (Figure 5.13). The fundamental role of 
NKCC1 in inducing excitatory GABAergic neurotransmission makes it an 
attractive target to curtail neuronal excitotoxicity following stroke. 
Bumetanide produced significant increases in the number of surviving 
neurons compared to the untreated and vehicle control mice three and five 
days following PTS (Figure 5.13). Therefore, the protective efficacy of 
bumetanide in reducing the neuronal loss in the days following PTS suggests 
that NKCC1 inhibition may have clinical application in stroke patients. This is 
highly important as its usage one, and 24 hours following PTS induced 
neuronal survival 3 and 5 days following the insult, representing an available 
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therapeutic agent with the potential to increase the therapeutic window of 
current stroke treatments. 
 
5.5 Discussion 
 
 
In this chapter, a reversal in the pattern of expression of the chloride 
exporters, KCC1-4 and NKCC1, importer of the CCC family of proteins, was 
observed following hypoxia in neuronal-like cells in vitro and in the penumbra 
following an in vivo mouse model of PTS. Furthermore, blockage of NKCC1 
activity with bumetanide rescued neuronal loss within the penumbra. 
 
5.5.1 Implications of the reversal in the expression of the CCCs 
following hypoxic insults 
 
CCCs are the master regulators of chloride homeostasis in the brain and this 
chloride balance is responsible for GABAAR-mediated postsynaptic activity 
(Kaila et al., 2014). Therefore CCCs modulate GABAAR-mediated activity 
and modifications in their regulation and expression have been shown to be 
involved in the development of various CNS pathologies (reviewed by Kahle 
et al.,  2015, Figure 5.1). However CCCs also have GABAAR-independent 
functions, in neuronal volume regulation, synaptogenesis, dendritic spine 
formation, interactions with trophic factors and intracellular molecular 
cascades (Blaesse et al., 2009). 
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A reversal in the chloride gradient mediated by NKCC1 upregulation and 
simultaneous KCC1-4 downregulation, promotes a shift in the GABAergic 
potential towards a less hyperpolarising or even depolarising state (Rivera et 
al., 1999; Figure 5.1). The inhibitory tone of GABA is essential for the correct 
development of signal transmission within the brain. Downregulation of the 
chloride exporters KCC1-4 expression was observed in the in vitro model of 
hypoxia at mRNA and protein levels (Figures 5.3, 5.5 and 5.6) alongside an 
upregulation of NKCC1 at protein level (Figure 5.4). This adaptation to 
hypoxia is similar to embryogenesis, where a reversal in the expression 
pattern of NKCC1 and KCC2 renders GABAAR-mediated responses 
depolarising (Rivera et al., 1999). This depolarisation increases the 
intracellular levels of Ca2+, activating downstream signalling cascades, which 
in turn promote the release of trophic factors and promote neuronal 
proliferation and synaptogenesis (Ben-Ari et al., 2007). Therefore, the in vitro 
response to hypoxia observed in this chapter could represent an adaptation 
of neurons to revert to earlier in development phenotypes and thus, 
potentially proliferative states. This adaptive response is, to a certain extent, 
similar to the adaptations observed following acute hypoxia in neuronal-like 
cells in Chapter 3. However, this strategy could also contribute to further 
depleting the energetic pool following hypoxia. Most importantly, GABAAR-
mediated depolarisation could contribute to excitotoxicity, which is 
responsible for the expansion of the penumbra and its recruitment into the 
core (Szydlowska and Tymianski 2010). 
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Inhibition of the KCCs using a non-specicific inhibitor, 
[(dihydroindenyl)oxy]alkanoic acid (DIOA), and KCC1-targetted knockdown 
with siRNA, both enhanced NGF-mediated neurite outgrowth in PC12 cells 
(Nagao et al., (2012). NGF treatment of PC12 cells was shown to inhibit 
KCC1 expression but not KCC2-4. NKCC1 is up-regulated following NGF 
treatment of PC12 cells and NKCC1 knock-down diminished neurite 
outgrowth (Nakajima et al., 2007). These results indicate that the chloride 
balance is fundamental for neurite elongation and that when CCCs 
expression is reversed, neurite outgrowth is enhanced. Although these two 
studies do not analyse the effect of hypoxia in PC12 cells, they provide an 
insight into the role of CCCs in neurite elongation and how this could parallel 
the results obtained in following hypoxia in Chapter 3. This is that reversal of 
CCCs expression could lead to immature adaptive responses (Figure 5.1) 
and that this temporary return to an immature phenotype may be protective 
to re-establish neuronal networks. 
 
Analysis of CCC expression in the in vitro model of hypoxia demonstrated 
that changes in the expression of these cotransporters are observed 
following acute hypoxic insults in neuronal-like cells. This has a great 
significance as it provides a platform to further investigate GABAAR-
dependent, and GABAAR-independent roles of the CCCs following hypoxia 
that could be translated to in vivo models. However, changes in CCCs 
expression and function may, or may not occur in neurons within the brain in 
vivo, and these findings were therefore replicated in a model of PTS in mice 
in order to determine their clinical relevance.  
232 
 
In vitro findings were confirmed in vivo as a highly significant increase in the 
expression of NKCC1 and decrease in the expression of KCC2 were 
observed in the penumbra of mice at one, three and five days following PTS 
(Figures 5.8 and 5.9). Although changes in CCCs expression do not 
necessarily determine changes in the activity of these transporters, the 
extraordinary reversal in expression observed in the penumbra compared to 
healthy or contralateral cortex, strongly suggest a modification in the chloride 
gradient promoted by NKCC1 and KCC2. A direct relationship between 
changes in the expression of KCC2 and NKCC1 in neuronal [Cl-]i has been 
previously demonstrated (Dzhala et al., 2010; Gagnon et al., 2013). This 
strongly suggests that alterations in the expression of the CCCs such as 
those observed herein, could potentially reflect changes in [Cl-]i, and 
therefore influence GABAAR-mediated potential (Succol et al., 2012). 
 
Several studies have addressed the expression of NKCC1 and KCC2 
following stroke. NKCC1 has been  shown to be upregulated in the peri-
infarct cortex following MCAO (Yan et al., 2003; Begum et al., 2015) and 
KCC2 downregulated under the same model (Jaenisch et al., 2010; Jaenisch 
et al., 2016). Only one study has shown KCC2 to be downregulated following 
PTS in individual motoneurons (Toda et al., 2014). However, studies that 
address the expression of both NKCC1 and KCC2 in a clearly-identified 
penumbra following PTS are seriously lacking. Therefore, understanding the 
pattern of expression of the CCCs in a precisely defined penumbra 
represented an unmet need for the development of this field of research. 
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The results described in this chapter show a reversal in the expression of 
both NKCC1 and KCC2, primary regulators of neuronal chloride trafficking in 
mammalian CNS, in a molecularly and precisely characterised penumbra, 
located up to 200 μm from the ischaemic core. Furthermore, changes in the 
expression of NKCC1 and KCC2 were not observed in the IGE zone. This is 
highly important as previous studies were targeted at a loosely defined peri-
infarct zone, which could lead to the misinterpretation of results (Yan et al., 
2003; Jaenisch et al., 2010; Begum et al., 2015; Jaenisch et al., 2016). 
Studies aimed at a vaguely defined peri-infarct area could in fact represent a 
combination of healthy tissue and the penumbra.  
 
5.5.2 KCC2 as a target for neuroprotection 
 
KCC2 expression was downregulated in the penumbra in the days following 
PTS, therefore the aim of this study was to rescue KCC2 activity through a 
specific KCC2 agonist (Gagnon et al., 2013). Neuronal loss was not 
significantly improved with the treatment of CLP257 following PTS, although 
a small increase in neuronal numbers was observed one and five days after 
the experimental stroke (Figure 5.12). The mechanism of action of CLP257 
is thought to be a result of an increase in the trafficking of existing KCC2 
protein complexes to the plasma membrane (Gagnon et al., 2013).  
 
Successful experiments with CLP257 in rescuing  KCC2 activity have been 
achieved in vitro through electrophysiological recordings in spinal cord slices 
in a peripheral nerve injury model (Gagnon et al., 2013), cortex slices in an 
ictogenesis model (Hamidi and Avoli 2015) and hippocampal slices in a 
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model of Alzheimer’s (Chen et al., 2017); but also in vivo via intraperitoneal 
injection in peripheral nerve injury animals (Gagnon et al., 2013) and in a 
neuropathic pain model (Lavertu et al., 2014). However, due to the poor 
pharmacokinetics of CLP257 the maximum efficacy of this drug was 
achieved two hours post injection (Gagnon et al., 2013) or with an attached 
chamber that perfused the drug for 30 minutes (Lavertu et al., 2014). Poor 
pharmacokinetics and short half-life might therefore be responsible for the 
results obtained in our model. However, the photothrombotic model of stroke 
presents the advantage of instantly disrupting the BBB (Schoknecht et al., 
2014), therefore giving greater access to drugs to neuronal tissue that 
otherwise would not be able to cross this barrier and exert their potentially 
beneficial effects. Therefore this model is useful in order to screen the 
potential of such drugs. 
 
An improved version of CLP257, CLP290, has been developed which 
presents an improved plasma concentration (Gagnon et al., 2013). However, 
this drug was not commercially available at the time of designing this study. 
It would be interesting to repeat this study with CLP290 in order to maximise 
the potential of KCC2 modulation and increase the drug’s exposure. The 
ability of novel drugs which possess a longer half-life and cross the BBB to 
reach their target location within the brain is a big limitation to reach clinical 
relevance. Therefore, more effort should be addressed into finding such 
compounds.  
 
235 
 
5.5.3 NKCC1 as a target for neuroprotection  
 
Expression of NKCC1 was shown to be dramatically upregulated in the 
penumbra 1, 3 and 5 days following PTS (Figures 5.8 and 5.9). Furthermore, 
this upregulation was suggested to occur rapidly (before one day) and 
maintained up to 5 days and beyond after stroke. NKCC1 expression affects 
GABAAR polarity by increasing neuronal [Cl-]i (Dzhala et al., 2010). This shift 
in chloride equilibrium potential renders GABAAR responses depolarising 
(Rivera et al., 1999) reversing normal GABA-mediated postsynaptic 
inhibitory tone. Therefore, NKCC1 is believed to participate in the spreading 
depolarisations and excitotoxicity that follows an ischaemic stroke in the 
penumbra (Beck et al., 2003; Steffensen et al., 2015; Martín-Aragón Baudel 
et al., 2017). In this study, it was hypothesised that treatment with 
bumetanide, an NKCC1 antagonist, could inhibit reversed chloride transport 
and subsequently reduce GABAAR-mediated depolarisation thereby 
decreasing neuronal loss associated with excitotoxicity.  
 
Treatment with bumetanide 1 and 24 hours following PTS decreased 
neuronal loss in the penumbra three and five days after stroke (Figure 5.13). 
These results highlight the role of NKCC1 upregulation in the penumbra in 
mediating neuronal loss, as pharmacological inhibition of its activity resulted 
in a significant increase in neuronal survival. Furthermore, the beneficial 
effect of bumetanide was observed three and five days following the insult, 
time points at which a second dose of bumetanide was injected at 24 hours. 
This underlines the potential of this drug to provide a longer therapeutic 
window than current pharmacological or mechanical strategies focused on 
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thrombolysis (Holmes et al., 2015; Akbik et al., 2016). These results support 
the idea that rescuing the penumbra could provide stroke victims with a 
longer therapeutic window therefore increasing the selection criteria for 
patients outside the current 4.5 hours therapeutic window for thrombolytic 
strategies.  
 
It could be argued that the protective role of bumetanide could be due to a 
reduction in oedema formation. Oedema formation is  secondary damage 
produced after stroke that contributes to neuronal loss and mortality 
(Sandoval and Witt 2008). This is caused by an increase in Na+ and water 
transport from the blood across the BBB to the brain (Betz 1996). A number 
of findings have revealed a role for NKCC1 in participating in Cl- and Na+ 
transport in BBB endothelial cells in the hours following an ischaemic event 
(Spatz et al., 1997; Wallace et al., 2012). Bumetanide decreased oedema 
formation in a permanent MCAO model in rats (O’Donnell et al., 2004), 
however, in this model, reperfusion does not take place, which is responsible 
for the breakdown of the BBB (Yang and Betz 1994). BBB breakdown takes 
place ∼4 hours after the onset of ischemia (Betz 1996) and the protective 
effects of bumetanide observed 3 and 5 days following PTS took place when 
a second dose of was injected 24 hours after PTS. Furthermore, the BBB is 
immediately disrupted following PTS (Schoknecht et al., 2014) and therefore, 
the beneficial effects of bumetanide cannot be attributed to a decrease in 
oedema formation mediated by reducing NKCC1 activity.  
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Drugs able to restore low neuronal [Cl-]i and therefore GABAAR-mediated 
inhibition in different neuronal types and pathological conditions, may provide 
novel therapies for different CNS disorders. High [Cl-]i and GABAAR-
mediated excitatory actions have been observed in different pathological 
conditions such as Autism Spectrum Disorders (ASD), seizures, spinal chord 
lesions, chronic pain, Down's syndrome, brain trauma and ischaemic stroke 
(Pizzarelli and Cherubini 2011; Ben-Ari 2014; Kaila et al., 2014). Bumetanide 
has been shown effective in many animal models and case studies for the 
treatment of these pathologies and is considered a safe compound with 
minimal side effects (Ben-Ari et al., 2016). This drug is currently under a 
phase one clinical trial for the treatment of neonatal seizures (Pilot Study of 
Bumetanide for Newborn Seizures Trial). However, another recent phase 1/2 
trial for the treatment of seizures in newborn infants with hypoxic ischaemic 
encephalopathy (NEMO trial), found that bumetanide, administered with 
phenobarbital (GABAAR agonist),  failed to improve seizure control and 
presents some side-effects (Pressler et al., 2015). However, newborn 
seizures present unique characteristics in comparison to other brain 
disorders where bumetanide still can be considered as a novel and promising 
therapeutic (Ben-Ari et al., 2016). 
 
High concentrations of bumetanide are needed to reach beneficial outcomes 
in brain pathologies, increasing undesirable side-effects such as diuresis 
(Wang et al., 2015). This is because of the non-selective action of 
bumetanide on both NKCC1 and NKCC2, which is highly expressed and 
plays an important function in the kidney (Brandt et al., 2010). Bumetanide 
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also presents poor brain penetration through the BBB (Römermann et al., 
2017) and a short half-life which together, accounts for a poor neuronal 
accumulation (Löscher et al., 2013). Therefore, novel, NKCC1-specific 
compounds with enhanced half-life and increased brain penetration are 
needed. To that end, derivatives of bumetanide are currently being 
developed (Lykke et al., 2016) which may bring some hope for the successful 
translation of the results here presented to clinical therapies. 
 
There is a great body of evidence suggesting a role for NKCC1 in the 
development of injury following stroke and its potential as a neuroprotective 
target (Yan et al., 2003; Chen et al., 2005; Begum et al., 2015; Xu et al., 
2016). Therefore, a different strategy to inhibit NKCC1 activity, other than 
direct pharmacological inhibition of this transporter, could reside in the 
modulation of its regulation.  However, the precise mechanisms that lead to 
NKCC1 activation following stroke are yet to be fully ascertained. A chloride 
sensing kinase, WNK3, is well expressed in the brain and thought to be 
responsible for NKCC1 activation (de los Heros et al., 2006). NKCC1 
activation occurs by the association and phosphorylation of WNK 3 with 
SPAK/OSR1 (Ste20/SPS1-related proline-alanine-rich protein kinase / 
oxidative stress-responsive 1), which in turn phosphorylates a cluster of 
conserved threonine residues in NKCC1 (Kahle et al., 2008). WNK3 
knockout mice as well as genetic inhibition of WNK3 or siRNA knockdown of 
SPAK/OSR1, resulted in decreased infarct volume in the MCAO model of 
stroke and increased resistance to ischaemic insults in vitro (Begum et al., 
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2015). These promising results open a novel strategy to achieve 
neuroprotection by targeting NKCC1 regulation.  
 
The failure of GABAAR agonists in the treatment of stroke (Cheng et al., 2004; 
Clarkson 2012) combined with the promising preclinical findings obtained by 
modulating the expression/activity of the CCCs, makes targeting NKCC1 and 
KCC2 very attractive candidates for the treatment of a great number of brain-
derived pathologies, and as neuroprotective targets following stroke (Martín-
Aragón Baudel et al., 2017). Special attention should be focused on 
combined therapies that potentiate both KCC2 activity/expression and 
NKCC1 downregulation/blockade in the acute phase of ischaemic stroke in 
the penumbra (Figure 5.2). 
 
As well as in the penumbra, this molecular response is observed during early 
mammalian brain development, where KCC2 levels are down-regulated and 
contribute to GABAAR–mediated depolarising response (Rivera et al., 1999). 
Neuronal excitation is responsible for growth and arborisation (Deisseroth et 
al., 2004) therefore KCC2 downregulation after hypoxia links with results 
discussed in Chapter 3. This is that neurons respond to hypoxia by promoting 
proliferative adaptations to hypoxic insults and that this response might be 
enhanced by KCC2 downregulation and NKCC1 upregulation. 
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5.5.4 Neurorehabilitation 
 
A different strategy in stroke intervention is based on promoting neuronal 
recovery in the days to months after ischaemic stroke. The classic approach 
to promote neurorehabilitation involves physical, occupational, and cognitive 
therapies (Dobkin 2004, 2008). However, drug treatments that enhance brain 
repair and plasticity post-stroke are not yet available. This strategy could 
open a different and enlarged therapeutic window as brain reorganisation in 
the peri-infarct zone has been shown to take place over weeks following the 
insult (Brown et al., 2009). 
 
Recent evidence suggests that, as opposed to during the acute phase of 
stroke, promoting excitation via glutamate receptors and suppression of 
GABAAR–mediated inhibition could promote stroke recovery in the long term 
(Clarkson et al., 2010; Clarkson et al., 2011). This functional gain relies on 
the modulation of motor learning and memory pathways (Krakauer 2006), 
which is in turn is based on increasing neuronal excitability (Clarkson and 
Carmichael 2009). Extrasynaptic GABAARs respond to ambient levels of 
GABA, which are known to be substantially increased following ischaemic 
events (Schwartz et al., 1995; Hutchinson et al., 2002) and produce long 
lasting tonic inhibition (Glykys and Mody 2007). Moreover, dampening 
GABAAR-mediated extrasynaptic tonic inhibition has been shown to enhance 
long-term functional recovery (Clarkson et al., 2010). This demonstrates that 
many of the molecular mechanisms involved in learning and memory could 
represent potential targets for neurorehabilitation following stroke. 
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Strategies that focus on promoting neurorehabilitation via GABAARs in the 
penumbra following ischaemic stroke would also benefit from careful 
consideration of GABAAR subtype-specific modulators. Tonic GABAARs in 
cortex contain either α5 or δ subunits (Glykys and Mody 2007). Reduced 
tonic inhibition through the specific modulation of α5 and δ subunit-containing 
receptors, results in enhanced cognitive performance, long term potentiation 
and neuronal excitability (Collinson et al., 2002; Atack et al., 2006; Dawson 
et al., 2006). There is a great controversy on the specificity of δ subunit-
specific modulators, the neurosteroids tetrahydrodeoxycorticosterone 
(THDOC) or gaboxadol and tracazolate as the most sensitive and specific 
agonists for the δ subunit (Zheleznova et al., 2009; Lewis et al., 2010). 
L655,708, an α5-specific antagonist, has been shown to reduce infarct size 
and improve motor recovery, in the long-term, when chronically administered 
starting three days post-stroke (Clarkson et al., 2010). However, when 
administered immediately following stroke, infarct size was increased, 
emphasising the importance of timing during the neuroprotective and 
subsequent neurorehabilitation phases of stroke (Figure 5.2). The lack of 
consideration of subtype-specific GABAAR modulators, combined with ill-
timed administration might also explain the failure of compounds that broadly 
act on synaptic GABAARs in stroke research. 
 
Cation chloride cotransporters, mediators of the GABAergic response, could 
therefore present a beneficial target in promoting neuronal recovery in the 
long-term following stroke (Figure 5.2, Martín-Aragón Baudel et al., 2017). 
This action would be opposed to the one discussed in this chapter which was 
242 
 
based on promoting neuroprotection and it would rely on decreasing 
GABAAR-mediated tonic inhibition. NKCC1 potentiators and KCC2 
antagonists would therefore increase neuronal [Cl-]i and facilitate GABAAR 
hyperpolarisation promoting functional recovery after stroke (Figure 5.1). 
 
A specific KCC2 antagonist, VU0463271, has been developed by Delpire and 
colleagues (2012) and used to induce epileptiform discharges (Sivakumaran 
et al., 2015). It has also been used to demonstrate the critical role of KCC2 
in regulating seizure event duration (Kelley et al., 2016). Therefore, this 
compound could restore impaired neuronal inhibition in the recovery phase 
following stroke. Increasing the activity of NKCC1 or upregulating its 
expression could, in turn, represent an alternative strategy to promote 
neurorehabilitation (Figure 5.2). Although specific NKCC1 agonists are not 
available yet, different strategies have been shown to potentiate its activation 
through the stimulation of the WNK3/SPAK/OSR1 system (Gagnon and 
Delpire 2010; Kahle et al., 2010; Nugent et al., 2012). These strategies could 
potentially participate in potentiating neuronal recovery. Therefore, future 
effort should be directed in finding novel and more specific CCCs modulators. 
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5.6 Summary 
 
In this chapter, the expression of the (N)KCC family of proteins in the 
neuronal-like cells PC12 and NT2 following hypoxia and following PTS in 
mice was characterised. Downregulation of the chloride exporters (KCCs) 
was observed in both in vitro and in vivo models whereas the chloride 
importer NKCC1 was upregulated. This reversal in expression of chloride 
transporters has been previously shown to affect GABAergic polarity and 
augment penumbral excitotoxicity. Following treatment with bumetanide, an 
NKCC1 antagonist, neuronal loss was reduced in the penumbra. These 
results highlight the potential of CCCs as neuroprotective targets and 
encourage further research to discover novel CCCs modulators that could 
reduce the burden associated with neuronal loss following stroke. 
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6. General discussion and future directions 
 
6.1 Summary of findings 
 
The main findings of this investigation can be summarised as follows: 
 
1. HIF-2α is the predominant driver of adaptation to acute hypoxia in vitro in 
neuronal-like PC12 and NT2 cells. Interestingly, these adaptations promote 
a regression to undifferentiated states. Preferential activation of HIF-2α 
dependant adaptation could therefore promote neuronal recovery and 
potentially reduce damage associated with ischaemic insult. Therapeutic 
manipulation of endogenous pathways driving neuronal adaptation to 
hypoxic stress could represent exciting possibilities to promote neurogenesis 
in the penumbra and enhance recovery following ischaemic stroke. 
 
2. For the first time, the penumbra following PTS in mouse brain has been 
fully analysed and the extent quantified over time using molecular markers. 
The peri-infarct zone following PTS can be anatomically and molecularly 
subdivided into the penumbra, located 200 μm from the infarct, and IGE zone 
in the area between 200 and 400 μm from the ischaemic core. The precise 
characterisation of the penumbra in the PTS model is highly significant, as it 
allows the study of molecular mechanisms of damage intrinsic to the 
heterogeneous penumbra. Furthermore, a continuing neuronal loss was 
observed up to five days following PTS, showing that the penumbra is 
progressively deteriorating. Therefore, this model provides a platform to 
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study the potential development of novel therapies targeted at rescuing this 
tissue from infarction.  
 
3. A significant reversal in expression of the CCCs was observed after acute 
hypoxia in vitro and in the penumbra in mice following PTS in vivo. A striking 
upregulation of NKCC1 expression was observed in the penumbra, alongside 
a concurrent reduction of KCC2 expression in vivo. The combined activity of 
NKCC1 and KCC2 regulates neuronal chloride trafficking and subsequently 
GABAAR polarity. The clear reversal in expression indicates a potential 
mechanism by which GABA-mediated depolarisation can contribute to 
excitotoxicity in the penumbra following stroke and accounts for the relative 
failure of GABAA-R targeting therapies in the treatment of ischaemic stroke. 
 
4. Modulating NKCC1 activity with the antagonist bumetanide significantly 
increases neuronal survival up to five days following PTS. Bumetanide was 
administered at 1 and 24 hours following the insult. Neuronal recovery was 
evident in the long-term (up to five days), providing potential for a novel 
therapeutic strategy with an increased secondary therapeutic window and an 
unexplored neuroprotective target compared to current strategies. 
 
Overall, the findings of this investigation provide two different platforms on 
which to study ischaemic stroke and two different and novel strategies to 
potentially reduce the personal, social and economic burden that stroke 
causes. However, these findings open a door for further investigation into the 
precise mechanisms by which HIF-2α–mediated adaptation to hypoxia could 
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be directed into a therapeutic strategy and how CCC-mediated 
neuroprotection and rehabilitation could be translated for use in human 
patients.  
 
6.2 Neuronal dedifferentiation as an adaptation to hypoxia to 
promote neuronal recovery 
 
Many molecular similarities can be observed between neurodevelopment 
and CNS tissue repair. In different neuropathologies, such as stroke, 
amyotrophic lateral sclerosis, Huntington’s disease or Alzheimer’s disease, 
evidence shows that the reversal of molecular events, which promote survival 
in mature neurons, are seen during neurodegeneration (reviewed by Kole et 
al., 2013). In the peri-infarct cortex surrounding the ischaemic core, neurons 
lose their perineuronal net, which are specialized extracellular matrix 
structures responsible for synaptic stabilisation in the adult brain and its loss 
promotes synaptic plasticity (Wang and Fawcett 2012; Yang et al., 2015). 
Furthermore, neurons within the peri-infarct area show modified intracortical 
inhibition (Clarkson et al., 2010), and become growth-factor dependent (Sist 
et al., 2014). These characteristics are mirrored in neurodevelopment, where 
neuronal plasticity is essential for the correct formation of new connections 
(Egorov and Draguhn 2013; Carmichael 2016).  
 
The findings of this investigation have revealed two different adaptations to 
hypoxia that also share similarities to neurodevelopment. First, the in vitro 
findings on HIF-2α-mediated regression to dedifferentiated states, and 
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second, in vivo and in vitro findings of a reversal in the expression of CCCs 
that could be responsible for a GABAAR-mediated change in polarity and 
excitability in neurons of the penumbra.  
 
Hypoxia has previously been shown to downregulate neuronal markers (Jögi 
et al., 2002) and participate in brain development and neurogenesis (Simon 
and Keith 2008). In particular, HIF-2α is expressed during murine 
development, participating in sympathetic nervous system formation (Nilsson 
et al., 2005). HIF-2α signalling in neuroblastoma cells promotes the 
maintenance of an immature, neural crest-like phenotype (Pietras et al., 
2009). Expression of neural crest genes is increased by hypoxia, and may 
drive towards a more immature phenotype in neuroblastoma cells (Jögi et al., 
2002). HIF-2α regulates several genes involved in proliferation and 
regeneration, including the OCT4 transcription factor which maintains stem-
like characteristics (Nichols et al., 1998) and neural stem cell pluripotency 
(Forristal et al., 2010; Kim et al., 2009). Therefore, the results of this work 
further support previous literature and indicate that neurons try to adapt to 
hypoxic insults by dedifferentiating into more immature phenotypes and that 
this response is suggested to be HIF-2α-driven.  
 
Significant alteration in CCC expression after acute hypoxia in vitro and 
following PTS in mice in vivo, also points towards an immature-like neuronal 
phenotype as a protective adaptation to hypoxia. However, in the short-term, 
CCC-mediated reversal of GABAAR polarity towards an excitatory response, 
might be detrimental for neuroprotection. This response would be beneficial 
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in the long-term following a stroke to promote neurorehabilitation (Clarkson 
et al., 2010), however, in the short term, it might contribute to the 
excitotoxicity-mediated recruitment of the penumbra into the infarcted core, 
and thus, accelerate neuronal loss (Szydlowska and Tymianski 2010; 
Steffensen et al., 2015). This hypothesis is strengthened by the results on 
NKCC1 blockage with bumetanide that led to increased neuronal survival in 
the penumbra following PTS.  
 
It is therefore conceivable that these two molecular adaptations induced by 
hypoxia might share some common regulatory modulation. However, 
although some molecular manipulations aimed at promoting immature 
phenotypes and neuronal proliferation, might be beneficial, it could also lead 
to deleterious events.  
 
 
 
6.3 A potential link between HIF and the CCCs  
 
 
It was interesting to consider that there may be a link between the HIF 
response and CCC expression/activity after ischaemia. There is a paucity of 
evidence in the literature of a direct link between the HIF-response in the 
regulation of the CCCs. To date, only one study in epithelial cells has 
provided direct evidence of the CCCs being regulated by HIF-1α, where 
microarray analysis identified NKCC1 mRNA repression by hypoxia and 
further experiments identified a HIF-1α binding site in the NKCC1 5′-UTR, 
confirming HIF-1α-mediated repression of NKCC1 in vivo  (Ibla et al., 2006). 
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However, the mechanism by which HIF-1α might induce NKCC1 repression 
has not yet been elucidated. Although this investigation was conducted in 
epithelial cells, it provides an insight into potential regulatory mechanisms of 
NKCC1 facilitated by the HIF response in neurons. The findings in Chapter 
3, revealed a preferential HIF-2α-mediated response to acute hypoxia in 
neuronal-like cells that could potentially explain the lack of significant 
changes in NKCC1 mRNA abundance in Chapter 5. However, HIF-1α 
expression has been identified in the penumbra as a driver of a wide range 
of cellular adaptations to hypoxia (Shi 2009), and therefore the striking 
increase in NKCC1expression in the penumbra following PTS in mice 
remains controversial. This suggests that HIF-1α-mediated repression might 
be tissue specific and therefore not repress NKCC1 expression in neurons. 
In agreement with this hypothesis, Lu et al. (2015) recently revealed a 
correlation between HIF-1α and NKCC1 expression following traumatic brain 
injury (TBI) and propose HIF-1α as a key player in neuronal NKCC1 
upregulation after TBI-induced severe brain oedema. 
 
Although a direct link between the HIF response and reversed CCC 
expression is yet to be confirmed, some indirect evidence suggests shared 
regulatory mechanisms between these two events. Repressor Element-1 
Silencing Transcription factor (REST), is a transcriptional repressor that has 
been demonstrated to regulate over 200 genes and is involved in mediating 
cellular adaptation to hypoxia (Cavadas et al., 2017). REST is widely 
expressed during embryogenesis in the brain, expression decreases during 
maturation, conferring neurons with a mature phenotype (Ooi and Wood 
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2007). Interestingly, it is also well expressed following ischaemia in neurons 
(Calderone et al., 2003), giving further credence to the notion of cells 
transiently reverting back to an immature phenotype. KCC2 (Yeo et al., 2009) 
and HIF-1α, but not HIF-2α (Cavadas et al., 2015) are amongst the genes 
regulated by REST, which represses their expression. REST promotes HIF-
1α downregulation in response to prolonged hypoxia, which prevents the 
deleterious consequences that prolonged activation of the HIF pathway can 
cause (Cavadas et al., 2015). Following ischaemic stroke, there is a 
prolonged situation of hypoxia in the penumbra (Spratt et al., 2011) and 
therefore, it is conceivable that, as it has been shown following global 
ischaemia (Calderone et al., 2003), REST could be activated in this 
therapeutically critical zone. Consequently, REST could potentially be 
responsible for the observed KCC2 downregulation in the penumbra, which 
as shown in this investigation together with an increase in NKCC1 
expression, has deleterious consequences for neuronal survival. Therefore, 
it would be interesting to further investigate the role of REST following stroke 
in regulating KCC2 expression and its potential as neuroprotective target or 
as a promoter of neurorehabilitation. 
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6.4 Impact, clinical relevance and future directions 
 
6.4.1 Dedifferentiation and proliferation  
 
 
In Chapter 3, preferential HIF-2-mediated adaptation in PC12 and NT2 cells 
following acute hypoxia was demonstrated. Furthermore, the adaptations 
mediated by this transcription factor were suggested to regulate 
dedifferentiation and regression to immature phenotypes. However, to ratify 
these findings and reveal the potential of HIF-2-mediated responses as a 
neuroprotective/neurorehabilitative strategy, further investigation would be 
required.  
 
Additional markers of dedifferentiation and immature neuronal phenotypes 
such as expression of the pluripotency factors Oct4, Sox2, and Nanog (Boyer 
et al., 2005) could be used. These transcription factors are essential in 
development and characteristic of embryonic stem cells (Aoi et al., 2008). 
Furthermore, to study the role of HIF-2 in regulating the process of 
dedifferentiation after ischaemia, knock-down of HIF-2 via siRNA, or 
CRISPR/Cas9-mediated knock out, would reveal its role in promoting the 
expression of markers of dedifferentiation and stem cell-ness. Fully 
differentiated PC12 and NT2 cells do not proliferate, and therefore it would 
be interesting to analyse if acute hypoxia stimulates regain of cell division. 
Simple proliferation assays such Alamar blue or tetrazolium salts in the long 
term following acute hypoxia would therefore indicate if neurons adapt to 
hypoxia by promoting proliferation. These experiments combined with HIF2-
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 genetic knockdown would ultimately indicate the potential involvement of 
HIF-2-mediated adaptations in promoting neurorehabilitation following 
stroke. 
 
In order to confirm in vitro findings, the results on HIF-2-mediated 
adaptation should be investigated in the PTS model in mouse. Analysing 
expression and nuclear localisation of the HIF family of transcription factors 
would yield useful information regarding their activity in the penumbra. 
Furthermore, the expression of immature neuronal markers such as 
doublecortin, a microtubule-associated phosphoprotein that promotes 
neurite extension and cell migration (Spampanato et al., 2012) or beta III 
tubulin, a cytoskeletal protein used to label immature neurons (Menezes and 
Luskin 1994), could be employed to see immature phenotypic changes in 
neuronal populations in the penumbra following PTS. The analysis of these 
markers would also link with results from Chapter 5, which showed an 
increase in NKCC1 expression and a decrease in KCC2 expression following 
ischaemic insults and which is a hallmark of premature neuronal phenotypes. 
 
Finally, to assess neuronal proliferation in the penumbra and potential 
restructuring following PTS, cell proliferation indicators such as 5-Bromo-2'-
deoxyuridine (BrdU) (Wen-Lei Li et al., 2008), would indicate a regenerative 
response in the post-ischaemic brain. Comparing the potential neurogenesis 
response in the penumbra after PTS with conditional knockout mice deficient 
for HIF-2 (Smeyne et al., 2015) and strategies aimed at potentiating HIF-
2-mediated adaptations such as erythropoietin production or exogenous 
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administration of erythropoietin, may reveal the benefit of these strategies in 
the long-term functional recovery from ischemic stroke. 
 
Data in Chapter 4 revealed a defined area of increased glial enrichment 
(IGE), within the penumbra lying between 200 and 400 m from the 
ischaemic core. Whilst, involvement of the immune response in the 
development of the damage following PTS was outside the scope of this 
investigation, employing GFAP immunolabelling as a hallmark of the 
penumbra revealed some interesting findings. Although a compact and 
homogeneous glial accumulation was observed in the immediate vicinity of 
the ischaemic core, conforming the glial scar, further GFAP labelling was also 
observed in independent glial cells in more remote areas from the penumbra, 
conforming what has henceforth been described in this investigation as the 
IGE zone. Therefore, it would be interesting to elucidate the origin of these 
cells and their function in the IGE zone, whether they represent locally 
activated glial cells, and if they proliferate or migrate from adjacent healthy 
tissue.  
 
 
6.4.2 Neuroprotection vs. neurorehabilitation 
 
Current neuroprotective therapies in ischaemic stroke rely solely on rapid 
reperfusion strategies. However, due to a limited therapeutic window (4.5 h), 
secondary effects and extensive exclusion criteria (Fugate and Rabinstein 
2015), less than 10% of all patients with acute ischaemic stroke receive the 
intravenous plasminogen activator alteplase in the UK (SSNAP 2016). It is 
therefore crucial to find novel therapeutic targets that could reduce neuronal 
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loss following reperfusion after an ischaemic incident and provide 
neuroprotection. The immediate effects of stroke were not the primary 
consideration in this work. The salvageable penumbra persists in mammalian 
brain days after stroke onset and continues to suffer recruitment to a core-
like state (Dohmen et al., 2008, Foley et al., 2010). In the PTS model, 
neuronal loss continued up to day five after the stroke, highlighting the 
importance of understanding the evolution of the penumbra in the longer term 
after the ischaemic insult and the presence of a longer secondary therapeutic 
window. However, timing is critical, as many of the molecular processes that 
present as attractive candidates to achieve neuroprotection are deleterious 
in the long term to promote neurorehabilitation and vice versa. Therefore, 
greater emphasis should be placed into understanding the precise timing in 
the development of damage following stroke. This study is the first to properly 
characterise the heterogeneous penumbra from a molecular point of view. 
 
The work herein focused on a potentially new and relatively unexplored 
therapeutic window aimed at achieving neuroprotection in the subacute 
phase of stroke. Physiological imaging in human studies have found that 
viable tissue within the penumbra at risk of infarction can be found up to 48 
hours following stroke onset (Leigh et al., 2017, Schlaug et al., 1999) and this 
was confirmed in the PTS model in mouse. However, an in-depth 
investigation identifying the precise timing of ionic dysregulation within the 
penumbra in the days following stroke and its precise contribution to 
excitotoxicity and peri-infarct depolarisations (PIDs) has yet to be 
ascertained. Results showed no differences at the three time points analysed 
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when considering neuronal stress (HSP70), glial reactivity (GFAP) or ionic 
dysregulation (NKCC1 and KCC2 reversal in expression). This indicates that, 
from a molecular perspective, neurons within the penumbra become quickly 
stressed and remain in this state where they are at risk of infarction, beyond 
five days following the insult. Therefore, it would be interesting to examine 
both longer (beyond five days) and shorter (below 24 hours) time points in 
order to further clarify the precise timing of the onset of penumbral risk and 
its decline over time. The data herein presents a novel potential therapeutic 
window below one and beyond five days following stroke to counteract 
excitotoxicity, but it would be particularly interesting to understand when this 
therapeutic opportunity ends. The temporal nature of the evolving penumbra 
is highly important, as a secondary therapeutic window represents a 
crossover between neuroprotection and neurorehabilitation, where potential 
neuroprotective strategies, such as counteracting neuronal excitement could 
be deleterious during the neurorehabilitation process.  
 
A great example of this dichotomy, is the reversed expression of NKCC1 and 
KCC2 in the penumbra following PTS in mice. The striking switch in 
expression strongly suggests modification of neuronal [Cl-]i that would 
subsequently affect GABAAR polarity, rendering it depolarising beyond five 
days following PTS. This reversal is present during development and other 
CNS pathologies (Rivera et al., 1999) in order to promote GABA-mediated 
neuronal proliferation, arborisation and differentiation (Ben-Ari et al., 2007); 
therefore, following ischaemic stroke, modified chloride transport might be a 
strategy aimed at promoting an transient immature phenotype that would 
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encourage neurorehabilitation (Wake et al., 2007). Although, an increased 
tonic GABAAR-mediated inhibition is observed in the long-term following an 
ischaemic event and blocking this inhibitory tone has been shown to promote 
and facilitate neuronal rehabilitation (Clarkson et al., 2010). Conversely, it 
could be speculated that modification of GABAergic tone, could augment 
excitotoxicity and thus, be detrimental for neuroprotection, as evidenced by 
many studies that have detailed the relative failure of targeting GABAA 
receptors after stroke (Cheng et al., 2004; Clarkson 2012). Data 
demonstrated that modulation of the chloride transport by antagonism of 
NKCC1 following PTS was neuroprotective and prevented neuronal loss up 
to five days after the insult.  Therefore, it would have been interesting to 
analyse the precise onset and duration of expression changes in NKCC1 and 
KCC2 reversal in a longer time-frame, where the neurorehabilitation phase 
of stroke begins. It would also be useful to determine more precisely the 
cycling of CCCs at the cell membranes, as just expression may not fully 
demonstrate the particular role of these transporters. Especially as KCC2 has 
been shown to rapidly cycle to and from the cell surface (Kahle et al., 2013). 
Furthermore, using NKCC1 agonists and KCC2 antagonists (separately and 
in combination) in a long-term study, would provide an opportunity to analyse 
the potential of CCC modulators in of promotion neurorehabilitation in the 
penumbra following ischaemic stroke. A long-term study was outwith the 
parameters of the current study.  
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6.4.3 Translating findings into mechanistic and functional studies  
 
Modulating NKCC1 activity with bumetanide has proven to be a successful 
strategy to reduce neuronal loss in the penumbra in the first five days 
following PTS in mice (Chapter 5). Future work should aim at discerning the 
precise mechanism behind this protection. An obvious future direction would 
be to confirm if changes in the expression of CCCs translate into changes in 
neuronal [Cl-]i. As the electroneutrality of CCC transport does not easily allow 
direct measurement of their activity, indirect measurement methods of 
chloride movement have been developed (Ludwig et al., 2017). Genetically 
engineered chloride sensors such as Clomeleon, encode fluorophores 
sensitive to [Cl-]i  and allow visualisation of chloride movement in and out of 
cells elicited by activation of CCCs and GABAAR (Kuner and Augustine 
2000). Clomeleon vectors could be transfected into cell lines such as PC12 
or NT2 (Friedel et al., 2013) and transgenic mice expressing Clomeleon are 
available (Berglund et al., 2006). Using such transfected cells exposured to 
in vitro hypoxic insults (Chapter 3) or organotypic brain slice cultures 
submitted to oxygen and glucose deprivation (Pond 2006) would 
demonstrate if the reversal in expression observed in this study following 
acute hypoxia and PTS corresponds to a change in neuronal [Cl-]i. 
Furthermore, electrophysiological measurements would further detail if 
changes in [Cl-]i affect GABAAR-mediated post-synaptic activity. These 
experiments would discern whether treatment with CCC modulators can 
effectively modify [Cl-]i and alter GABAAR polarity as a strategy to counteract 
excitotoxicity and promote neuroprotection in the salvageable penumbra in 
the days following ischaemic stroke.  
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Abstract
Stroke causes severe neuronal damage as disrupted cerebral blood flow starves neurons of
oxygen and glucose. The hypoxia inducible factors (HIF-1α and HIF-2α) orchestrate oxygen
homeostasis and regulate specific aspects of hypoxic adaptation. Here we show the impor-
tance of HIF-2α dependant signalling in neuronal adaptation to hypoxic insult. PC12 and
NT2 cells were differentiated into neuronal-like cells using NGF and retinoic acid, and
exposed to acute hypoxia (1% O2). Gene and protein expression was analysed by qPCR
and immunoblotting and the neuronal-like phenotype was examined. PC12 and NT2 differ-
entiation promoted neurite extension and expression of neuronal markers, NSE and KCC2.
Induction of HIF-1αmRNA or protein was not detected in hypoxic neuronal-like cells, how-
ever marked induction of HIF-2αmRNA and protein expression was observed. Induction of
HIF-1α target genes was also not detected in response to acute hypoxia, however signifi-
cant induction of HIF-2α transcriptional targets was clearly evident. Furthermore, hypoxic
insult dramatically reduced both neurite number and length, and attenuated expression of
neuronal markers, NSE and KCC2. This correlated with an increase in expression of the
neural progenitor and stem cell-like markers, CD44 and vimentin, suggesting HIF-2αmolec-
ular mechanisms could potentially promote regression of neuronal-like cells to a stem-like
state and trigger neuronal recovery following ischaemic insult. Our findings suggest the HIF-
2α pathway predominates over HIF-1α signalling in neuronal-like cells following acute
hypoxia.
Introduction
Blockage of cerebral arteries starves neurons of oxygen and glucose, triggering a cascade of
events leading to irreversible cell death [1]. The tissue surrounding the blockage is partially
perfused, therefore neurons here are vulnerable, yet salvageable, and must adapt to survive, to
prevent further loss of neuronal tissue [2].
The hypoxia inducible factors (HIFs) are master regulators of oxygen homeostasis and criti-
cal for adaptation to hypoxic insult [3]. The HIF alpha subunit exist as three isoforms; HIF-1α,
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-2α and -3α. HIF-1α and 2α are structurally similar and share common transcriptional targets,
including Slc2A1 and VEGF [4,5]. HIF-1α and -2α also regulate distinct subsets of genes and
elicit different cellular fates. HIF-1α regulates Pdk and LdhA expression to maintain metabo-
lism, and can activate Bnip3 to trigger apoptosis, whilst HIF-2α promotes angiogenesis, cell
division and tissue regeneration by regulating the expression of EPO, Cyclin D1 and the stem
cell marker, Oct4, respectively [4,6]. By contrast, HIF-3α exists in several alternatively spliced
forms and may negatively regulate HIF-1α and -2α [7–9].
There has been considerable interest in the importance of HIF regulated pathways in the
pathogenesis of stroke yet their role in stroke pathophysiology, particularly HIF-1α, is contro-
versial. Targeted knockout of neuronal HIF-1α increased ischaemic damage, infarct volume
and mortality following transient cerebral artery occlusion [10], whilst indirect induction of
HIF, via genetic ablation of Phd2, reduced infarct size and improved sensorimotor function
following transient ischaemia [11], suggesting HIF-1α mediated adaptation may be neuropro-
tective. However, neuronal-specific knockdown of HIF-1α and HIF-2α expression was shown
to decrease infarct size and improve neuronal survival in the early acute stages of middle cere-
bral artery occlusion [12], suggesting HIF signalling could contribute to stroke-associated
damage.
HIF-1α and -2α display temporal differences in signalling[6]; HIF-1α appears to be involved
in adaptation to acute hypoxia whilst HIF-2α mediates adaptation to chronic hypoxic stress
[13]. The timescale of HIF signalling may therefore be critical for effective recovery from
stroke. Indeed, whilst ablation of neuronal HIF-1α and HIF-2α is reported to be beneficial in
the hours following stroke, loss of HIF-1α and -2α correlated with increased apoptosis and
reduced sensorimotor function in later stages [12]. This may be due to the importance of
angiogenesis in stroke-associated neurogenesis [14,15] and HIF’s key role in tuning VEGF sig-
nalling and angiogenesis [5,16]. These studies highlight the intricacies of HIF signalling, and
their potential importance in neuroprotection and recovery from stroke damage.
Adaptation is central to neuronal recovery and stroke repair, however therapies promoting
neuronal repair and regeneration are currently lacking. Fully understanding the adaptive
mechanisms triggered in response to stroke is essential to develop novel therapeutics to
enhance neuronal repair and regeneration, and limit the damage and disability associated with
stroke [17].
In this study, neuronal cell lines were used as a model to study the molecular changes occur-
ring in response to acute hypoxic stress. We observed preferential activation of HIF-2α depen-
dant adaptive mechanisms in neuronal-like cells in response to acute hypoxia and an absence
of HIF-1α dependant signalling. We also observed increased expression of neural progenitor
stem cell-like markers, thought to be transcriptionally regulated by HIF-2α. Together, these
findings underscore the importance of HIF-2α signalling in neuronal adaptation following
acute hypoxic stress and highlight the potential for neuronal repair and regeneration.
Experimental procedures
Cell culture
PC12, NT2 and MCF7 cell lines were obtained from the American Type Culture Collection
(ATCC). NT2 and MCF7 cells were maintained in Dulbecco’s Modified Eagle’s Media
(DMEM, Gibco) supplemented with 10% (v/v) heat-inactivated foetal bovine serum (FBS,
Sigma) and 1% (v/v) penicillin-streptomycin (Sigma). PC12 culture media was also supple-
mented with 5% (v/v) heat-inactivated horse serum (Sigma). Cells were grown at 37˚C in 5%
(v/v) CO2 atmosphere under high humidity.
HIF-2α signalling in hypoxic neuronal-like cells
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PC12 and NT2 differentiation
PC12 cells were cultured on poly-L-lysine (0.1 mg/mL, Sigma) coated 6-well plates at a density
of 2x106 cells/well. After 24 hours, media was replaced with differentiation media (200 nM
nerve growth factor (NGF; Sigma, Cat no: N0513), 1% (v/v) horse serum (Sigma) and 1% (v/v)
penicillin-streptomycin in DMEM), and replenished every 2–3 days. NT2 cells were differenti-
ated into a neuronal population by the method by Pleasure et al., (1992)[18]. Briefly, cells were
seeded at 1 x106 in a T75 flask and grown in complete culture media containing all-trans-reti-
noic acid (ATRA, Sigma, 10 μM); media was replaced twice per week. After 4 weeks of ATRA
treatment, NT2 cells were sub-cultured and grown for a further 2 weeks in media containing
cytosine arabinoside (1 μM) and fluorodeoxyuridine (10 μM); media was replenished every
3–4 days. Cell morphology was analysed via bright field microscopy and images were captured
using an inverted microscope and camera (Zeiss, Primovert and Axiocam) at 20x
magnification.
AlamarBlue. Cells were seeded at 105 cells/well in a 96-well plate. After 24 hours, media
was removed and 100 μL fresh media was added per well. AlamarBlue (ThermoFisher) was
added to a final concentration of 10% (v/v). Negative controls contained media only without
cells. Absorbance was measured at 550 nm and 600 nm using a plate reader (Elisa Reader LT-
5000MS, LabTech International Ltd., Uckfield, UK) and data analysed using Manta software.
Normoxic cells were taken to represent 100% mitochondrial activity and results were
expressed as a percentage of mitochondrial activity compared to normoxic conditions.
Trypan blue staining. Cell number was determined using a Neubauer bright line haemo-
cytometer and trypan blue (Sigma) staining. Following trypsinisation, cells were resuspended
in complete media and diluted 1:1 (v/v) with trypan blue. The number of viable and non-viable
cells were counted using a haemocytometer and the average viable:non-viable ratio was
recorded as the total viable cells/mL. The percentage of viable cells (%) was calculated as: [1.00
–(number of trypan blue positive cells/number of total cells)] × 100.
Experimental hypoxia
Acute hypoxia was induced in PC12 and NT2 cells following differentiation. MCF7 cells were
seeded 24 hours prior to the induction of hypoxia at a density of 2 x106 cells/well in a 6 well
dish. Cells were placed in a modular hypoxic chamber (Billups-Rothenberg, Inc.) and hypoxia
was induced following the method by Wu and Yotnda (2011)[19]. Briefly, the chamber was
sealed and flushed with 1% O2 gas mixture at a flow rate of 20 L/minute for 10 minutes then
incubated at 37˚C in a 5% CO2 incubator. After 1 hour, the chamber was purged again with
1% O2 gas mixture at 20 L/minute for a further 10 minutes then incubated at 37˚C in a 5%
CO2 incubator for the remainder of the experimental exposure. The pH of the media remained
stable using these hypoxic conditions.
RNA extraction and analysis
Cells were harvested on ice by scraping into ice cold PBS and collected by centrifugation at
4˚C at 3000 rpm in a benchtop centrifuge. RNA was extracted using Tri reagent (Ambion) at a
ratio of 1 mL per 1x106 cells following the manufacturer’s instructions. RNA concentrations
were determined using a NanoDrop spectrophotometer (ThermoFisher Scientific). RNA
purity and integrity was assessed by Bioanalyzer (Agilent) and only samples with an RNA
integrity number (RIN) >7 were used for downstream analysis. cDNA was synthesised using
the nanoScript 2 Reverse Transcription premix kit (Primer Design) according to the manufac-
turer’s instructions using a thermal cycler (Applied Biosystems Light Cycler 480).
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Quantitative real-time PCR (qPCR)
Oligonucleotides were obtained from MWG Eurofins (UK) and are listed in Table 1. qPCR
reactions (20 μL) containing 300 nM oligonucleotides, 1X PrimerDesign Precision qPCR Mas-
termix, and 25 ng of cDNA in RNAse/DNAse free DEPC-H2O. Controls included reactions
containing cDNA from a reaction without reverse transcriptase (negative control) and cDNA
replaced with nuclease-free water (template negative). Reactions were performed in triplicate
using a StepOne™ Real Time PCR system (Applied Biosystems) under standard conditions and
analysed using StepOne™ Software, V2.2. Stable reference genes were identified via Genorm
analysis (PrimerDesign, UK) from a panel of 12 human or rat reference genes. Gene stability
was calculated with qbase+ software (Biogazelle). Expression of target genes were analysed rel-
ative to topoisomerase (TOP1) in PC12 cells and beta actin (ACTB) in NT2 and MCF7 cells
and quantified using the 2–[delta][delta]Ct method [20].
Immunostaining
Cells were lysed in NP-40 lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 5mM EDTA, 1% NP-
40) containing 1X Halt™ protease inhibitor cocktail (ThermoFisher) for 30 minutes on ice and
clarified by centrifugation at 4˚C at 13000 rpm for 5 minutes. Protein concentrations were esti-
mated by bicinchoninic acid assay (BCA) analysis[25] and samples were prepared in reducing
Laemmli buffer (Sigma) and boiled before use. Twenty micrograms of cell lysate was resolved
via 8, 10 or 12% SDS-polyacrylamide gel, transferred to 0.45 μm nitrocellulose membrane
(Millipore) and blocked with 5% (w/v) non-fat milk (Marvel) in TBS-tween (0.1% v/v) for 1
hour. Protein expression was analysed via immunoblotting using anti-NSE (AbCam,
#AB16808), anti-KCC2 (Merck Millipore, #07–432), anti-actin (Santa Cruz, #SC-1615), anti-
HIF1α (BD Sciences, #610958; Abcam, #ab1), anti-HIF-2α (1:500, R&D Systems, #AF2886),
anti-HIF-3α (Acris antibodies, #AP20606PU-N), anti-CD44 (CST, #5640) or anti-Vimentin
Table 1. The forward (F) and reverse (R) oligonucleotides used in this study.
Target
gene
Sequence 5’-3’ Species specificity
CA9 F:AGGGTGTCATCTGGACTGTG, R:TGTGTGGCTCGGAAGTTCAG Human/Rat
Caspr1 F:TGACTCTGAACTTGGAGGGTCGTG, R:TATAGCGCATCCATGTGCCAGTCT Human/Rat
CD44 F:GGATCAGGCATTGATGATGATGA, R:TTGGGTTCCACTGGGTCC Human/Rat
CHOP F: AGCTGGAAGCCTGGTATGAGG, R: GTGCTTGTGACCTCTGCTGG Human/Rat
Grp78 F:TATGGTGCTGCTGTCCAGG, R:CTGAGACTTCTTGGTAGGCAC Human/Rat
HIF-1α F:GTACCCTAACTAGCCGAGGAAGAA, R:GTGAATGTGGCCTGTGCAGT, F:GCATCTCCACCTTCTACCC, R:
CTCTTTCCTGCTCTGTCTG,
Human [21], Rat
[22]
HIF-2α F:ACCTGGAAGGTCTTGCACTGC, R:TCACACATGATGATGAGGCAGG Human/Rat
HIF-3α F:AGGATTGCAGAAGTGGCTGG, R:ATACTGCCCTGTTACTGCCTG Human/Rat
NEFH F:AGGAGTGGTTCCGAGTGAG, R:GGAGATAACTGAGTACCGGC Human/Rat
Nrn1 F:GCATCTGGTGAATAATCGCTCACG, R:ACTGAAGGAGGCGACGACAATAGC Human/Rat
PDI F:TGCCCAAGAGTGTGTCTGAC, R:CTGGTTGTCGGTGTGGTC Human/Rat
Ptbp2 F:TTTGTCCGGTTCGGCAATGG, R:GGACTACTGAGAACACTGCCTG Human/Rat
SLC2A1 F:GCTGTGCTTATGGGCTTCTC, R:CACATACATGGGCACAAAGC, F:CCTTGCCTGAGACCAGTTGAA, R:
ACAGCAGGGCAGGAGTGTC
Human, Rat [23]
SLC2A3 F:CAATGCTCCTGAGAAGATCATAAAGG, R:GAATTGCGCCTGCCAAAG, F:CGCCTGATTATTGGCATCTT, R:
TCCAAACCAAAGACCTGAGC
Human, Rat [24]
Tmod1 F:GCTCTTGCTGAAATGCTGAA, R:AAGGCTGGCTCTGGTTGTC Human/Rat
Vimentin F:AGATTCAGGAACAGCATGTCC, R:AGCCTCAGAGAGGTCAGC Human/Rat
https://doi.org/10.1371/journal.pone.0185664.t001
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(BD Sciences, #550513) at a dilution of 1:1000 in 3% non-fat milk in 1x TBS-tween (0.1% v/v).
Anti-goat 680LT (LI-COR, #925–68024), anti-rabbit 680LT (LI-COR, #925–68021) and anti-
rabbit 800 CW (LI-COR, #925–32280) IRDye conjugated secondary antibodies, were used at a
dilution of 1:10000 in 5% (w/v) non-fat milk in 1x TBS-tween (0.1% v/v) containing 0.01%
SDS. Membranes were imaged using a LI-COR Odyssey imaging system (LI-COR, Cambridge,
UK) and analysed using Image Studio v2.0.
Statistical analysis
All analyses were conducted using GraphPad Prism v7.0 (GraphPad Software Inc). Results are
shown as the mean ± SEM, where n = 3. For single comparisons, significance was determined
using unpaired Student’s t-test; for multiple comparisons relative to untreated values, signifi-
cance was determined using ANOVA with Dunnett’s correction; p<0.05; p0.01;
p0.001.
Results
Characterising the in vitro changes associated with the neuronal-like
phenotype
PC12 cells were treated with 200 nM NGF and differentiation into neuronal-like cells was
assessed morphologically. NGF treatment of PC12 cells rapidly initiated signs of differentia-
tion. Untreated cells presented with round cell bodies, however after 3 days NGF treatment,
PC12 cells developed neurite-like projections (Fig 1A). After 8 days, PC12 cells displayed a typ-
ical neuronal-like morphology with long projections and interlaced axon-like structures (Fig
1A, white arrow).
The relative expression of neuronal markers during PC12 cell differentiation was assessed
by qPCR. Neuritin 1 (Nrn1) and tropomodulin 1 (Tmod1) expression was significantly
increased (p = 0.004 and p<0.001 compared to untreated cultures) in PC12 cells after 8 days of
NGF treatment (Fig 1B). By contrast, contactin associated protein 1 (Caspr1) expression was
downregulated (p = 0.4331) by NGF treatment (Fig 1B). As Nrn1, and Tmod1 are characteristi-
cally expressed in neurons[26,27], their upregulation supports the morphological neuronal-
like changes in PC12 cells (Fig 1A).
Human NT2 cells differentiate into neuronal-like cells following all-trans-retinoic acid
(ATRA) treatment[28]. NT2 cells started to produce axonal-like structures one week after
ATRA treatment (data not shown), and these structures became thicker and longer after
extended culture in ATRA (Fig 1C). NT2 cells also displayed longer projections and a typical
neuronal morphology; ganglion-like clusters (Fig 1C, central panel, black arrow) and inter-
laced axon-like structures (Fig 1C, right panel, white arrow), as observed in primary neuronal
cultures[29]. A homogenous population of neuronal-like cells was produced by sub-culturing
NT2 in the presence of mitotic inhibitor, cytosine β-D-arabinofuranoside (C-Ara), to remove
non-differentiated cells.
Nrn1, Tmod1 and Caspr1 expression was also assessed in NT2 cells (Fig 1D). Like PC12
cells, expression of Nrn1 and Tmod1 significantly increased (p<0.001) in NT2 cells during dif-
ferentiation (Fig 1D). By contrast, Caspr1 expression was significantly downregulated
(p = 0.004) by ATRA treatment (Fig 1D). These results support the observed phenotypic
changes in NT2 (Fig 1C) and are characteristic of neuronal differentiation [30,31].
Given the current interested in the chloride co-transporters (CCC) and their potential role
in neuronal adaptation to ischaemic stroke [32], expression of neuron-specific enolase (NSE)
[33] and the neuronal specific chloride co-transporter, KCC2 [34], were analyzed by
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Fig 1. Characterising PC12 and NT2 morphology, gene and protein expression following differentiation into
neuronal-like cells. A: Representative bright-field microscopy images of PC12 cell morphology after 3 and 8 days in the
presence of NGF, (20x magnification). B: Relative Nrn1, Tmod1 and Caspr1 mRNA expression in differentiated PC12
cells was analysed by qPCR. C: Representative bright-field microscopy images of NT2 cell morphology were taken 4
weeks after treatment with all-trans-retinoic acid (ATRA 4w) and a further 2 weeks after treatment with cytosine
arabinoside (Ara-C) (ATRA 4w + 2w Ara-C); (20x magnification). D: Relative Nrn1, Tmod1 and Caspr1 mRNA expression
HIF-2α signalling in hypoxic neuronal-like cells
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immunoblotting (Fig 1E). Low basal KCC2 and NSE expression was detected in both PC12
and NT2 cells (Fig 1E) and a striking increase in expression of both markers was observed
upon differentiation, particularly KCC2. Together, these data indicate differentiation of PC12
and NT2 cells induces changes in morphological, gene and protein expression, consistent with
a neuronal-like phenotype.
Determining PC12 and NT2’s response to hypoxia
Mitochondrial activity was analysed in differentiated PC12 and NT2 cells, 2, 4, 8 and 24 hours
after hypoxia via alamarBlue to determine a suitable exposure time for hypoxia (Fig 2A).
Induction of hypoxia and the hypoxic response is well characterised in MCF7 cells [35,36], so
these were included as a positive control throughout this study to verify acute hypoxic condi-
tions were achieved. Little reduction in activity was observed 2 hours post-hypoxia, however a
dramatic reduction in activity (p<0.001) was observed after 4 hr in all cell lines (Fig 2A). PC12
and MCF7 cells showed an intense decrease in activity at 4, 8 and 24 hr (Fig 2A), whilst NT2
cells were more resistant to hypoxic insult at these time points (Fig 2A).
The effect of acute hypoxia on viability of differentiated PC12 and NT2 cells was also
assessed by their ability to exclude trypan blue dye. Eight hours of acute hypoxia significantly
decreased PC12, NT2 and MCF7 cell viability (p<0.001); using this method, NT2 cells were
more sensitive than PC12 cells to hypoxic insult (Fig 2B). Longer exposure to acute hypoxia
(24 hours) resulted in a large number of detached cells (data not shown). Therefore, eight
hours hypoxic insult was used in all subsequent experiments (unless otherwise stated) as it
maintained sufficient viable cellular material for analysis. Detached cells were removed and
only viable cells were analysed.
Increased HIF-2α stability is observed in hypoxic neuronal-like PC12 and
NT2 cells
Neuronal-like PC12 and NT2 cell adaptation to acute hypoxic stress was investigated by assess-
ing HIF-1α, HIF-2α and HIF-3α gene expression. MCF7 cells were included as a positive con-
trol to verify acute hypoxia was successfully induced. HIF-1α mRNA expression was detected
in all three cell lines, however a significant reduction in HIF-1α expression (p = 0.008) was
observed in PC12 cells following hypoxia, and only a small increase in expression (p = 0.02)
was observed in NT2 cells (Fig 3A). By contrast, and in keeping with work by others [35],
MCF7 cell displayed a dramatic 11.3-fold up-regulation of HIF-1α mRNA (p<0.001), 8 hr
after hypoxia (Fig 3A). Hypoxia triggered a significant increase (p<0.001) in HIF-2α mRNA
expression in differentiated PC12 and NT2 cells (Fig 3A, 2.4- and 2.6- fold respectively) whilst
HIF-2α expression in hypoxic MCF7 cells was significantly decreased (p<0.001). HIF-3α
mRNA showed relatively stable levels of expression in PC12 and NT2 cells and was relatively
unchanged in response to hypoxia (Fig 3A). By contrast, HIF-3α mRNA was upregulated
(p = 0.0037) in MCF7 cells by hypoxic insult (Fig 3A).
HIF-1α protein undergoes post-translational stabilisation in response to hypoxic stress [37]
(summarised in Fig 4). HIF-1α expression was analysed by immunoblotting using commer-
cially available antibodies recognising distinct HIF-1α epitopes (400–550 aa and 610–727 aa).
in differentiated NT2 cells was analysed by qPCR. E: Representative immunoblot analysis showing NSE and KCC2
protein expression in undifferentiated (U) and differentiated (D) PC12 and NT2 cells. Equal protein loading was assessed
by immunoblotting for actin. A and C: Scale bar represents 50 μm; white arrows indicate interlaced axon-like structures
and black arrows indicate ganglion-like clusters. B and D: Data is presented as the mean ± SEM; n = 3; **p0.01,
***p0.001.
https://doi.org/10.1371/journal.pone.0185664.g001
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Fig 2. The effect of hypoxia on neuronal-like PC12 and NT2 cells. A: MCF7, PC12 and NT2 mitochondrial activity was analysed
using alamarBlue 2, 4, 8 and 24 hours after exposure to hypoxia and expressed as a percentage of normoxic cell activity. B: MCF7, PC12
and NT2 cell viability was analysed via trypan blue staining 8 hours after exposure to hypoxia (8) and compared to staining of normoxic
(N) cells. Data is expressed as mean ± SEM; n = 3; ***p0.001.
https://doi.org/10.1371/journal.pone.0185664.g002
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Fig 3. Increased HIF-2α stability is observed in neuronal-like PC12 and NT2 cells following hypoxia. A:
Relative HIF1-3αmRNA expression was analysed in MCF7 and differentiated PC12 and NT2 cells exposed to 8
hours of hypoxia by qPCR. Data is expressed as mean ± SEM; n = 3; *p<0.05, **p0.01, ***p0.001. The
dotted line represents basal gene expression. B-C: Representative immunoblots of HIF-1α (B), HIF-2α (Ci), HIF-
3α (Cii) protein expression in MCF7 and differentiated PC12 and NT2 cells, 1, 2, 4, 8 or 24 hours after exposure
to hypoxia. B and C: Equal protein loading was assessed by immunoblotting for actin.
https://doi.org/10.1371/journal.pone.0185664.g003
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A variety of conditions and antibody dilutions were tested however, HIF-1α induction in
response to hypoxia was not detected in differentiated PC12 at any of the time points analysed
(Fig 3B) and only a very slight increase in HIF-1α expression was detected in differentiated
NT2 cells. By contrast, HIF-1α induction was clearly detected in MCF7 cells (Fig 3B, panel i
and ii) after 2 hours of hypoxia and reached a maximum induction after 4–8 hours (Fig 3B,
panel ii). HIF-1α induction in MCF7 verifies the validity of the experimental conditions and
antibodies used here.
Bands corresponding to HIF-2α were readily detected in PC12, NT2 and MCF7 cells and
their intensity increased after 4 hours of hypoxia (Fig 3C, panel i). HIF-3α expression was evi-
dent in both neuronal-like cell lines under normoxic conditions (Fig 3C, panel ii) however, a
differential response to hypoxia was observed between PC12 and NT2 cells. HIF-3α expression
was initially induced by hypoxia in PC12 cells yet reduced below basal expression at 8 hours
(Fig 3D). By contrast, the intensity of HIF-3α expression progressively decreased in NT2 cells
after 4 hours of hypoxia (Fig 3D). HIF-3α expression was not detected in MCF7 cells under
either normoxic or hypoxic conditions.
Fig 4. HIF mediated adaptation to hypoxic stress. A: Under physiological oxygen concentrations, HIF-1α/2α are hydroxylated by prolyl
hydroxylases (PHD), promoting HIF-1α/2α binding to the E3 ligase, von Hippel-Lindau protein (pVHL), and their ubiquitination [3]. This maintains very
low basal expression of HIF-1α/2α due to rapid proteasomal degradation. B: Under hypoxic conditions, PHD activity is inhibited [38]. This stabilises
HIF-1α/2α expression, enhancing binding to HIFβ and translocation to the nucleus and transcription of various hypoxia-responsive genes[3]. HIF-1α
and -2α share regulation of several genes, yet also regulate distinct subsets [4,6]. HIF-3α function is not yet fully understood. Abbreviations: CHOP,
CCAAT-enhancer-binding protein homologous protein; EPO, Erythropoietin; Grp, Glucose regulated protein; HIF: Hypoxia Inducible Factor; PDI,
protein disulphide isomerase; PHD, Prolyl hydroxylase; VEGF, Vascular epithelial growth factor; VHL, Von Hippel Lindau.
https://doi.org/10.1371/journal.pone.0185664.g004
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Together, these findings suggest that under the experimental conditions tested here, HIF-
1α is not stabilised in response to acute hypoxia in the neuronal-like cell models examined.
The observed induction of HIF-2α and HIF-3α mRNA and protein expression suggests neuro-
nal-like cells may activate different arms of the hypoxic adaptive machinery and HIF-2α medi-
ated signalling may predominate over HIF-1α signalling in hypoxic neuronal-like cells.
Hypoxic adaption via HIF-2α predominates in neuronal-like cells
To further analyse potential differences in hypoxic adaptation in neuronal-like cells, regulators
of HIF-1α and HIF-1α signalling were investigated. Ptbp2 (poly pyrimidine track binding pro-
tein 2), binds the internal ribosome entry site in HIF-1α’s 50-UTR, promoting efficient HIF-1α
translation and up-regulation during hypoxia [39]. Carbonic anhydrase, isoform 9 (Ca9) con-
tains a hypoxia-responsive element in its promoter [40] and is dramatically up-regulated fol-
lowing hypoxia via HIF-1α transcriptional regulation [41].
Ptbp2 and Ca9 gene expression was analysed by qPCR (Fig 5A). Increased Ptbp2 expression
was observed in hypoxic neuronal-like PC12 (p = 0.0069) and NT2 cells (p<0.001), while little
change in Ptbp2 expression was observed in hypoxic MCF7 cells (Fig 5A). By contrast, Ca9
expression remained relatively unchanged in hypoxic PC12 and NT2 cells (Fig 5A) yet was sig-
nificantly upregulated in MCF7 cells (p<0.001). This is in keeping with HIF-1α dependant
regulation of Ca9 expression [41] and the observed lack of HIF-1α induction in neuronal-like
cells (Fig 3).
Slc2A1 and Slc2A3 encode the glucose transporters, GLUT1 and 3, and their expression is
regulated by HIF-1α and HIF-2α [42]. Slc2A1 expression was significantly increased in neuro-
nal-like PC12 (p = 0.007) and NT2 cells (p = 0.004), and MCF7 cells in response to hypoxia
(Fig 5A). A small but significant increase in Slc2A3 expression was also detected in neuronal-
like PC12 (p = 0.02) and NT2 cells (p = 0.01) following hypoxia (Fig 5A) however Slc2A3
expression was not detected in MCF7 cells or induced by hypoxic insult (Fig 5A), in keeping
with GLUT3’s status as a neuronal specific glucose transporter [43].
Hypoxic neuronal-like cells are more resistant to ER stress
Hypoxic stress triggers accumulation of misfolded proteins in the endoplasmic reticulum (ER)
[44]. The unfolded protein response (UPR) serves to redress ER homeostasis by fine-tuning
protein translation and enhancing folding capacity [45]. Growing evidence suggests HIF and
UPR dependent pathways interact to coordinate gene expression, metabolism and cell survival
[46].
Expression of UPR markers, Grp78, PDI and CHOP, was measured via qPCR in neuronal-
like PC12 and NT2 cells, 8 hours after hypoxic insult (Fig 5B). Grp78 expression was
unchanged by hypoxia in PC12 and NT2 cells yet was significantly increased (p = 0.0086) in
MCF7 cells (Fig 5B). CHOP expression was also unchanged by hypoxia in NT2 cells yet was
significantly reduced in hypoxic PC12 cells (p = 0.0039) and increased in hypoxic MCF7 cells
(p = 0.0064) (Fig 5B). PDI expression was relatively unchanged in hypoxic PC12 cells but
showed a small but significant reduction (p = 0.0260) in hypoxic NT2 cells (Fig 5B). Collec-
tively, this suggests neuronal-like cells present a higher resistance to ER stress following acute
hypoxia under our experimental conditions.
Hypoxic adaption in neuronal-like cells drives expression of genes
associated with a neuronal progenitor phenotype
Whilst HIF-1α and -2α share target genes, HIF-2α regulates gene expression independently of
HIF-1α and promotes different aspects of hypoxic adaptation [6] (Fig 4). HIF-2α regulates
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expression of stem cell markers [47] and maintains the undifferentiated state, via expression of
neural crest and stem cell-associated genes [48]. Vimentin and CD44 are highly expressed in
neuronal precursor cells [49,50], however expression declines during development as neurons
become post-mitotic. In post-mitotic neurons, vimentin is replaced by neurofilaments [51].
Expression of the neuronal marker, neurofilament heavy chain (NEFH) [52] was evident in
differentiated PC12 and NT2 cells yet undetected in MCF7 cells (Fig 5C); basal expression was
also unaffected by hypoxic insult in PC12 and NT2 cells. Vimentin expression was significantly
upregulated in PC12 (p = 0.0033) and NT2 cells (p = 0.0119) following hypoxia (Fig 5C). CD44
expression was also dramatically increased in hypoxic PC12 cells (p = 0.003), whilst expression
was only modestly effected in hypoxic NT2 cells (1.6-fold increase; p = 0.43; Fig 5C). Vimentin
and CD44 expression were not significantly altered in hypoxic MCF7 cells (Fig 5C).
Fig 5. HIF-2α dependant pathways are preferentially activated in differentiated PC12 and NT2 cells following hypoxia. Relative expression of HIF-
1α related target genes (Ptbp2, CA9, SLC2A1 and SLC2A3) (A); UPR related genes (Grp78, CHOP and PDI) (B); and HIF-2α related target genes
(NEFH, Vimentin and CD44) (C), were analysed in MCF7 and differentiated PC12 and NT2 cells, 8 hours after hypoxia, using qPCR. Data is expressed as
mean ± SEM; n = 3; *p<0.05, **p0.01, ***p0.001. The dotted line represents basal gene expression. D: Representative immunoblots showing
induction of CD44 (i) and vimentin (ii) protein expression in normoxic (N) or hypoxic (4 or 8 hours hypoxia) MCF7 and differentiated NT2 cells. Equal
protein loading was assessed by immunoblotting for actin (iii).
https://doi.org/10.1371/journal.pone.0185664.g005
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CD44 and vimentin expression was also analysed by immunoblotting. CD44 and vimentin
expression were readily detected in normoxic NT2 cells and markedly induced by hypoxia (Fig
5D). CD44 expression was unchanged in hypoxic MCF7 cells (Fig 5D), however vimentin was
not detected in MCF7 cells in either normoxic or hypoxic conditions (Fig 5D). Together, these
findings show strong induction of HIF-2α regulated genes in hypoxic neuronal-like cells and
suggest the HIF-2α dependant cellular regeneration arm of the adaptive hypoxic response pre-
dominates over the HIF-1α arm in neuronal-like cells following acute hypoxia.
Hypoxia promotes a regression to undifferentiated states in neuronal-like
cells
Neuron specific markers, NSE and KCC2 were dramatically induced following neuronal dif-
ferentiation of PC12 and NT2 cells (Fig 1E). NSE and KCC2 expression was assessed by immu-
noblotting to determine whether hypoxia could reverse the expression of these neuronal
markers. The dramatic increase in NSE expression was attenuated following hypoxia in differ-
entiated PC12 cells, whereas NSE expression remained unchanged by hypoxia in differentiated
NT2 cells (Fig 6A, panel i). The striking induction of KCC2 expression observed following dif-
ferentiation was also dramatically reversed in hypoxic PC12 cells after as little as 8 hours of
hypoxic insult and severely reduced in hypoxic NT2 cells (Fig 6A, panel ii).
Differentiated PC12 and NT2 display neurite-like processes and gangliar-like structures
(Figs 1F and 6B). The neuronal-like morphology was dramatically modified in as little as 8
hours of hypoxic insult (Fig 6B); the number of differentiated PC12 and NT2 cells presenting
Fig 6. Hypoxia promotes a regression of neuronal-like cells to undifferentiated states. A: Representative immunoblots showing the change in
NSE (i) and KCC2 (ii) protein expression in normoxic (N), differentiated (D) or differentiated and hypoxic (D+H, 8 hours) PC12 and NT2 cells. Equal
protein loading was assessed by immunoblotting for actin (iii). B: Representative bright-field microscopy images of differentiated PC12 and NT2
morphology after exposure to 8 hours of normoxia or hypoxia (20x magnification). Scale bar represents 50 μm. White arrows indicate interlaced axon-
like structures and black arrows indicate ganglion-like clusters.
https://doi.org/10.1371/journal.pone.0185664.g006
HIF-2α signalling in hypoxic neuronal-like cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0185664 October 2, 2017 13 / 20
with neurites was dramatically reduced and the length of neurites was evidently shortened.
These results combined with the observed HIF-2α dependant induction of neural progenitor
cell markers (Fig 5B and 5D) suggest adaptations promoted by HIF-2α following acute hypoxic
insult could drive neuronal-like cells into a more immature phenotype.
Discussion
Stroke is the second leading cause of death and disability worldwide [53]. PC12 and NT2 cells
have been extensively used as models to study neuronal differentiation and neurological
pathologies, including stroke [54–56]. Furthermore, NT2 cells are currently undergoing phase
1 and 2 clinical trials as neuronal grafts for stroke patients [57,58]. Whilst these cells are not
primary neurons, differentiated PC12 and NT2 cells are a valid and commonly used source of
neuronal-like cells, and an excellent model to study the hypoxic molecular adaptations that
occur in vivo, following stroke.
Numerous studies have investigated the role of HIF-1α in neuronal adaptation to hypoxia
[59,60] (Fig 4). HIF-2α and HIF-3α signalling have received less attention, however, recent
work demonstrates HIF-2α is an essential component of hypoxic adaptation [6]. Likely, these
pathways are complimentary and co-ordinated signalling of both HIF-1α and HIF-2α is
required to promote survival and adaption following hypoxic insult (Fig 4). To our knowledge,
this is the first study to dissect the importance of HIF dependant adaptation and downstream
signalling in differentiated neuronal-like cells following hypoxia.
HIF-1α expression and induction following hypoxia has been reported in PC12 and NT2
cells [61,62] and neuroblastoma cells [59], therefore our observed lack of HIF-1α induction
and signalling following acute hypoxia, as well as through chemical induction of hypoxia,
using colbalt chloride (data not shown), was surprising. However, closer scrutiny reveals fun-
damental methodological differences with these studies which may account for the absence of
HIF-1α induction, such as employing undifferentiated cells [62,63], culturing cells on
uncoated plates [64], using different exposure times [65] or oxygen concentrations that confer
mild hypoxia [62]. Interestingly, we observed consistent, preferential induction of HIF-2α
over HIF-1α expression in differentiated PC12 and NT2 cells when acute hypoxia was induced,
for 8 hours, with slightly different gas mixtures (1% O2/99% N2 and 1% O2/5% CO2/99% N2,
data not shown). Our model utilises fully differentiated post-mitotic neuronal-like cells, and is
therefore potentially more representative of neuronal cell function than undifferentiated cells.
Despite the lack of HIF-1α induction in PC12 and NT2 cells, acute hypoxic conditions were
achieved. MCF7 cells were used as a positive control as they show intense HIF-1α expression
following acute hypoxia [35,36]. Hypoxia was induced simultaneously with NT2 and PC12
cells and rapid HIF-1α stabilisation and intense activation of HIF-1α signalling was observed
in control MCF7 cells, confirming acute hypoxia was established. Marked induction of Ptbp2
and Slc2A1was observed in hypoxic PC12 and NT2 cells; genes thought to be specifically regu-
lated by HIF-1α [66]. However, many HIF-1α specific genes have also been shown to be regu-
lated by HIF-2α, including Slc2A1 (GLUT-1)[67], underscoring the potential importance of
HIF-2α signalling in hypoxic adaptation of neuronal-like cells.
Surprisingly, neuronal-like PC12 and NT2 cells are refractory to HIF-1α stabilisation in
response to acute hypoxia and activation of HIF-1α signalling was absent. Instead, significant
induction of HIF-2α mRNA and stabilisation of HIF-2α and HIF-3α protein was evident in
hypoxic PC12 and NT2 cells. HIF-1α, HIF-2α expression is detected in undifferentiated neu-
roblastoma cells [59] however HIF-1α expression appears to be dominant and HIF-2α induc-
tion was only observed in certain cells under complete anoxia (0% O2). These findings suggest
the HIF-2α arm of the hypoxic adaptive response may predominate over HIF-1α dependant
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mechanisms in differentiated neuronal-like cells and underscore the need to use differentiated
neuronal in vitro models as a platform to investigate the molecular changes occurring follow-
ing ischaemic stroke.
HIF-2α regulates several genes involved in proliferation and regeneration, including the
OCT4 transcription factor which maintains stem-like characteristics [68] and neural stem cell
pluripotency [69,70]. HIF-2α signalling also maintains cells in an undifferentiated state.
Expression of neural crest genes is increased by hypoxia, and may drive a more immature phe-
notype in neuroblastoma cells [59]. Increased expression of the stem cell marker, CD44 and
early neuronal progenitor marker, vimentin, was readily observed in hypoxic neuronal-like
cells and were accompanied by loss of neuronal markers, NSE and KCC2, and neuronal mor-
phology. HIF-2α dependant hypoxic adaptation therefore may promote regression of neuro-
nal-like cells to a more undifferentiated, and thus potentially transient, proliferative, state prior
to repair. In doing so, HIF-2α signalling may have some utility in triggering neuronal repair,
recovery and regeneration following acute hypoxic insult (Fig 4). Indeed exogenous adminis-
tration of the HIF-2α target, EPO, can promote angiogenesis and neurogenesis following neo-
natal ischaemia in rats [71]. Preferentially activating the HIF-2α dependant arm of the hypoxic
adaptive response could therefore represent a novel strategy to minimise damage associated
with ischaemic stroke and promote neural repair and regeneration.
In the adult brain, neurogenesis occurs in the subventricular and hippocampal subgranular
zones and to a lesser extent, the striatum and cerebral cortex [72]. Neural stem cell prolifera-
tion is dramatically increased following stroke [51,73] and progenitor cells can migrate to sites
of infarct [74], however the vast majority of these immature neurons fail to survive, likely due
to unfavourable environmental conditions or lack of functional connections [51,75]. Transient
hypoxia can increase the number of mitotic neurons and expression of proliferative markers
in cultured embryonic rat cortical neurons [76] whilst mild hypoxia favours proliferation and
differentiation of neural spheres [77]. Together, these studies suggest sub-lethal hypoxic insult
could potentially promote self-renewal in vivo. In the heart, chronic stabilisation of HIF-1α
and HIF-2α protects against ischaemia reperfusion injury in adult mice [78] and systemic hyp-
oxia promotes cardiomyocyte proliferation [79]. This suggests hypoxic stress may also act as a
driving force for proliferation and a potential therapeutic tool in regenerative medicine.
The role of HIF in the pathophysiology of ischaemic stroke and its impact on neuronal sur-
vival remains controversial. In vivo global and focal ischaemia models provide conflicting
results as genetic manipulation of neuronal HIF-1α has been reported to be both neuroprotec-
tive and detrimental [10,80]. HIF-1α overexpression has also been associated with dendritic
overgrowth and abnormal patterning of cortical neurons [81]. Activation of HIF-1α depen-
dant signalling may therefore be potentially deleterious to neurons in ischaemic stroke. Com-
bined loss of HIF-1α and HIF-2α has been found to be detrimental for functional recovery
after ischaemic stroke but surprisingly beneficial in the early stroke phase [12]. This suggests
partial compensatory mechanism exist between the two transcription factors.
Ischaemic neuronal injury is a multifunctional process [1,2]. Spatial and temporal factors
combined with the intensity of ischaemic challenge will all impact upon HIF dependant adap-
tation and whether downstream signalling promotes neuroprotection, ischaemia induced cell
death or neuroproliferation. These areas require significantly greater research and specific
therapeutic agents targeting HIF-1α and HIF-2α are needed to delineate the intricacies of HIF
signalling and understand their therapeutic potential.
Due to the potential of small populations of neural stem cells to regenerate neuronal tissue
and drive repair and recovery of damaged regions of brain tissue, understanding the mecha-
nisms involved in promoting self-repair and how non-neurogenic areas in the brain can revert
to neural stem/progenitor cells is crucial. Our results show the HIF-2α arm of the hypoxic
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adaptive response may predominate over the HIF-1α arm in neuronal-like cells and suggest
this could promote regression to a more dedifferentiated state. Whilst caution must be taken
in extrapolating in vitro findings to an in vivo setting, it is possible that preferential activation
of HIF-2α dependant adaptations in the small population of neuronal cells surviving the tran-
sient hypoxia of a stroke could drive expression of stem-like genes and promote the dedifferen-
tiation of these cells. These dedifferentiated cells could then promote the self-renewal and
growth of neuronal cells in the hours to days following a stroke. Ultimately, this could promote
the repair of damaged neuronal tissue and reduce the long-term damage associated with
ischaemic insult. Therapeutic manipulation of endogenous pathways driving neuronal adapta-
tion to hypoxic stress could represent exciting possibilities to enhance repair and recovery of
the stroke damaged brain and promote neurogenesis, and ultimately reduce stroke-associated
disability.
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